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2. ABBREVIATIONS 
bHLH basic domain helix-loop-helix 
bp base pair 
CAS class A specific 
CAT chloramphenicol acetyltransferase 
cAMP cyclic adenosine 5'-monophosphate 
cDNA complementary deoxyribonucleic acid 
cdk cyclin dependent kinase 
CNS central nervous system 
CMV cytomegalovirus 
COUP TF chick ovalbumine upstream promoter transcription factor 
CRE cAMP response element 
C-terminal carboxyl-terminal 
dBcAMP dibutyryl cyclic-AMP 
E-box immunoglobulin enchancer core consensus sequence 
EMSA electrophoretic mobility shift assay 
E1A12S, E1A13S adenovirus oncogenes 
ER-TR estrogen-thyroid response element 
GAP43 growth-associated protein 43 
GR glucocorticoid-progesteron response element 
HLH helix-loop-helix 
HRE hormone response element 
KLH Keyhole Limpet Hemocyanin (carrier) 
LH loop-helix 
MAP2 microtubule-associated protein 2 
MEF1 muscle creatine kinase enhancer E-box 
mRNA messenger ribonucleic acid 
NF-L neurofilament light subunit 
N-terminal amino-terminal 
pRb retinoblastoma protein 
RA retinoic acid 
RAR retinoic acid receptor 
RARE retnoic acid response element 
RNP regulator of neuronal proliferation 
RXR retinoid X receptor 
TR thyroid hormone receptor 
VDR vitamin D3 receptors 
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3. INTRODUCTION 
Initiation of transcription is considered to be the most crucial step of gene ex­
pression. Selective transcription of genes generates specific patterns of regula­
tory proteins. The nodal point of cell fate determination is regulation of genes 
in Gl phase of cell cycle. Cell cycle is controlled by a certain set of genes 
which are required for cell cycle progression. Under certain circumstances a 
cell may become arrested in Gl phase, exit cell cycle (GO phase) and undergo 
terminal differentiation. Differentiation is controlled by set of genes whose role 
is to block cell proliferation and activate cell-lineage specific genes. Interplay 
of different transcription factors is a part of these regulatory processes. In addi­
tion, differentiation of cells includes a complex mechanism of signaling which 
integrates and coordinates transcriptional and posttranscriptional control of 
gene expression. Different types of transcription factors are involved in the 
control of genes which respond to internal and/or external signal(s). Several 
groups of transcription factors have been identified and classified on the bases 
of their protein structure and DNA binding properties. 
Transcription factors of helix-loop-helix (HLH) family (c-myc, E2F, MyoD, 
Id etc.) have been demonstrated to carry important function during development 
and cell differentiation. Role of E2F is well established during cell cycle pro­
gression. Also, the function of MyoD during myogenesis is described as a 
regulator of lineage specific gene expression. Several other HLH family tran­
scription factors such as ubiquitously expressed basic helix-loop-helix (bHLH) 
transcription factors have been demonstrated to regulate transcription of target 
genes as partners of tissue specific transcription factors (MyoD). However, the 
exact role of these transcription factors is still obscure. 
Nuclear hormone receptor transcription factors are required for activation of 
target genes in a hormone dependent manner. Role of the nuclear hormone re­
ceptor family transcription factors (retinoic acid receptors, retinoid X receptors, 
thyroid hormone receptors, steroid hormone receptors etc.) is relatively well-
studied during development and differentiation. Nuclear orphan receptors are a 
subclass of nuclear hormone receptor family and their ligands are unknown. 
Role of the nuclear orphan receptors in these processes is not well understood 
so far. 
Nervous system is an important part of multicellular organisms (excl. 
plants). Nerve cells are generated and system of communications between dif­
ferent parts of an organism are created, refined, and remodeled during embry­
onic development. All neurons are generated once and are not subsequently 
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replenished. Molecular mechanisms underlying neurogenesis are not well un­
derstood yet. However, neuronal determination during embryonic development 
is relatively well-studied in Drosophila. In particular, requirement of HLH tran­
scription factors encoded by genes daughterless, hairy, Enhancer of split, ex-
tramacrochatae and achate-scute as well as an orphan receptor transcription 
factor encoded by seven-up has been well established in the regulation of neu­
ronal determination of progenitor cells in Drosophila. To date, vertebrate 
homologues of these genes are identified. Based on remarkable degree of simi­
larity between several mammalian HLH genes and Drosophila proneuronal 
genes, it is likely that mammalian HLH factors are also involved in regulation 
of neuronal development. 
The main objective of the present thesis work is to characterize the role of 
HLH and nuclear orphan receptor transcription factors during neurogenesis. 
The first aim of this work is to describe expression of mouse bHLH transcrip­
tion factors MEla and ME2 during neurogenesis, to characterize DNA-binding 
and dimerization properties of these factors, and to demonstrate their ability to 
regulate transcription in neuronal cell lines. The second aim is to characterize 
HLH and orphan receptor (COUP TF I) transcription factor which block neu­
ronal differentiation of teratocarcinoma cells. The third aim is to localize basal 
promoter of the orphan receptor transcription factor COUP TF II and to char­
acterize specific effects of this promoter in response to RA and cAMP treat­
ment in different cell lines. 
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4. REVIEW OF THE LITERATURE 
4.1. CELL CYCLE AND DIFFERENTIATION 
Initial differentiation requires suppression of cell cycle progression genes. 
Negative regulators of cell cycle progression, such as retinoblastoma proteins 
(pRb, pl07, pl30), have been identified. These proteins share a specific domain 
called the pocket domain that is required for binding of other cellular proteins 
such as E2F, cyclins, MyoD and Id. Interaction between pRb family members 
and these proteins results in the timely transcription of genes encoding factors 
essential for cell cycle progression (E2F, [Cao et al, 1992]) or induction of the 
differentiated state (MyoD [Gu et al., 1993]). These complexes are cell cycle 
phase-dependent and may be critical in cell-growth regulation (Ikeda et al., 
1996; Zwicker et al, 1996). 
4.1.1. Retinoblastoma proteins regulate cell differentiation 
The retinoblastoma tumor suppressor protein (pRB) is a transcriptional re­
pressor that regulates gene expression by physically associating with transcrip­
tion factors of E2F family members. 
Transgenic animals lacking pRbl or expressing mutant pRbl gene have 
been analyzed to address the function of pRb proteins. These animals either 
died or showed a number of abnormalities in neuronal and haematopoietic de­
velopment (Jacks et al., 1992; Clarke et al, 1992). 
A variety of cyclins and cyclin dependent kinases (cdk) have been demon­
strated to be involved in the modulation of pRb function. Gl cyclins function as 
regulatory subunits of cdk which phosporylate pRb (pl07) and inactivate its 
growth-inhibitory function (Pagano et al, 1992; Hall et al, 1993; Ohtsubo et 
al, 1995). Hyperphosphorylated pRb releases active E2F which switches on 
genes required for S-phase initiation and progression. (Fig. 1). Several proteins 
are able to inhibit cdk's and suppress cell-cycle progression by maintaining 
pRb protein hypophosphorylated. These proteins have been divided into two 
groups (1) universal inhibitors such as p21 (Shiyanov et al., 1996), and (2) spe­
cific inhibitors for cyclin D-dependent kinases, like the INK proteins (Chan et 
al, 1995) (Fig. 1). 
The most extensively characterized targets of pRB are the members of E2F 
transcription factor family. 
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Figure 1. Hypothetical model of pRb, E2F and Id2 in cell proliferation and differentia­
tion ( explanations in the text). 
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4.1.2. E2F transcription factors have dual role in cell cycle regulation 
E2F family bHLH transcription factors directly regulate transcription of a di­
verse set of genes involved in DNA replication and cell growth control, in­
cluding E2F gene itself (Hsiao et al, 1994). E2F1 expression is sufficient to 
induce entry into S phase of the cell cycle. E2Fs require DPs as dimerization 
partners to activate transcription of cell cycle progression genes (Wu et al., 
1996). A number of known cell cycle regulators such as pRb, p53, cdk-2, cdk-4 
and certain cyclins appear to exert their effects by altering E2F activity. These 
regulators are commonly mutated in cancer cells and play important role in co­
ordination of cell cycle (Adams and Kaelin, 1995; Ohtsubo, et al, 1995; Xu et 
al, 1994). Interaction of pRb and E2F leads to the inhibition of E2F/DP1 het-
erodimer-mediated transactivation (Heiin et al., 1993). Also, it has been sug­
gested that pRb/E2F active complex may block transcription directly by bind­
ing to target gene promoter (Fig. 1). pRb in this complex blocks the basal tran­
scription machinery by inactivating surrounding transcription factors (Wein-
traub et al, 1995). 
Recently, mice homozygous for a nonfunctional E2F1 allele has been char­
acterized. Mice lacking E2F1 are viable and fertile, but developed a broad spec­
trum of tumors (Yamasaki et al, 1996). This unexpected result demonstrates 
that E2F1 may function as a tumor suppressor. 
Also, it has been demonstrated that the above-mentioned cell cycle factors 
are involved in the process of cell differentiation. pRb and related proteins have 
been proposed to function as a possible partners involved in the modulation of 
E2F activity during cell differentiation. In situ hybridization analysis have 
shown presence of pRB and E2F transcripts in proliferating as well as differen­
tiating cells during neuronal development of spinal cord (Zhao et al, 1995). 
E2F plays dual role during differentiation of PI9 cells: proliferating cells con­
tain free E2F and E2F complex with cycline A. In contrast, differentiated cells 
do not contain detectable amount of free E2F and contain a specific complexes 
which do not contain cyclin A (Reichel, 1992). Teratocarcinoma P19 cell dif­
ferentiation is accompanied by the changes in the cdk-activities, pRB expres­
sion and E2F DNA-binding (Kranenburg et. al, 1995). In the Gl phase of the 
proliferating cells amount of pRB proteins appears to be limited and E2F may 
form transcriptionally active complexes. As these cells exit the cell cycle, 
amount of hypophosphorylated pRb forms exceed the amount of E2F, and 
causes consequently repression of S-phase specific genes (Ikeda et al, 1996). 
These data indicate that E2Fs regulate cell cycle progression genes and are 
also involved in the regulation of cell differentiation genes. In either case dif­
ferent partners may be recruited (Fig. 1). 
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4.2. HELIX-LOOP-HELIX TRANSCRIPTION FACTORS 
Helix-loop-helix transcription factors are involved in the regulation of cell pro­
liferation and differentiation as well as in the control of various developmental 
pathways (Jan and Jan, 1993; Weintraub, 1993). HLH Transcription factors 
have been grouped into different classes depending on their expression patterns 
and structural characteristics (Fig. 2). 
4.2.1. Class A bHLH transcription factors 
4.2.1.1. Structure and expression 
Subclass A consists of the HLH transcription factors which contain basic do­
main adjacent to the helix-loop-helix motif (bHLH). These proteins contain at 
least five functional domains. 
i i i  m u  I I  I  —  I  I  ( A ,  
L Z  N L  L H  b H L H  C A S  
NH2 I ^ I COOH (B) 
b  H L H  
NH2 1 COOH (O 
H L H  
NH2 I I —=• COOH (D ) 
b H L H  L Z  
Figure 2. Schematic representation of differences between the functional domains of 
HLH proteins. (A) class A bHLH transcription factors represented after 
MEla; common and restrictive features of class B (B), Id- like (C), and class 
C (D) transcription factors. 
Highly conserved helix-loop-helix domain is responsible for protein-protein 
interaction and basic domain is the DNA-binding module of the protein (Murre 
et al, 1989a; Murre et al, 1989b; Lassar et al, 1989; Davis et al, 1990; Neu­
man et al, 1993b). Nuclear localization region (Klein et al, 1993) and an addi­
tional loop helix (LH) motif, which is involved in transcriptional activation 
(Davis et al, 1990; Henthorn et al, 1990; Quong et al, 1993), are also clearly 
defined. Class A bHLH transcription factors contain a class A specific domain 
(CAS). CAS is believed to form a loop and a helix and can assumingly mediate 
a specific interaction between class A and tissue-specific transcription factors 
(Zhang Y. et al, 1991) (Fig. 2). 
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Several factors of the subclass are described from Drosophila to mammals: 
Da encoded by Drosophila daugtherless (Caudy et al., 1988), mouse E2A (El2, 
E47) (Murre et al, 1989a), ME1( MEla, MElb) (Neuman et al., 1993a), hu­
man HEB, (Hu et al, 1992) and HTF4 (Zhang et al, 1991), rat REBß, REBa 
(Klein et al, 1993), chick CTF4 (Tsay et al, 1992) and Gl (Neuman et al, 
1993a), Akv murine leukemia virus ALFlb, ALFla (Nielsen et al, 1992), hu­
man E 2-2, ITF2 (Henthorn et al, 1990), mouse ME2 (Neuman et al, 1993a), 
and MITF2 A and B (Skerjanc et al, 1996). 
Based on the expression patterns it has been postulated that class A bHLH 
proteins are ubiquitously expressed (Murre et al, 1989a, b). All these factors 
are expressed in a nontissue-specific manner and have dynamic and partially 
overlapping expression patterns. The exact role of these proteins has been diffi­
cult to determine. To regulate transcription, bHLH proteins form homo- and 
heterodimers and bind specifically to a DNA consensus sequence CANNTG, 
known as an E-box (Ephrussi et al, 1985; Murre et al, 1989a, b). 
Functional redundancy of an individual class A transcription factor is sug­
gested. It has been shown that a double knockout of the E2A gene in mouse 
embryonic stem cells had no effect on differentiation of muscles, erythrocytes, 
neurons and cartilage (Zhuang et al, 1992). Block of expression of individual 
class A bHLH transcription factors had no detectable effect on proliferation and 
differentiation of neural tube cells. At the same time, simultaneous blocking of 
these factors in cultured neural tube cells resulted in the reduction of differenti­
ating neurons (Suda et al, 1994). 
4.2.1.2. Dimerization 
An important role of class A proteins as necessary dimerization partners for 
tissue-specific bHLH proteins during cell differentiation has been shown in va­
riety of systems. The E2A gene products heterodimerize with tissue specific 
class B (MyoD) transcription factors(chapter 4.2.2.). These active heterodimers 
turn on expression of tissue-specific genes and induce myogenesis (Davis et. al, 
1987; Pinney et al, 1988; Lassar et al, 1989; Lassar et al, 1991; Bain et al, 
1994; Zhuang et al, 1994). Recently, a splice variants of the class A transcrip­
tion factor mITF2 has been described. These proteins have been demonstrated 
to form MyoD/ mITF2 heterodimers in vitro. Alternatively spliced forms of 
mITF2 could either activate or have no influence on the MyoD regulated tran­
scription of target gene. (Skerjanc et al, 1996). The presence of different sets 
of class A proteins, which have different DNA-binding specificities, suggests 
selective interactions with different binding sites of target genes. The ratio of 
different class A bHLH proteins during differentiation is probably important for 
the right timing of cell-type specific gene expression. 
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On the other hand, formation of homodimers of class A transcription factors 
has been observed during haematopoiesis. The ratio, of two different bHLH 
transcription factors E2A/E2-2, changes and these proteins have different 
DNA-binding properties during B-cell development. The level of E2A proteins 
increases while the level of E2-2 decreases during B-cell maturation. Binding 
of E2-2 to the E-box has been detected only in pre-B cells but not in mature 
B-cells (Bain et al, 1993). E2A null-mutant mice fail to generate mature 
B-cells while other haematopoietic lineages are intact. No class B specific het-
erodimerization partners have been found from tested B cells which indicates 
that these E2A homodimers are capable specifically direct B cell differentiation 
(Bain et al, 1994; Zhuang et al, 1994). Also, variable expression pattern has 
been shown for two alternatively spliced E2A gene transcription factors El2 
and E47 in different organs and cell lines (Watada et al, 1995). 
The presence of different sets of class A proteins which have different 
DNA-binding specificities suggests selective interactions with different binding 
sites of target genes. The ratio of different class A bHLH proteins during dif­
ferentiation is probably important for the right timing of cell-type specific gene 
expression. The various spatial and temporal expression pattern of class A pro­
teins suggest the possibility that, under certain circumstances, these ho­
modimers appears to be cell-type specific and carry responsibility of cell fate 
determination during development. Thus, differently spliced forms of class A 
bHLH transcription factors as well as proteins coded by different genes may 
either dimerize with the same class B tissue-specific transcription factor or ho-
modimerize and activate or repress transcription. 
In addition, class A transcription factors form inactive complexes with Id 
family transcription factors. 
4.2.2. Class B bHLH transcription factors 
Tissue-specific bHLH proteins (Fig. 2) comprise the largest family of HLH 
transcription factors which include extensively characterized myogenic proteins 
(MyoD and myogenin) that regulate muscle differentiation (Davis et al, 1987; 
Pinney et al, 1988) Class B transcription factors have tissue and cell type spe­
cific expression pattern and they are believed to bind DNA as heterodimers 
with class A bHLH proteins (Murre et al, 1989a, b; Lassar et al, 1989; Lassar 
et al, 1991). They also form functional homodimers (Nielsen et al, 1992; 
Klein et al, 1993). 
The family consists of the following proteins identified so far: (1) Droso­
phila products of the genes achaete-scute AS-C, hairy and Enchancer of split 
(Ghysen and Dambly-Chaudiere, 1989; Campos-Ortega and Jan, 1991; Cabrera, 
1992). (2) vertebrates myogenic factor MyoD (Davis et al, 1987) (3) neural 
specific factors NeuroD (Lee et al, 1995), BETA2 and 3 (Peyton et al, 1996), 
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MASH1 and 2, (Johnson et al, 1990), XASH (Ferreiro et al., 1995), NSCL1 
and 2, (Lipkowitz et al, 1992), HES1 and 3 (Sasai et al, 1992). 
4.2.2.1. Involvement of class B bHLH transcription factors 
in regulatory processes 
To date, MyoD is described as a nodal point for activation of several down­
stream muscle regulators during the muscle differentiation. MyoD requires 
class A (E12/E47) transcription factors to form transcriptionally active het­
erodimers. These heterodimers have been demonstrated to bind to the E-box 
sequences of genes which regulate transcription of muscle differentiation spe­
cific genes (chapter 4.2.1.2.). 
MyoD and Id HLH proteins form transcriptionally inactive heterodimers. 
Dominantly negative Id transcription factor abolishes DNA binding properties 
of these complexes. This results in inhibition of lineage specific gene expres­
sion and differentiation (Benezra et al, 1990; Wilson et al, 1991). 
4.2.2.2. Class B transcription factors in neurogenesis 
In Drosophila, AS-C (Campos-Ortega and Jan, 1991) bHLH transcription fac­
tors have been described as a positive regulators of sensory organ formation. 
Hairy and Enhancer of split gene products function as transcriptional repress­
ors during Drosophila neural determination. 
HES1 is expressed at high levels throughout ventricular zone which consist 
of neural precursor cells but not in the outer layers where differentiated cells 
are present in the developing CNS of mammals (Sasai et al, 1992). Overex­
pression of HES1 results in repression of differentiation of retinal progenitor 
cells and accordingly, HES1 null-mutant mice show acceleration of the retina 
differentiation (Tomita et al, 1996). The hairy related transcription factors 
(HES) form active homodimers, which may repress transcription of various 
genes, including their own genes by direct binding to N-box (CACNAG) se­
quences (Tietze et al, 1992). However, the possible mechanism of repression 
by hairy-related proteins (HES1) has been assumed to be direct binding to 
DNA (N-box) in target gene promoter rather than interfering with activator 
proteins (Takebayashi et al., 1994). 
NeuroD (Lee et al., 1995) and MASH 1 (Johnson et al, 1990), neural-spe­
cific bHLH proteins, are expressed transiently in mammals during neuronal 
differentiation. MASH1 is induced in differentiating PCI2 cells (Johnson et al, 
1990). MASH1 null-mutation mice died at birth, and showed severe losses in 
olfactory and autonomous neurons (Guillemot, 1995). Thus, NeuroD has been 
demonstrated to act as neuronal determination factor and MASH1 as a deter­
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mination factor for olfactory and autonomous neurons but assumingly it is not 
essential for development of most of the CNS. 
4.2.3. Id like HLH transcription factors 
4.2.3.1. Structural difference with other HLH proteins 
Id-like proteins, which contain the HLH motif but lack the basic domain, 
(Fig. 2) may interact with above-described class A and class B bHLH tran­
scription factors. Those heterodimers do not bind DNA (Benezra et al, 1990). 
Id proteins appear to dimerize without DNA stabilization because of better 
packed hydrophobic core (Wibley et al, 1996). 
4.2.3.2. Involvement in the regulatory processes 
Id family consists of a number of structurally related members, Id 1-4. Analysis 
of functions and spatial-temporal expression patterns show differences between 
these family members: Id2, unlike Idl and Id3, binds to pRB related proteins 
(Lasorella et al, 1996) and is involved in pRB mediated cell cycle block. The 
role of Id2 as a partner of the class A and B bHLH transcription factors during 
myogenesis has been studied. Expression of dominant negative Id2 gene inhib­
its the ability of these bHLH transcription factors to carry out their functions 
(Benezra et al, 1990). 
The inhibitory role of Id proteins has been described during haematopoiesis. 
Id proteins are expressed only in B-lymphoid progenitor cells but not in mature 
B cells. High levels of Id transcription factors repress the activity of class A 
bHLH transcription factors during B cell differentiation in vivo (Wilson et al, 
1991). The Id2 and Id3 show distinct and variable expression patterns in T and 
B cell lines during human lymphocyte differentiation (Ishiguro et al, 1995) and 
Idl transcription factor has been demonstrated to block erythrocyte terminal 
differentiation (Lister et al, 1995). 
The inhibitory role of different Id transcription factors have been described 
during neuronal development and established in neuronal cell lines. The Idl 
and E2-2 (class A bHLH transcription factor) proteins form transcriptionally 
inactive heterodimers in neuronal cells (Einarson and Chao, 1995). The Id2 is 
expressed in the ventricular zone of neuroepithelium in the rapidly dividing cell 
population during early neurogenesis. After the first neuronal populations are 
born, the expression of Id2 is down-regulated in the neuroepithelial cells. How­
ever, the expression remains high in some areas of the developing brain 
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(Neuman et ai, 1993b). Id transcription factors are not expressed in the sym­
pathetic nervous system and adrenal medulla, where precursor cells differentia­
tion and proliferation occur simultaneously (Duncan et al., 1992). The Id2 ex­
pression is cell line specific in neuronally differentiating cells. The level of the 
Id2 mRNA is upregulated (PCC7), downregulated (NG108) or unchanged 
(N18) during differentiation (Neuman et al., 1993b). Consistent with their role 
as inhibitors of differentiation, expression of Id genes is high in undifferenti­
ated cells. However, variable expression patterns of Id transcription factors in 
different cells suggests that these factors may have different functions in differ­
ent cell types and during different stages of differentiation. 
Promoter analysis of Id2 gene demonstrated the presence of multiple E-box 
sequences which suggest that the bHLH proteins have a role in the regulation of 
Id2 gene expression (Neuman et al., 1995). 
4.2.4. Class C bHLH transcription factors 
4.2.4.1. Structural differences 
Class C bHLH transcription factors contain a basic region helix-loop-helix 
leucine zipper motif in the C-terminal part. Well-studied members of class C 
family are myc and related factors which have important regulatory role in 
many different cell proliferation and differentiation processes. Several other 
class C factors have been isolated: USF ( Gregor et al., 1990), AP-4 (Hu et al, 
1990) and TFE3 (Beckmann et al., 1990). The class C bHLH proteins form 
dimers with other class C protein to activate transcription of target genes. Class 
C bHLH transcription factors do not form heterodimers with Id family proteins 
(Sun et al., 1991). 
4. 3. HLH TRANSCRIPTION FACTORS ARE INVOLVED 
IN THE CELL CYCLE REGULATION 
Id family HLH proteins have high expression in proliferating cells and their 
expression is downregulated during differentiation (Ellmeier et al., 1992). 
Iavarone et al., (1994) have demonstrated that HLH protein Id2 physically as­
sociates with the hypophosphorylated form of pRb (Fig 1). Later studies have 
shown that high levels of Id2 relieved cell cycle arrest induced by cdk inhibitor 
in the presence of pRb (Lasorella et al., 1996). It has been also demonstrated 
that pRb proteins may repress transcription independently of E2F proteins. This 
repression is mediated by the pocket region of pRb proteins. Inhibition is direct 
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and requires interactions with another protein instead of E2Fs (Bremner et al., 
1995). These observations suggest that Id proteins have an important role in the 
regulatory events of cell cycle. 
4. 4. HLH TRANSCRIPTION FACTORS 
DURING CELL DIFFERENTIATION 
Development of a specialized cell type is a two step process. First step is the 
determination of a cell lineage and second is an activation of set of cell-type 
specific genes. To date, role of HLH transcription factors has been described in 
cell-type specific gene regulation at the molecular level by in vitro analysis. 
These observations demonstrate that heterodimers of class A and class B bHLH 
proteins are involved in regulation of the cell-lineage specific genes during 
terminal differentiation. 
Well studied is synergism of class A and class B bHLH transcription factors 
during myogenesis. During terminal differentiation of myoblasts, interactions 
between specific factors and nonspecific class A transcription factors activate 
differentiation specific genes. Complexes of E12/MyoD and E47/MyoD have 
been identified in developing muscle cells. On the other hand, competition for 
E12/E47 by Id dominant negative transcription factor has been postulated to 
extinguish muscle-specific gene expression by precluding interaction of 
E12/E47 with MyoD or myogenin under conditions when Id levels are high. Id 
level decreases in response to differentiation signals. These changes result in 
the release of free MyoD and E12/E47 which can form heterodimers capable of 
switching on differentiation specific genes. The class A proteins have been im­
plicated in muscle, lymphoid, pancreatic and neural development, which sug­
gest that these transcription factors may interact with tissue-specific HLH 
regulators of several cell types. Thus, tissue-specific factors may regulate ex­
pression of lineage specific genes and inhibit other developmental programs by 
sequestration of commonly required dimerization partners of tissue-specific 
bHLH factors. This competition for commonly required bHLH binding partners 
may exclude alternative developmental programs (Davis et al., 1987; Pinney et 
al., 1988; Benezra et al., 1990; Lassar et al., 1991; Neuman et al., 1993a;). 
Also, HES1 has been described to heterodimerize efficiently with E12/E47 
proteins in differentiating myoblasts (Sasai et al., 1992). Consequently, HES 1 
may repress differentiation by similar mechanism discussed above (Ishibashi et 
ai, 1994). 
Studies in invertebrates suggest that bHLH factors play a crucial role in 
neurogenesis also. For example, Drosophila AS-C bHLH factors are positive 
regulators and hairy and Enhancer of split encoded factors are negative regu­
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lators for sensory organ formation (Ghysen and Dambly-Chaudiere, 1989; Ca­
brera, 1992; Campos-Ortega and Jan, 1991; Jan and Jan, 1993). 
MASH1 transcription factor which is expressed in neuronal precursor cells 
and HES family transcription factors are mammalian homologues of Droso­
phila above mentioned factors. It has been suggested that HES1 prevents mam­
malian neural differentiation in the CNS by inhibiting bHLH transcription fac­
tors, such as MASH1, from binding to the E-box sequences of target genes. 
Thus, it is possible that an interplay of these transcription factors has an im­
portant role during mammalian neurogenesis. However, the possible bHLH 
partners of HES'l protein are not identified yet. (Ishibashi et al, 1994 and ref­
erences herein). 
4.5. NUCLEAR HORMONE RECEPTORS 
Many members of the nuclear hormone receptor superfamily mediate control of 
differentiation, development, and homeostasis in vertebrates by ligand depend­
ent regulation of gene transcription. Among the best characterized members of 
the superfamily of nuclear hormone receptors are receptors for retinoids, thy­
roid hormones, steroid hormones, and glycocorticoids. Extensive studies have 
shown that the members of this superfamily activate and/or repress gene tran­
scription through direct binding to discrete eis-acting elements known as hor­
mone response elements. Beside the ligand dependent nuclear hormone recep­
tors, a group of transcription factors with high homology to the nuclear hor­
mone receptors have been isolated. These factors are known as orphan recep­
tors which ligands are virtually unknown. 
4.5.1. Structure and response elements 
Nuclear hormone receptors have two specific common regions. DNA-binding 
domain (DBD) is a short, well conserved cysteine rich domain which forms two 
zinc finger structures. C-terminal part is known as ligand binding domain 
(LBD) (Fig. 3). This region is relatively well conserved between different 
members of the subfamilies. Based on the structure of zinc fingers and different 
functions, nuclear hormone receptors can be divided into subfamilies. First 
group consists of receptors for glucocorticoid, progesteron, androgen and min-
eralocorticoids (GR) and second for estrogen, thyroid hormone (TR), retinoids 
(RAR, RXR) and vitamin D3 (VDR) receptors (ER-TR) (Umesono et al, 1989; 
Beato, 1989 and references herein). 
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DNA sequences responsive to nuclear hormone receptors have been found 
in many inducible genes. These hormone response elements contain two differ­
ent palindrome motifs. The core consensus of GR response element half-site is 
GAACA. The DNA motif is recognized by first amino acid residues glycin-
serin in the first zinc finger of these receptors. The ER-TR response element 
half-site is GGTCA with different spacing between the half-sites of each re­
sponse element. The binding is possible with receptors which contain glutamic 
acid-glycin in the N-terminal zinc finger (Sthrale et al., 1987). 1-3-4-5 rule of 
binding by RXR, VDR, TR, and RAR has been postulated. These receptors 
bind to A/GGGTCA direct repeats with a spacing of 1-3-4-5 bp-s respectively 
(Umesono et al., 1991). 
4.5.2. Retinoic acid receptors and receptors of retinoids 
The vitamin A derivative retinoic acid (RA) and other retinoids regulate large 
spectrum of biological processes including differentiation and morphogenesis. 
RA and retinoid signals are mediated by nuclear receptors. Retinoic acid re­
ceptors (RAR) activate transcription in response to RA treatment by binding to 
the response element of the target genes (Petkovich et al., 1987). RARs have a 
modular structure which comprises six different domains (Fig 3). 
NH2 I A I B D F ICOOH 
DBD LBD 
Figure 3. Schematic representation of nuclear hormone receptor transcription factors. 
The N-terminal hypervariable region (A) and immediately adjacent, highly con­
served region (B) carry cell and promoter specific activation functions. The 
DNA-binding domain (C) has two zinc finger structures which determine DNA 
binding specificity and are involved in receptor dimerization. This region is 
most highly conserved (93-95% identity between RARs). The hinge region (D) 
shows 61-74% of conservation. The C-terminal ligand binding domain (E) is 
the second most highly conserved (75-86%) and beside ligand binding it has a 
number of additional functions, including dimerization and transcriptional acti­
vation. The C-terminal region (F) mediates dimerization (Fig. 3). (De Luca, 
1991; Luisi et al., 1991; Zhang X.-K. et al, 1991). 
Receptors of retinoids known as retinoid X receptors (RXR) have been dis­
covered. All three isolated receptors of this subfamily have low homology to 
RAR's. RXRs form active heterodimers with RAR s and increase DNA-binding 
specificity of RAR's. In addition, RXR's may function as auxiliary receptors 
for TRs and VDRs. RXRs bind DNA as homodimers in response to the 9-eis 
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retinoic acid treatment. These homodimers act in the regulation of transcription 
(Tran et al., 1992). Analysis of retinoids and their corresponding receptors have 
revealed that both RAR and RXR may play an important role during develop­
ment of vertebrates. 
4.5.3. Orphan receptors 
Orphan receptors share structural homology with nuclear hormone receptors 
described above and their ligands are virtually unknown. 
4.5.3.1 Members of the subfamily and their structure 
The chicken ovalbumin upstream promoter transcription factor (COUP TF) was 
first identified by O'Malley group from the HeLa and chick oviduct extracts. 
They have described low and high molecular weight forms (at least 8) of COUP 
TFs and identified two highly conserved proteins named COUP TF I and COUP 
TF II (Wang et al., 1991). The COUP TFs homologues have been isolated from 
different organisms including Drosophila (Mlodzik et al., 1990), zebrafish 
(Fjose et al., 1993) and human (Miyajima et al., 1988; Ladias and Karathana-
sis, 1991). 
COUP TFs are classified on the basis of structure of DNA-binding domains 
as members of the ER-TR subfamily of nuclear hormone receptors. COUP TFs 
have relatively short N-terminal domain compared to other members of the su­
perfamily. Probably, there might be less steric hindrance from the smaller do­
main allowing the freedom required for any structural changes in the flexible 
hinge region which is likely the reason of promiscuous DNA-binding of the 
orphan receptors. COUP TFs bind as functional homodimers to spatial variants 
of the GGTCA repeats with different spacing. In contrast, other nuclear hor­
mone receptors from the ER-TR family require determined specific spatial or­
ganization of the binding sites. (1-2-3-4-5 rule of the binding for steroid hor­
mone receptors) (Cooney et al., 1992). It has been shown that COUP TFs lack 
dimerization domain in their DNA-binding domain which has been observed in 
other families of the superfamily (Ladias and Karathanasis, 1990). 
4.5.3.2. Target genes and mechanism of action 
Analysis of COUP TFs in a variety of systems demonstrate that these factors 
repress transcription mediated by thyroid and retinoid hormone receptors. Re­
pression of the human transferrin gene (Sawaya and Schaeffer 1995), human 
acetytransferase chimeric promoter (Quirin-Stricer et al, 1994) and peroxisome 
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proliferator-responsive element (Miyata et al, 1993) transcription, have been 
demonstrated. As discussed above, RXR heterodimers with VDR, TR and RAR 
have higher DNA binding and transactivation activity than homodimers of 
these proteins. Important role of COUP TF I/RXR inactive heterodimers has 
been demonstrated in retinoid response pathway. These complexes have been 
suggested to restrict multitude of the retinoid responses in certain cell types 
(Tran et al, 1992). COUP TF/RXR heterodimers repress whereas heterodimers 
of RARs/RXRs activate reporter gene transcription. It demonstrates competi­
tion for heterodimerization partners in retinoid response pathway (Cooney et 
al, 1992). COUP TFs form active homodimers which may independently bind 
to variety of thyroid-steroid hormone receptor binding sites and repress hormo­
nal induction of target gene. Thus, competition for the DNA binding sites is 
possible. In addition, COUP TF I has been shown to mediate an active silencing 
of reporter gene transcription. Transfer of putative ligand binding domain of 
COUP TF to GAL4 DBD resulted in repression of the reporter gene transcrip­
tion. It confirmed that COUP TF possesses silencing function within its C-ter­
minal domain (Cooney et al, 1993). Thus, inhibition of transcription by COUP 
TFs can occur at three different levels: (1) by competition for DNA binding site 
occupancy; (2) the formation of nonfunctional heterodimers between COUP TF 
and RXR; (3) and by active silencing of transcription with the C-terminal do­
main of COUP TF s. 
Besides inhibition of transcription, COUP TFs may also function as stimu­
latory transcription factors. Neurotransmitter dopamine may activate COUP TF 
I, which becomes converted to positive transcriptional regulator in vitro (Power 
et al, 1991). COUP TF I stimulates transcription of arrestin gene by binding to 
a direct repeat with a 7-bp spacer located upstream of the transcription start site 
(Lu et al, 1994). In combination with HNF4 transcription factor COUP TFs 
may stimulate activity of phosphoenole pyruvate carboxykinase gene (Hall et 
al, 1995). 
4.5.3.3. Role in differentiation 
Complex expression patterns of COUP TF I and COUP TF II during develop­
ment argue for their functional role in several developmental processes. In Dro­
sophila, seven-up gene is required for the development of the embryonic central 
nervous system and specific photoreceptor cells of the eye (Mlodzik et al, 
1990). Detection of COUP TFs transcripts reveal discrete spatial and temporal 
expression pattern within special domains of the central and peripheral nervous 
system during zebrafish (Fjose et al, 1993), chick (Lutz et al, 1994) and 
mouse (Pereira et al, 1995) embryogenesis. These data indicate that COUP TFs 
may play a crucial role in controlling a subset of neural-specific programs dur­
ing development. 
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Very little is known about the functional role of COUP TFs during mam­
malian cell differentiation. Thyroid hormone and retinoids have been demon­
strated to promote terminal muscle differentiation via activation of the muscle 
specific MyoD gene. Since the COUP TF II mRNA level decreases during the 
myoblast differentiation, it may be involved in the differentiation as a partner of 
these receptors. In vitro studies have revealed COUP TF II binding to thyroid 
hormone response elements of MyoD and myogenin genes. Thus, COUP TF II 
functions as an antagonistic regulator of myogenesis via direct effects on the 
tissue specific bHLFI genes. These observations provide direct evidence for the 
developmental role of COUP TF II during mammalian cell differentiation 
(Muscat et al., 1995). 
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5. AIMS OF THE PRESENT STUDY 
A general objective of the present thesis was to describe the role of HLH and 
nuclear orphan receptor transcription factors during neurogenesis. The specific 
aims of the work were: 
1. To characterize class A bHLH transcription factors ME1 and ME2 during 
neurogenesis: 
compare their expression patterns during mouse embryonic development 
and in adult brain; 
determine their dimerzation properties and specificity of binding to different 
E-boxes; 
characterize their interactions with a negative regulator (Id2); 
examine their activities in different neuronal cell lines. 
2. To study blocking and reversion of neuronal differentiation using teratocar-
cinoma PCC7 cells as a model system: 
isolate genes which block retinoic acid induced neuronal differentiation and 
initiate proliferation; 
study orphan receptor COUP TFI induced block of neuronal differentiation; 
analyze effects of these regulators on the expression of neuron differentia­
tion marker genes. 
3. To characterize COUP TF II gene promoter; to analyze its cell type specific 
regulation by RA, dBcAMP and COUP TF transcription factors. 
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6. MATERIALS AND METHODS 
Libraries 
Postnatal day 1 mouse brain library in lambda ZAP II vector (Stratagene) (I, II), 
subtraction library of teratocarcinoma PCC7 (undifferentiated and neuronally 
differentiated) (Neuman et al, 1995) (III), 
mouse genomic library (Clontech) (V). 
Plasmids 
Bluescript SK(Stratagene), 
Bluescript SK ME2 — mouse ME2 cDNA in EcoRV site (I), 
Bluescript II KS DR1 — DR1 HRE in EcoRV site (Neuman et al, 1995) (V), 
Bluescript II KS ß-RARE — ß-RARE HRE in EcoRV site (V), 
Bluescript II KS CRBPI — CRBPI HRE in EcoRV site (Neuman et al, 1995). 
pBLCAT2 (Luckow and Schütz, 1987), 
pBLCAT2 (MEF)X4, TKCAT — four copies of MEF1 site earring E-box oli­
gonucleotides (CACCTG) (II), 
pBLCAT2 DR1 — DR1 HRE in Hindlll-Xbal site (IV), 
pBLCAT2 ß-RARE — ß-RARE HRE in Hindlll-Xbal site (IV), 
pBLCAT2 CRBP I — CRBP I HRE in Hindlll-Xbal site (IV), 
pC AT3 N-4000/B gill, pCAT3N-1500/BglII, pCAT3N-621 /Bglll, pCAT3N 
-320/ApaI, pCAT3N-97/ApaI, pCAT3N-320/SacII, pCAT3N-40/SacII, 
pCAT3N-285/ApaI, pCAT3N-200/ApaI, pCAT3N-StyI/ApaI, — COUP TF II 
promoter fragments cloned into the unique Bglll site (V). 
pRcCMV (InVitrogen) 
pRcCMV ME2 — full length ME2 cDNA subcloned into Hindlll site (II), 
pRcCMV(-216) — ME2 truncated expression vector (II), 
pRcCMV ME la — Spel-BstEII full length was blunted and subcloned into 
Hindlll site with Hindlll linkers (II), 
pRcCMV Id2 — contains Id2 full length cDNA Xbal-Hindlll fragment (II), 
pRcCMV E1A12S, pRcCMV E1A13S — adenovirus E1A12S cDNA and, 
E1A13S cDNA (gift from Nevins and Moran) (III), 
pRcCMV E2F — E2F1 cDNA subcloned into Hindlll and NotI site (Neuman et 
al, 1995) (III), 
pRcCMV RNP1 — RNP1 cDNA cDNA subcloned into Hindlll and NotI site 
(HI), 
pRcCMV RNP2 — RNP2 cDNA subcloned into Hindlll and NotI site (III), 
pRcCMV ME1 — ME1 cDNA Spel-BstEII full length was blunted and sub­
cloned into Hindlll site with Hindlll linkers (Neuman et al, 1993) (II, III), 
pRcCMV COUP TF I — mouse COUP TF I cDNA from newborn library (IV), 
pRcCMV COUP TF II — COUP TF II cDNA (V). 
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Cell Lines 
cervical carcinoma C33A, human (American Type Culture Collection ATCC) 
(V), 
glioblastoma C6, rat (ATCC) (V), 
glioblastoma U373, human (ATCC) (V), 
fibroblasts 3T3, mouse(ATCC) (V), 
neuroblastoma N18 (II), 
neuroblastoma-glioma NG108 (II) 
teratocarcinoma VCCI, mouse (from S. E. Pfeiffer) (III, IV, V). 
Antibody 
anti-CAS linked to the carrier KLH, IgG fraction of the anti-rabbit polyclonal 
serum purified on Protein G-Sepharose Fast Flow affinity chromatography (II). 
Methods 
DNA cloning and sequence analysis (I, II, III, IV, V) 
Screening of bacteriophage X library (V) 
Polymerase chain reaction (PCR) (II, III, IV) 
Northern blotting (I, II, III, IV) 
RNA in situ hybridization (I, II) 
Electrophoretic mobility-shift assay (EMSA) (II, IV) 
Primer extension (V) 
ß-galactosidase assay (V) 
Chloroampenicol acetyl transferase (CAT) assay (II, IV, V) 
RNase protection (V) 
In vitro transcription site directed mutgenese (V) 
Exonuclease III digestion (V) 
Transfection of the cells (II, III, IV, V) 
Cell culture (II, III, IV, V) 
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7. RESULTS AND DISCUSSION 
7.1. CLASS A bHLH TRANSCRIPTION FACTORS ME1 AND 
ME2 DURING NEUROGENESIS (I, II) 
The role of class A transcription factors during myogenesis and haematopoiesis 
as partners for tissue specific HLH transcription factors has been well charac­
terized. The role of these factors during neurogenesis is still obscure. We iso­
lated (ME2) and characterized (ME2 and ME1) two class A bHLH transcription 
factors which are expressed during mouse neurogenesis. 
7.1.1. ME2 trascription factor — a member of class A bHLH tran­
scription factor family (I) 
The proneural genes were originally identified as essential regulators of Droso-
phila nervous system development. Many of these proneuronal genes were 
identified as helix-loop-helix transcription factors (Jan and Jan, 1990). Based 
on remarkable similarity between Drosophila proneuronal and mammalian 
bHLH genes it is likely that mammalian bHLH transcription factors are also 
involved in the neuronal development. In order to study the role of bHLH tran­
scription factors during neuronal differentiation we cloned mouse ME2 cDNA 
which is related to Drosophila neurogenic gene da, from postnatal day 1 cDNA 
library. Sequence analysis revealed that ME2 is mouse homologue of human 
ITF2 bHLH transcription factor (Henthorn et al, 1990).Homology of these 
factors is 98% at amino acid level and 94% at nucleotide level. ME2 has high 
homology to known class A bHLH transcription factors in the HLH region 
(80% to daughterless, 95% to ME1, 97% to El2 and 90% to E47) (Neuman et 
al, 1993a) 
7.1.2. Expression of ME1 and ME2 during mouse development (I, II) 
Northern blot analyses demonstrated high levels of ME1 and ME2 mRNAs 
during embryonic development. During the early postnatal development ME1 is 
expressed at low level whereas ME2 expression remains high and gradually 
decreases as the mouse brain reaches maturity (Neuman et al, 1993a). 
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At embryonic day 12, ME2 expression is detectable in the cerebral cortex, 
cerebellum, pons, medulla and spinal cord (I; Fig. 2A) as detected by in situ 
hybridization analysis. From the embryonic day 18 until adulthood, ME2 is ex­
pressed at high levels in the pyramidal cells of hippocampal layers CA1-CA4, 
and in the granular cell layer of the dentate gyrus(I; Fig. 2C). At postnatal 
day 7, expression of ME2 is remarkably high in the visual cortex which is un­
dergoing a critical period of development (I; Fig. 2B) and in the subependymal 
region extending from the anterior lateral ventricle into the olfactory bulb (I; 
Fig. 2C, El8 and P7). Cerebellar granule and Purkinje neurons and the ven­
tricular zone of the olfactory bulb express ME2 at all stages studied (Fig. 2C). 
In non-neuronal tissues, myotomes and developing limbs have the strongest 
hybridization signal at embryonic day 12. 
We examined differences and similarities between ME1 and ME2 expres­
sion patterns in adult mouse brain. Parallel in situ hybridization analyses 
showed high levels of ME1 and ME2 expression in the internal granular cell 
layer of the cerebellum, and granular cells of the dentate gyrus of the hip­
pocampus where also low level ME1 expression was detected (II; Fig. 2A, B). 
ME2 is expressed at high levels in pyramidal cells from CA1-CA3 whereas 
ME1 expression is barely detectable. ME1 expression was not detectable in the 
cerebral cortex where ME2 signals were observed. 
Expression of ME1 and ME2 are generally distinct but show some spatial 
and temporal overlap in several regions. These data demonstrate that ME1 and 
ME2 are expressed in the regions of neuronal cell proliferation and initial dif­
ferentiation. This expression pattern is similar to E2A expression with high 
level of mRNA in the ventricular zone (area of intensive cell proliferation) dur­
ing embryonic development (Roberts et al, 1993). Also Gl, chick homologue 
of ME1, is expressed in regions of cell proliferation. 
Our data demonstrate specific expression of ME2 during development and 
also distinct but overlapping expression patterns of MEla and ME2 in the re­
gions of neuronal plasticity in the adult brain. These observations suggest that 
ME1 and ME2 may have a regulatory function in developmental processes as 
well as during neuronal plasticity. 
7.1.3. DNA binding properties of ME1 and ME2 in vitro (II) 
Analyses of DNA binding and dimerization properties of MEla and ME2 dem­
onstrate that both factors form dimers and bind to the E-box sequences. Elec-
trophoretic mobility shift assay was used to examine DNA binding of C-ter-
minal fragment of the MEla which contains bHLH motif and 24 amino acids. 
Truncated C-terminal fragment containing last 300 amino acids was used to 
analyze ME2 protein. ME1 and ME2 proteins were expressed in E. coli and 
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purified by metal affinity chromatography. An oligonucleotide containing the 
E-box found in the muscle creatine kinase enhancer (MEF1) was used to study 
MEla and ME2 DNA binding properties. Our analyses demonstrate that ME1 
and ME2 bind as homodimers to oligonucleotide carrying the MEF1 site. 
Specificity of ME 1/DNA and ME2/DNA complexes was confirmed by super-
shift using polyclonal antibody raised against the CAS domain. Preimmune se­
rum was used as a control (II; Fig. 3B, D). 
MyoD protein was used to investigate whether MEla or ME2 could form 
functional heterodimers with a class B bHLH protein. We observed formation 
of MEla homodimers, MEla/MyoD heterodimers, and MyoD homodimers. 
MyoD homodimer formation is likely a result of high concentration of the pro­
teins used in this assay. Additionally we found that incubation of ME2 with 
MEla or MyoD results in a formation of complex with an intermediate electro-
phoretic mobility suggesting existence of ME2/MEa heterodimers. These re­
sults demonstrate that MEla, ME2 and MyoD form homo- and heterodimers in 
vitro and bind MEF1 DNA. DNA-binding specificity of MEla and ME2 ho­
modimers was analyzed using competition assays. 25-fold excess of each of 
several competitors was added to a reaction mix containing 40 ng of MEla or 
ME2 protein and 40 fmoles of MEF1 probe. A strong competitor E-box element 
would decrease the signal from the labeled shifted DNA-protein complex. The 
specific sequences of the various E-boxes used for this assay are indicated in 
Table 1 (II). The MEla/DNA complex is competed successfully with a 25-fold 
excess unlabeled MEF1 oligonucleotide but not with non-specific DNA (II; 
Fig. 4A, lanes 3 and 5). DNA containing |nE5 E-box competed equally well 
with the MEF1 probe whereas DNA containing (iE2 E-box did not (II; Fig. 4A, 
lanes 6 and 7). The c-fos E-box located in the c-fos promoter reduced the spe­
cific binding by 50% (Fig. 4A, lane 9). A relatively weaker competition was 
obtained with the K E2 E-box (II; Fig. 4A, lane 8). These data clearly demon­
strate that MEla homodimers bind different E-boxes with different affinities. 
The ME2/DNA complex was greatly reduced by the addition of 25-fold excess 
of unlabeled MEF1 oligonucleotide. A similar excess of nonspecific DNA did 
not affect the amount of specific binding (II; Fig. 4B, lane 3, 5). DNA contain­
ing |llE5 E-box or |oE2 binding site competed as well as MEF1 probe (II; Fig. 
4B, lanes 6, 7). However, DNA containing the K E2 site did not compete for 
binding with the MEF1 E-box (II; Fig. 4B, lane 8). The c-fos E-box slightly 
reduced the specific binding (II; Fig. 4B, lane 9). These results show that MEla 
and ME2 homodimers recognize a variety of E-box sequences and also that 
they are characterized by significantly different DNA-binding specificities. 
To elucidate specific functions of MEla and ME2 in neurogenesis we ex­
amined their ability to activate transcription from a minimal promoter linked to 
several MEF1 E-boxes. We constructed two expression vectors pRcCMV 
MEla and pRcCMV ME2, and a reporter plasmid TKCAT (MEF)X4 with four 
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MEF1 E-boxes upstream of the basic TK promoter. Cotransfection of MEla or 
ME2 expression vector with reporter plasmid resulted in significant increase in 
CAT expression in N18 neuronal cells and in NG108 neuroblastoma-glioma 
cell line (II; Fig. 5). These data clearly indicate that both factors function as 
transcriptional activators in mammalian neuronal cells. In contrast, previous 
studies revealed transcriptional activation only with GAL4:ITF2 chimeric pro­
tein (ITF2 is human homologue of ME2) which activated transcription of a re­
porter plasmid with GAL4 binding sites (Henthorn et al, 1990). In our experi­
ments ME2 behaves as a strong activator on its own. Furthermore, truncated 
form of ME2, which lacks the first 216 N-terminal amino acids is still capable 
of stimulating the gene expression through the MEF1 E-box. 
7.1.4. Interaction of ME1 and ME2 
with the inhibitory factor Id2 in vitro (II) 
Id -like proteins have been described to interfere differentiation by forming in­
active heterodimers with bHLH proteins during embryonic development. We 
cotransfected expression plasmids pRcCMV Id2, pRcCMV MEla or pRcCMV 
ME2 and CAT-reporter into neuroblastoma N18 cells to test effects of Id pro­
teins on transcriptional activity of MEla and ME2. A significant reduction in 
CAT activity was observed in the presence of the expression vector pRcCMV 
Id2. Thus, Id2 inhibits transcriptional activity of both MEla and ME2 in neu­
ronal cells. Since Id proteins are believed to prevent binding of bHLH proteins 
to DNA due to the formation of inactive heterodimers, we examined the pro­
tein-protein interactions of MEla, ME2 and Id2 using EMS A and MEF-1 E-box 
DNA. We found that both MEla and ME2 form not-DNA-binding complexes 
with Id2 protein. 
7.2. BLOCK AND REVERSE OF DIFFERENTIATION (III, IV) 
Neuroblasts exit cell cycle and become arrested in the GO phase during neu­
ronal differentiation. This transition is accompanied by switching off cell cycle 
specific genes. Our goal was to identify genes that are capable to dedifferenti­
ate neuronally differentiated teratocarcinoma cells and initiate proliferation. 
Teratocarcinoma PCC7 cells stop proliferation and differentiate into neu-
ronal-like cells after treatment with retinoic acid (RA) alone or RA plus dibu-
tyryl cyclic-AMP (dBcAMP). Differentiation is irreversible as removal of RA 
and dBcAMP does not cause dedifferentiation and reentry into the cell cycle. 
Thus, one could to study these cells as a model for nerve cell differentiation. 
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We used CMV promoter-based expression vectors in our experiments. CMV 
promoter activity is weak in proliferating PCC7 cells and is induced about 
45 times after induction of differentiation by RA and dBcAMP in transient as­
says using bacterial CAT gene as a reporter. Neuronal differentiation of PCC7 
cells is also inducible with RA alone and this treatment does not induce CMV 
promoter activity. By contrast, dBcAMP treatment alone stimulates CMV pro­
moter activity but does not result in neuronal differentiation. pRcCMV eukary-
otic expression vectors allow expression of introduced genes at high levels 
during neuronal differentiation of PCC7 cells treated with RA and dBcAMP, or 
at low levels during neuronal differentiation of PCC7 cells induced with RA 
alone. Thus, CMV promoter-based eukaryotic expression vectors allow expres­
sion of introduced genes at different levels during neuronal differentiation. 
7.2.1» Blocking neuronal differentiation of the teratocarcinoma 
PCC7 cells (III) 
We developed an expression cloning system for the detection and isolation of 
cDNAs which block differentiation and induce proliferation of neuronally dif­
ferentiated teratocarcinoma PCC7 cells. As a first step, we generated subtrac­
tion cDNA library from undifferentiated versus differentiated PCC7cells. PCC7 
cells stop proliferation and differentiate into neuron-like cells after treatment 
with RA and dBcAMP. Expression screening of the subtraction cDNA library 
was performed to isolate genes which block neuronal differentiation of PCC7 
cells and induce proliferation. The cDNA library in pRcCMV expression vector 
was transfected into neuronally differentiated PCC7 cells. Cultures of neuron-
ally differentiated cells did not contain proliferating cells as it was estimated 
using thymidine incorporation and cell cycle analysis. After 3 weeks of selec­
tion in the presence of G418, three proliferating clones were isolated. Cells of 
these clones continued proliferation in the presence of RA an dBcAMP and 
were morphologically identical to the original undifferentiated PCC7 cells. 
These clones were propagated in the presence of RA and dBcAMP and trans­
fected cDNAs were isolated using PCR and retested for dedifferentiation and 
induction of proliferation. Sequence analysis revealed that one cDNA corre­
sponds to mouse homologue of human E2F1; second cDNA, RNP1 (Regulator 
of Neuronal Proliferation), lacks significant homology to any GeneBank se­
quences: and third cDNA, RNP2, is 99,5% homologous to HLH transcriptional 
regulator Id4. 
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7.2.2. Expression of E2F, RNP1, and RNP2 
in differentiating PCC7 cells (III) 
Neuronal differentiation results in downregulation of E2F1, RPN1 and RPN2 
expression in PCC7 cells. E2F1 mRNA level decreases slightly after 3 days of 
differentiation. The level of RNP1 mRNA decreases significantly during the 
first 24 h of differentiation and is undetectable by 48 h. Decrease of RNP2 
mRNA levels occurs more gradually and mRNA disappears by the third day of 
differentiation (III; Fig. 2). E2F expression during initial step of differentiation 
is consistent with the data demonstrating that E2F expresses in the adult nerv­
ous system and may have a role during initial steps of differentiation (Zhao et 
al., 1995). 
7.2.3. Efficiency of isolated cDNAs to initiate proliferation (III) 
Efficiency of isolated RNP1 and RNP2 cDNAs to dedifferentiate and initiate 
proliferation of neuronally differentiated PCC7 cells was tested by transfection 
of cDNAs into neuronally differentiated PCC7 cells (the same conditions used 
in screening the expression library) and by transfection into proliferating PCC7 
cells (followed immediately by treatment with dBcAMP and RA to induce neu­
ronal differentiation). Adenovirus oncogene E1A12S and E1A13S forms, 
bHLH transcription factor ME1 and the pRcCMV vector without insert were 
used as controls. ME1 is expressed in several proliferating cell types and is 
downregulated during differentiation. No proliferating clones were observed 
after transfection with ME1 cDNA or pRcCMV vector without insert. All three 
isolated cDNAs, E2F, RNP1 and RNP2 induced the formation of proliferating 
clones with the same efficiency under both experimental conditions. The effi­
ciency of El A to induce proliferation is approximately 10 times higher than for 
E2F, RNP1 and RNP2 cDNAs (III; Table 1). 
7.2.4. Effect of overexpression of RNP1 and RNP2 
on neuronal specific genes (III) 
Expression of NF-L and GAP43 genes was studied to analyze the effect of 
RNP1 and RNP2 overexpression on neuronal differentiation. To normalize dif­
ferences in the expression of RNP1 and RNP2 between individual clones we 
used randomly selected pools of RNP1 and RNP2 expressing clones. Northern 
blot analyses demonstrated expression of the RNP1 and RNP2 mRNAs after 
treatment with dBcAMP and RA as a result of CMV promoter induction by 
dBcAMP in transfected PCC7 cells. In non-transfected cells NF-L is undetect-
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able in proliferating cells, and its level increases after differentiation begins. 
The induction of NF-L 3.5 kb mRNA occurs more rapidly than that of 2.5 kb 
mRNA. Overexpression of RNP1 results in the delay in the induction of NF-L 
gene, and this induction is transient. The increase of NF-L mRNA is detectable 
on the second day after induction with RA and dBcAMP, and the mRNA level 
decreases on the third day. No expression of NF-L was detected in RNP2 pools 
(III; Fig. 3). 
GAP-43 is expressed at relatively low levels in undifferentiated PCC7 cells, 
and its mRNA levels rapidly increase after induction with RA and dBcAMP. 
No induction of GAP-43 was detected in RNP1 overexpressing pools, after 
treatment with RA and dBCAMP; moreover, its mRNA becomes undetectable 
after 1 day of treatment. No expression of GAP-43 was detected in undifferen­
tiated RNP2 overexpressing pools or after induction with RA and dBcAMP (III; 
Fig. 3). 
We isolated three different genes which overexpression blocks neuronal dif­
ferentiation and induces proliferation of neuronally differentiated PCC7 cells. 
E2F family factors are known to be key regulators of cell cycle progression. 
Transcription factor E2F1 plays a central role in the cell cycle regulation 
through its ability to activate genes necessary for Gl/S phase transition. Activ­
ity of E2F is regulated by formation of transcriptionaly inactive or inhibitory 
complexes with pRB family members. During the Gl phase of the cell cycle 
pRB becomes hyperphosphorylated by cyclin/cdk complexes which leads to the 
release of transcriptionally active E2F (Beijersbergen et ai, 1995). Overexpres­
sion of E2F may lead to a situation where pRb is limiting and thus results in the 
excess of active E2F which may trigger the initiation of the cell cycle. Alterna­
tively, excess of E2F could sequester pRBs and block expression of the differ­
entiation specific genes as it has been demonstrated for the muscle cell differ­
entiation. Knock-out experiments demonstrate that pRB is necessary for normal 
neurogenesis. The RNP2 is highly homologous to Id4, a helix-loop-helix tran­
scriptional regulator which may block neuronal differentiation by forming in­
active heterodimers with bHLH transcription factors that are expressed in neu­
ronally differentiating cells. 
Our analysis of neuronal-specific genes demonstrate that overexpression of 
RNP1 and RNP2 interferes with the induction of NF-L and GAP43 gene ex­
pression. RNP2 suppresses expression of the neural marker genes NF-L and 
GAP43 after induction with RA and dBcAMP. In contrast overexpression of 
RNP1 does not suppress expression of NF-L and does suppress GAP43. These 
observations argue that isolated genes RNP1 and RNP2 have at least partially 
different mechanisms of action during blockage of neuronal differentiation. 
Delayed and transient induction of NF-L gene in RNP1 overexpressing cells 
after induction with RA and dBcAMP suggest that it does not completely block 
signal transduction at the initial stages of neuronal differentiation. However, 
overexpression of RNP1 suppresses expression of GAP43 which demonstrates 
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that RNP1 completely blocks expression of at least one neuronal specific gene 
in PCC7 cells. Our results support the hypothesis that different neuronal genes 
are regulated by a different mechanisms. 
7.2.5. Orphan receptor COUP TF I arrests 
the morphological differentiation of PCC7 cells (IV) 
Above we demonstrated that overexpression of E2F, RNP1 and RNP2 results in 
the suppression of neuronal differentiation of PCC7 cells. The neuronal differ­
entiation of PCC7 cells is a result of RA and dBcAMP treatment. Reason of the 
differentiation blockade could be suppression of RA effects by elevated levels 
of these factors during RA induced differentiation. Nuclear hormone receptors 
(RARs and RXRs) mediate RA effects on gene expression. COUP TFs are ex­
pressed in the developing nervous system and interact with nuclear hormone 
receptors to regulate expression of different genes. Importance of ligand-
activated nuclear hormone receptors during neurogenesis is well described. At 
the same time, role of orphan receptors is unknown. To study the possible func­
tion of COUP TF I during neuronal differentiation, we generated COUP TF I 
overexpressing PCC7 cell lines and analyzed RA-induced neuronal differentia­
tion of these cells. 
Using randomly selected clones we analyzed correlation between COUP TF 
I expression and morphological differentiation in response to RA and dBcAMP 
induction. Two of the tested clones demonstrated induced expression of COUP 
TF I mRNA and failed to differentiate morphologically (IV; Fig 2A, Fig. 3). To 
verify if the loss of morphological differentiation is a result of COUP TF I ex­
pression or selection of aberrant clones, we examined those clones during neu­
ronal differentiation induced by RA alone. No inhibition of morphological dif­
ferentiation of PCC7 clones were observed and no COUP TF I mRNA expres­
sion detected after treatment with RA alone. In contrast, expression of COUP 
TF I was induced after induction with dBcAMP plus RA as well as with 
dBcAMP alone (IV; Fig. 2B). These results demonstrate that overexpression of 
COUP TF I blocks neuronal differentiation of PCC7 cells. 
Flow cytometric analyses were performed to characterize changes in the cell 
cycle during differentiation of control and COUP TF I overexpressing PCC7 
cells. During normal growth of wild type PCC7 cells and COUP TF I overex­
pressing clones, the percentage of cells in Gl phase was 41-42%, in S phase 
36-38%, and in G2 phase 20-24%. Differentiation of wild type PCC7 cells 
blocks cell cycle in Gl phase and percentage of cells in G1/G0 reaches 98% 
after three days of treatment. In contrast, treatment of COUP TF I overex­
pressing cells with RA and dBcAMP results in a significantly smaller reduction 
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of the proliferation rate: the portion of cells in G1/G0 phase increase from 41-
42% in day 0 to 64-65% at day three (IV; Fig. 5, Table 1). 
7. 2.6. Effect of COUP TF I on the expression 
of neuronal marker genes (IV) 
We characterized expression of NF-L, GAP43 and MAP2 genes during neu­
ronal differentiation of wild type and COUP TF I overexpressing PCC7 cells. 
Differentiation of PCC7 cells results in induction of NF-L and MAP2 genes 
48 h and GAP43 gene 12 h after treatment with RA and dBcAMP. Overexpres­
sion of COUP TF I results in no changes of NF-L expression, delayed induction 
of GAP43 gene expression, and blocked expression of MAP2 gene after induc­
tion of neuronal differentiation with RA and dBcAMP. Induction of neuronal 
differentiation without stimulation of COUP TF I expression results in stimula­
tion of all neuronal marker genes similar to control (IV; Fig 4). 
7.2.7. Induction of RARE enhancers 
in COUP TF I-overexpressing cells (IV) 
COUP TFs have demonstrated to form inactive heterodimers with RXRs and 
bind to retinoic acid response elements (RARE) from different genes as ho­
modimers to repress the retinoic acid response. To investigate whether COUP 
TF I blocks RA signaling pathway in neuronally differentiating PCC7 cells, we 
analyzed the activities of CAT reporter constructs containing different RAREs 
in front of the thymidine kinase promoter in COUP TF I overexpressing cells. 
We analyzed three different RAREs: ß-RARE, a direct repeat with a 5-bp 
spacer that is activated by RARa; the CRBP I-RARE, a direct repeat with a 
2-bp spacer that is optimally activated by RAR/RXR heterodimers but not RXR 
homodimers and the DR1, a direct repeat that contains a 1 -bp spacer and has a 
high affinity to COUP TF I and RXRs. All three reporter constructs are induci­
ble in PCC7 cells with RA or RA and dBcAMP, and dBcAMP potentiates the 
effect of RA. In COUP TF I overexpressing clones treated only with RA, in­
duction of ß-RARE and CRBPI is reduced and no induction was detected from 
DR1. Induction of COUP TF I by adding dBcAMP to RA results in further in­
hibition of ß-RARE- and CRBPI-mediated transcription (IV; Fig. 6). Interest­
ingly, transcription activity of the ß-RARE containing reporter is inhibited in 
COUP TF I overexpressing cells. This result contradicts to the data of the co-
transfection experiments with COUP TF I and RARa which demonstrate that 
COUP TF I does not inhibit induction of ß-RARE by RARa (Tran et al, 1992). 
All three RARs and RXRa and RXRß have been described in differentiating 
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PCC7 cells. In differentiating PCC7 cells, expression of all three RARs and 
RXRs is induced and it is unknown which of the RAR/RXR complexes are in­
volved in the induction of ß-RARE enhancer in our experiments. It is possible 
that ß-RARE induction is mediated by RAR/RXR complexes other than RARa 
homodimers and that these complexes are differently affected by COUP TF I. 
7.3. CHARACTERIZATION OF THE PROMOTER REGION 
OF COUP TF II GENE (V) 
COUP TF II is expressed in a complex spatio-temporal pattern during develop­
ment of several organ systems including nervous system. This complex expres­
sion pattern argues for a different mechanisms of COUP TF II gene regulation 
in different cell types. 
7.3.1. Localization of the 5' regulatory region 
We isolated and cloned 1.5 kb 5' end fragment of the COUP TF II gene. The 
transcription start site was mapped by primer extension and RNase protection 
analyses using RNA isolated from embryonic day 11, 13, and 15 mouse em­
bryos. Both methods demonstrated the presence of several transcription start 
sites. The 5'-proximal region contains several consensus TATA box sequences 
in the location where all the transcription start sites are localized. To determine 
the sequences that are essential for transcription of mouse COUP TF II gene, 
various portions of the 5'-flanking region were fused to the bacterial CAT gene 
as a heterologous reporter gene. The reporter plasmids we transfected tran­
siently into the mouse teratocarcinoma PCC7, mouse fibroblast 3T3, and hu­
man cervical carcinoma C33A cells. This deletion analysis demonstrated that 
the COUP TF II basal promoter is localized in the 200 bp region upstream from 
the major transcription start site (V; Fig. 1 A, IB). 
7.3.2. The regions responsible of RA and dBcAMP effect 
Since COUP TF II is involved in the modulation of retinoic acid responses and 
may function as a part of the regulatory loop, we analyzed the effect of all-trans 
RA on the activity of its promoter. We used CAT-reporter constructs to identify 
regions responsible for RA and cAMP. Expression of all three RAR and RXR 
genes and induced expression of RARs during RA treatment has been demon­
strated in PCC7 cells. Transient transfection of COUP TF II promoter-CAT 
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Plasmids containing different fragments of 5' regulatory region demonstrated 
that RA treatment induces promoter activity of all plasmids which contain more 
than 40 bp of the promoter region and localizes responsive region between nu­
cleotides -97 to -40. The same promoter region is also responsive for dBcAMP 
treatment. Cotreatment with RA and dBcAMP stimulated COUP TF II pro­
moter activity about 15-20-fold (V; Fig. 2). The additive effect of RA and 
dBcAMP suggest that RA and dBcAMP have different pathways to stimulate 
COUP TF II promoter activity. Sequence analyses of -97 to -40 bp COUP TF 
II promoter region revealed a cAMP response element (CRE) and a possible 
consensus sequence for hormone response element (HRE) localized next to 
each other. Mutations were introduced into these elements to assess their func­
tionality. Mutations which destroyed proposed HRE did not affect inducibility 
of COUP TF II promoter activity, however mutations in CRE or in both CRE 
and HRE together completely blocked the effect of dBcAMP and cooperative 
induction by RA and dBcAMP (V, Fig. 3). These results demonstrate that RA 
has indirect effect on the COUP TF II promoter activity in PCC7 cells. 
7.3.3. Effects of RA and dBcAMP on the COUP TF II promoter 
activity in different cell lines 
CAT assays demonstrated different effects of RA and RA plus dBcAMP treat­
ment to the COUP TF II promoter in different cell lines. In rat glioblastoma C6 
and human glioblastoma U373 cells the activity of promoter-CAT constructs 
decreased but in mouse fibroblast 3T3 and human cervical carcinoma C33A 
cell lines activities did not changed after treatment (V; Fig. 4A and B). Thus, 
analyses of COUP TF II promoter activity in different cell lines revealed that 
all-trans retinoic acid either stimulates (PCC7), suppresses (C6, U373) or has 
no effect (3T3, C33A) on transcription. These results suggest that COUP TF II 
is involved at least in two different functions of retinoids. First, in cells where 
COUP TF II promoter activity is stimulated by retinoids, it may function as a 
part of negative feedback loop to suppress effects of retinoids. Second, in cells 
where COUP TF II promoter activity is suppressed by retinoids, the retinoid 
response may be longer lasting. COUP TF II may also be involved in timing the 
switches of retinoic acid mediated gene regulation. 
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7.3.4. Possible regulation of RA induced COUP TF II promoter 
activity by COUP TFs (V) 
Transcription factors COUP TF I and COUP TF II block the stimulatory effect 
of RA on transcription of several genes. We demonstrated that transcription 
from COUP TF II promoter is induced by RA which likely suggests feedback 
mechanism between RA level and COUP TF II expression level in PCC7 cells. 
We examined the possibility that COUP TF I and COUP TF II block the 
stimulatory effect of RA on COUP TF II promoter. Promoter-CAT construct 
and COUP TF I or COUP TF II expression vectors were cotransfected into 
PCC7 cells. As a positive control, plasmid containing a RARß2 promoter lacZ 
reporter construct that has be shown to be inducible with activated RARs and 
RXRs was used. CAT assays demonstrated that both COUP TFs slightly sup­
press RA plus dBcAMP induced COUP TF II promoter activity. In contrast, 
COUP TF I and COUP TF II completely inhibited RA plus dBcAMP induced 
RARß2 promoter. (V; Fig. 4C). This is an additional indication that RA does 
not directly regulate COUP TF II promoter activity through activation 
RAR/RXR complexes. 
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8. SUMMARY AND CONCLUSIONS 
It has been shown that helix-loop-helix transcription factors regulate expression 
of tissue specific genes during cellular differentiation. In particular, several 
bHLH transcription factors are regulators of cell fate. We isolated and charac­
terized cDNA encoding mouse class A bHLH transcription factor ME2. Se­
quence analyzes of ME2 revealed high homology of bHLH domain with the 
other known class A bHLH transcription factors. ME2 is expressed in cerebral 
cortex, Purkinje and granular cell layers of the cerebellum, olfactory neuro-
ephithelium, pyramidal cells of hippocampal layers CA1-CA4, and in the 
granular cells of dentate gyrus. To evaluate differences and similarities between 
two class A bHLH transcription factors MEla and ME2, we studied expression 
patterns of MEla and ME2 in the adult brain. In situ hybridization analyses 
revealed distinct but in some regions overlapping pattern of these two bHLH 
transcription factors in the areas where neuronal plasticity occurs. 
DNA-binding assay results show that both proteins bind to E-boxes as 
homo- and heterodimers with remarkable differences in DNA-binding speci­
ficities. These differences in DNA-binding properties suggest that above men­
tioned factors regulate transcription through selective interactions with differ­
ent binding sites of target gene. In vitro DNA-binding assay revealed MEla and 
ME2 interaction with dominantly negative transcription factor Id2, also. 
Id2/MEla and Id2/ME2 heterodimers do not bind to the E-box sequences be­
cause the DNA-binding ability of these class A transcription factors is abol­
ished by inhibitory factor Id2. 
We tested activities of these HLH transcription factors in neuronal cell lines. 
Class A bHLH transcription factors (MEla or ME2) activate transcription of 
reporter gene in neuronal cells, and their coexpression of MEla or ME2 with 
Id2, a HLH transcription factor, interferes capability of these bHLH transcrip­
tion factors to enhance transcription of the reporter gene. 
Based on our data, we hypothesize that MEla and ME2 may activate gene 
expression of different target genes and therefore are likely to be differently 
involved during neurogenesis. 
We studied retinoic acid (RA) induced neuronal differentiation of teratocar­
cinoma PCC7 cells. These cells differentiate into neuron-like cells after induc­
tion with RA or RA plus dibutyryl c-AMP (dBcAMP) and are used as a model 
system of neuronal differentiation. Our approach was to identify factors that 
induce proliferation of neuronally differentiated teratocarcinoma PCC7 cells. 
Mouse E2F1 and novel cDNAs RNP1 and RNP2 (Regulator of Neuronal Pro-
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liferation) were isolated. We demonstrate that overexpression of E2F1, RNP1, 
and RNP2 cDNAs in neuronally differentiated PCC7 cells results in blocking 
differentiation and initiation of proliferation. 
Role of COUP TF orphan receptors in neurogenesis is virtually unknown. 
COUP TF transcription factors regulate activity of ligand-activated nuclear 
hormone receptors or function independently in the regulation of gene expres­
sion. Expression of COUP TFs and interactions with nuclear hormone receptors 
have been observed in the developing nervous system. We generated COUP TF 
I overexpressing teratocarcinoma PCC7 cell lines to study possible function of 
COUP TF I during neuronal differentiation. COUP TF I overexpression results 
in the blockade of morphological differentiation after induction to differentiate. 
Also, cells overexpressing COUP TF I do not stop proliferating after RA and 
dBcAMP treatment and possess suppressed transcriptional activation from dif­
ferent RA response elements. Our observations suggest that COUP TF I plays 
an important role in the control of neurogenesis by modifying activities of 
RAR/RXRs which regulate expression of neuronal-specific genes as well as 
genes regulating cessation of proliferation and initiation migration and differ­
entiation of neuroblasts. 
We tested effects of RNP1, RNP2 and COUP TFI on the expression of dif­
ferentiation specific genes. Expression of RNP1 and RNP2 blocks NF-L and 
GAP43 gene transcription in differentiating PCC7 cells. In contrast, COUP TF 
I expression does not affect NF-L gene, although delays expression of GAP43 
gene and represses MAP2 gene expression completely. These observation indi­
cate that initiation of differentiation specific genes is allowed during prolifera­
tion and is not necessarily downregulated by blockade of the neuronal differen­
tiation. These data also support the hypothesis that different neuronal genes are 
regulated by different mechanisms during differentiation. 
COUP TF II has a complex expression pattern during development suggest­
ing that different mechanisms are involved in the regulation of its expression. 
The molecular mechanisms responsible for the spatial and temporal expression 
of COUP TFs are still poorly understood. We isolated and analyzed the 5' 
regulatory region of the mouse COUP TF II gene and demonstrated that the 
basal promoter is localized in a -200 bp region 5' from major transcription start 
sites. 
We examined the cell type specific effects of RA and dBcAMP on COUP 
TF II promoter and revealed different cell type specific effects from repression 
to activation of the gene expression. We localized the cAMP response element 
to the region localized 74 nucleotide upstream from the major transcriptional 
start site. Also, in vitro promoter analysis demonstrate that the effect of RA is 
not directly mediated by the binding of RARs or RXRs to the studied promoter 
sequences. Weak inhibition of RA induced COUP TF II promoter activity was 
observed by coexpression of COUP TF I or COUP TF II transcription factors. 
We conclude that HLH transcription factors and nuclear hormone receptor 
transcription factors have an important role in the neurogenesis. Our data indi­
cate regulatory role of MEla, ME2 and Id2 in neurgenesis like it has been dem­
onstrated for the related bHLH transcription factors during myogenesis and 
haematopoiesis. Studies on teratocarcinoma PCC7 cells demonstrated that 
E2F1, a HLH transcription factor and RNP2 a HLH transcription factor Id4 
homologue are able to interfere neuronal differentiation and support prolifera­
tion in the presence of the inductor, RA. Retinoids regulate expression of cell-
type specific genes through specific nuclear hormone receptors, RARs, RXRs. 
COUP TFs are known as inhibitory molecules of nuclear hormone receptor 
transcription factors and in our experiments COUP TF I arrested neuronal dif­
ferentiation of PCC7 cells. We observed the role of HLH transcription factors 
during neuronal differentiation and neuronal development as well as role of 
COUP TF I during induced neuronal development. 
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10. HELIX-LOOP-HELIX- JA TUUMASEOSELISTE 
HORMOONIRETSEPTOR-TRANSKRIPTSIOONI-
FAKTORITE OSA NEUROGENEESIS 
Kokkuvõte 
Rakkude diferentseerumise mehhanismi spetsialiseerunud kudedeks pole veel 
ammendavalt kirjeldatud. Protsessi alguseks on prolifereeruvate rakkudega 
toimuvad muutused mis viivad rakutsükli katkemisele (G0-faas) ja sellele järg­
nevale suunatud geenide avaldumisele, kuni kasvuomaselt ekspresseerunud 
geenide kogum asendub spetsialiseerunud rakule omasega. 
Rakutsükli peatumine G0-faasis on diferentseerumise sõlmpunktiks. Mõne­
de transkriptsioonifaktorite osa selles on teada. Näiteks helix-loop-helix (HLH) 
perekonna E2F-valgu ja retinoblastoomi valgu pRb vahekord määrab, kas rakud 
jätkavad jagunemist või diferentseeruvad. Teine HLH perekonna valk Id2 ole­
tatavasti osaleb diferentseerumisel. Id2 võib seonduda pRb-le vahetult või toi­
mib tsükliini kinaaside (pl6, p21) vahendusel. Imetajate rakkude diferent­
seerumise spetsiifilisust tagavad aluselise domeeniga HLH (bHLH) valgud. Osa 
nendest valkudest ekspresseerub koeomaselt, teine osa koetüübist sõltumatuna. 
Transkriptsiooni reguleerivad nad kui homo- või heterodimeerid, seondudes re­
guleeritavate geenide promootorite kindlatele järjestustele (E-box). Samuti 
seonduvad nad eespoolmainitud Id-valkudega, kusjuures vastavad heterodimee­
rid ei aktiveeri transkriptsiooni. Nii lihasrakkude kui ka vereloomerakkude ku­
junemine toimub bHLH-faktorite kaasabil (MyoD/E2A). Hormoonide mõju di­
ferentseerumisele vahendavad ka tuumaseoselised hormooniretseptorid. 
Drosophila neurogeneesis on olulised HLH ja tuumaseoselised hormooni-
retseptor-transkriptsioonifaktorid. Vastavate faktorite homolooge on leitud ka 
selgroogsetel. Kõrgelt konserveerunud talitluslikult olulised piirkonnad viitavad 
nende faktorite talitluslikule sarnasusele nii selgrootutel kui ka selgroogsetel 
loomadel. 
Käesolevas töös uurisime hiire bHLH-transkriptsioonifaktorite ME1 ja ME2 
ekspressiooni areneval hiire lootel ja täiskasvanud looma ajus. Nimetatud fak­
torid ekspresseeruvad nii närvikoe arengu seisukohalt olulistes piirkondades kui 
ka täiskasvanud looma aju neuraalse plastilisuse piirkondades. In vitro analüüs 
näitab, et need faktorid võimendavad mRNA sünteesi neuraalsetes rakkudes ja 
Id2-faktor pärsib selle mõju. Erinevatele vaadeldud E-box-]ärjestustele seondu­
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vad uuritud faktorid erinevalt. Viimatinimetatu viitab uuritud faktorite võimali­
kule talitluslikule eripärale ja nende regulatoorsele tähtsusele diferentseeru­
misel. 
Neuraalse diferentseerumise mudelina võib vaadata teratokartsinoomi 
PCC7-rakuliini. Nimetatud rakuliin diferentseerub retinoolhappega (RA) mõju­
tamisel neuronitelaadseteks rakukogumikeks. Eraldasime PCC7-rakuliinist neu-
raalset diferentseerumist pärssivad geenid. Need olid hästituntud E2F-trans-
kriptsioonifaktor ja seni iseloomustamata faktorid RNP-1 ja RNP-2 (viimati­
nimetatu on Id4 homoloog), mis peatasid diferentseerumise ja suunasid dife­
rentseerunud rakud prolifereeruma. RA mõju rakus on vahendatud retinool-
happe- ja retinoidiretseptorite ja orfanretseptorite, näiteks COUP TF-ide 
(chicken ovalbumine upstream promoter transcription factor) koos- ja vastu­
mõjudega. Analüüsisime COUP TF I transkriptsioonifaktori poolt indutseeritud 
diferentseerumiseblokki PCC7-rakuliinil. Osutus, et COUP TF I kõrge tase nen­
des rakkudes takistab morfoloogilist diferentseerumist. Uuritud diferentseeru­
mist pärssivate faktorite (RNP1, RNP2 ja COUP TF I) mõju markergeenidele 
(NF-L, GAP43 ja MAP2) PCC7-rakuliinis on erisugune, alates täielikust eks­
pressiooni peatumisest (RNP2 mõju NF-L, GAL43 ja COUP TFI mõju MAP2 
ekspressioonile), osalise peetuse (RNP1 mõju NF-L ekspressioonile) ja täieliku 
puudumiseni (COUP TF I mõju GAP43 ekspressioonile). Saadud tulemus viitab 
erinevale mehhanismile uuritud markergeenide ekspressiooni suunamisel ja 
sellele, et diferentseerumisel avalduvate geenide ekspressioon võib alata juba 
jagunevas rakus. 
Retinoolhappe vallandatud diferentseerumisel on oluline osa orfanretsep-
toritel. Et uurida orfanretseptori COUP TF II geeni regulatsiooni, isoleerisime 
selle geeni promootori, lokaliseerisime minimaalse transkriptsiooni aktiveeriva 
piirkonna sellel ja oletatavad cAMP ja RA mõju vahendavad DNA järjestused. 
Osutus, et RA mõju vaadeldava geeni promootorile on kaudne. Promootori 
analüüs erinevatel rakuliinidel (teratokartsinoom PCC7, hiire fibroblastid 3T3, 
roti glioblastoom C6, inimese glioblastoom U373 ja emakakaelakartsinoom 
C33A) näitab RA transkriptsiooni võimendavat toimet PCC7-, pärssivat glio-
blastoomidel C6- ja U373- ja efekti puudumist 3T3- ja C33A-rakuliinidel. Or­
fanretseptorite COUP TF I ja COUP TF II mõju uuritud promootorile on nõr­
galt pärssiv. Selles töös näitame, et HLH transkriptsioonifaktorid ja COUP TF 
osalevad närvisüsteemi arengus. 
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Abstract 
We report the isolation of a cDNA encoding the mouse class A bHLH transcription factor ME2 and the analysis of its 
expression. ME2 is expressed in the cerebral cortex, Purkinje and granule cell layers of the cerebellum, olfactory neuroepithe-
lium, pyramidal cells of hippocampal layers CA1-CA4, and in the granular cells of the dentate gyrus. The specific expression of 
ME2 during development and in the regions of neuronal plasticity in the adult brain suggest that ME2 may have a regulatory 
function in developmental processes as well as during neuronal plasticity. 
Key words: Brain development; Helix-leop-helix; Gene expression; Plasticity; Mouse development 
Basic-helix-loop-helix (bHLH) transcription factors 
play important roles during development in many or­
ganisms [3). These proteins have a conserved helix-
Icop-helix (HLH) domain essential for dimerization as 
well as a basic domain which mediates DNA binding 
[7] to a common hexanucleotide sequence known as the 
E-box (CANNTG) [8]. Class A bHLH proteins can 
form homo- and heterodimers [7] and contain an addi­
tional loop-helix (LH) domain used for transcriptional 
activation [11] and a class A specific (CAS) domain of 
unknown function [13]. Three class A bHLH genes 
homologous to Drosophila daughterless are expressed 
in the developing and adult nervous system of mam­
mals. E2A gene is expressed at high levels in areas of 
cell proliferation whereas its expression is undetectable 
in nonproliferative regions of the brain and spinal cord 
[12]. ME1 gene [9], also known as HTF-4 [13], HEB [2], 
ALF1 [10], and REB [4], is expressed at relatively high 
levels in proliferating neuroblasts and decreases signifi­
* Corresponding author. Fax: (1) (303) 491-7907. 
cantly when cells initiate differentiation [9]. In this 
paper, we describe the expression of ME2, the mouse 
homolog of human ITF-2 gene. 
Cloning. ME2 cDNA [9] was used to screen a post­
natal day 1 mouse brain cDNA library in lambda 
ZAPII vector (Stratagene). Filters were washed at high 
stringency conditions (0.2 x SSC, 65°C). Fifteen clones 
were isolated and characterized. For analyses and se­
quencing, the phage DNA with insert was converted to 
its plasmid form using an in vivo excision protocol 
(Stratagene). 
In situ hybridization. In situ hybridization was per­
formed as described elsewhere [9]. The hybridization 
buffer contained 5 x SSPE, 50% formamide, 12% dex-
tran sulfate, yeast tRNA, and Denhardt's solution. The 
entire coding sequence of ME2 was subcloned into the 
Bluescript vector SK (Stratagene) and used to synthe­
size single-stranded antisense and sense RNA probes 
using T3 and T7 RNA polymerases, respectively. Probes 
were partially hydrolyzed with 0.2 M NaOH on ice for 
30 min and neutralized with 1 M acetic acid. The 
hybridization was performed at 50°C for 15 h followed 
0169-328X/94/S07.00 C 1994 Elsevier Science B.V. All rights reserved 
SSDI 0169-328X(94>00090-2 
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CAAAGTGCCTCCGATQGATGAACCCOGCAAACCCTG 36 
AACTrGTTCAQGCTTCAGATTGTAACTGGCGATCTGAQGGOGAAAATGAQGTGCTCOGTGAATTTTCCTTGGTTTGTGTGATTTTGCTAAA 126 
ATGCATCACCAACAGCXIAATGGCTGCCTTACXX^CÄÄCAAAGAGCTGAGTGÄTTTACTGGATTTCAGTGCGATCTTTTCGCCTCCTCTA 216 
M H H Q Q F M A A L G T D K E I S D L L D F S A H F S P P V  3 0  
AGCAGTOOGAAAAATQGACCAACTTCTTTOGCGAGTOGACATrTCACTOGCTCAAATGTAGAAGACAGAAGTAGCTCAGOGTCCTQGQGA 306 
S S G K N G P T S L A S G H F T G S N V E D R S S S G S W G  6 0  
ACTOGAQGCCATCCAAGCCCGTCCAGGAACTATOGAGATQQGACTCCCTATGACCACATGACTAGCAQGGATCTTQQGTCACACGACAAT 396 
T  C G H P S P S R N Y G D G T P Y D H H T S R D L G S H D N  9 0  
CTCTCTCCACCTTTTGTCAATTCCAGAATACAAAGTAAAACAGAAAGOCKCTCATACTCATCrrATOOGAGACAAAACCTTCAGaCTTGC 486 
LSPPFVNSRIQSXTERGSYSSYGRENVQGC 120 
CACCAGCAGAGTCTCCTCOGAOGOGACATQGATATaOGCAATCCAOGAACCCTTTCGCCCACCAAACCTGGCTCCCAGTACTATCAGTAT 576 
HQQSLLCGDMDMGNPCTLSPTKPGSQYYOY 150 
TCAAGCAATAATGCCCGCOGGAGGCCTCTTCACAGTAGTGCCATQGAQGTACAGACAAAGAAAGTCCGAAAAGTTCCTCCGQGTTTGCCG 666 
SSNNARRRPLHSSAHEVQTKKVRKVPPGLP 180 
TCTTCAGTCTACGCTCCTTCAGCCAGCACTGCCGACTACAACAGQGACTCGCCAGGCTATCCTTCCTCCAAGCCAGCAGCCAGCACTTTC 756 
SSVYAPSASTADYNRDSPGYPSSKPAASTF 210 
CCTAGCTCCTTCTTCATGCAAGATOGCCATCACAGCAGCGACCCTTGGAGCTCCTCCAGCGOGATGAATCAGCCCGGCTACGCAOOGATG 846 
PSSFFMQDCHHSSDPWSSSSGMNQPGYAGM 240 
CTQQGCAATTCTTCTCATATCCCACAGTCCAjGCAGCTACTGTAGCCTGCATCCACATGAACCTTTGAGCTATCCATCCCACTCCTCGGCA 936 
LGNSSHIPQSSSYCSLHPHERLSYPSHSSA 270 
GACATCAACTCCAGTCTTCCTCCGATGTCCACGTTCCATCGTAGTOGCACAAACCATTACAGCACCTCTTCCTCCACACCCCCTGCCAAC 1026 
DINSSLPPMSTFHRSGTNHYSTSSCTPPAN 300 
GGAACAGACAGTATAATQGCAAACAGAOGAACTGGQGCAGCAGGCAGCTCQCAGACTGGAGACQCTCTGQQGAAAGCCCTAGCTTCGATC 1116 
GTDSIMANRGTGAAGSSQTGDALGKALASI 330 
TATTCTCCTCACCACACGAACAACAGCrrTTCCTCCAATCCTTCAACTCCTGTGGGCTCCCCTCCTTCACTCTCAGCAGGCACAGCTGTT 12 06 
YSPDHTNN SFSSHPSTPVGSPPSLSAGTAV 360 
TGGTCTAGAAATOGAGGACAOGCCTCGTCATCTCCCAATTATGAAQGACCCTTCCACTCACTGCAAAGCCGAATCCÄAGACCGTTTCGAA 1296 
K S E B G G P A S S S F H y t G P t . U S l . O S B  I  E D R L E 390 
bOOr-BKLXX 
AGACTQGACGATGCGATTCATCTTCTCCGGAACCACGCAGTQGGCCCGTCCACAGCTGTGCCTGGTQGCCATOQGGACATGCATQGGATC 1386 
R T ,  D n A T H V I .  B N H A V r t P  S T A V P G G H G D M H G  I  4 2 0  
ATOOGACCCTCCCACAACXXJAGCGATOGGTAGCCTOGGCTCAOGGTACOGAACTAGTCTTCTCTCAGCCAACAGACACTCGCTCATGGTT 1476 
MGPSHNGAMGSLGSGYGTSLLSANRHSLMV 450 
QGOGCCCACCGTGAAGATOGCGTGGCTCTGAGAGGCAGCCATTCTCTCCTGCCAAACCAGGTTCCGGTCCCACAACTTCCGGTCCAGTCT 1566 
GAHREDGVALRGSHSLLPNOVPVPOLPVQS 480 
GCAACTTCCCCTGACTTGAACCC ACCCCAAGACCCTTACAGAGGGATGCC ACCAOGCCTCCAGOGCCAGAGCGTGTCTTCTGGTAGCTCT 1656 
ATSPDLNPPQDPYRGMPPGLQGQSVSSGSS 510 
GAGATCAAATCCGACX3ACGAGOGCGATGAGAACCTGCAAGACACAAAATCTTCTGAGGACAAGAAATTAGATGACGACAAGAAGGATATC 174 6 
EIXSDDEGDENL0DTKSSEDKKLDDDKKD1 540 
AAATCAATTACTAGCAATAACGATGATGAGGACCTGACCCCAGAGCAGAAQGCTGAGCGCGAGAAGGAACQGAQGATGGCCAATAATGCC 1836 
K S I T S N N D D E D L T P E O K A  E R E K F .  R R M A N N A  5 7 0  
CGTGAGCGCCTGAQQGTCCGAGATATCAACGAQGCTTTCAAGGAGCTTQGCCGTATGGTGCAGCTCCACCTGAAGAGCGACAAGCCCCAG 1926 
r e r l r v r d t n e a f k e l c r m v o l h l k  s p y  P  O  6 0 0  
fcaalc MLXX-LOOP-MLIX 
ACCAAGCTCCTGATTCTCCACCAGGCCGTQGCTGTCATCCTCAGCCTQGAGCAGCAAGTTCGAGAAAGGAATCTGAACCCGAAAGCTGCC 2016 
T r 1, i. 7 L—H—Q &__Y_Ž Y I L S—J. E QQVBERNLMPKAA 630 
c  &  a  
TGTCTGAAAAßAAfiGGAGGAAGAGAAQGTGTCCTCAGAGCCTCCCCCACTCTCCTTCGCTGGCCCACACCCTGC3GATGGGAGACGCAGCG 2106 
CLKRRF.F. EKVS SEPPPLSLAGPHPGMGDAA 660 
AATCACATGGGACAGATGTGAAAAGGTCCAAGTTGCTACCTTGCTTCATTAAACAAGAGACCACTTCCTTAACAGCTGTATTACCCTAAA 2296 
N H M G 0 M 
CCCACATAAACACTGCTCCTTAACCCCGTTTTTTTTTGTAAATAAGACAAGTCTGAGTAGTTATCAATCGCAGACGCAAGAGGTTTCAGC 2386 
ATTCCCAATTATCCTCGTGCCGGACTCAACTAACACATGTACAGATGTGAAAAGGTCCAAGTTGTCACCTTGCTTCAT 24 64 
Fig. 1. Nucleotide and deduced amino acid sequences of ME2. The underlined amino acid sequences correspond to loop-helix, basic-helix-loop-
helix, and CAS domains. 
A. Soosaar et ai. / Molecular fbuin Research 25 (1994) 176-180 
4 E12 
Cbx P  
LCC 
c 
E18 
Cb 
ME 
m Mi­
se 
ß EIS 
P? 
CC 
'
KSE . 
AF 
PO 
Cb 
OB 
£ 
A»/ 
„Cb 
>;•••,šaaäMBg^ 
V .  cc 
HC^r 
OB 
D7 
im 
AO 
% 
•cc;; 
HCWK 
iSE 
"Cb.' 
cc 
mcT 
U s  
16 
A Scx)saar et ai. /Molecular Brain Research 25 (1994) 176-180 179 
by RNase treatment at 37°C. The sections were washed 
twice in 2 X SSC at 50°C, once in 0.2 X SSC 55°C, and 
finally in 50% formamide/2 X SSC at 50°C for 1-2 h. 
The slides were stained with Giemsa. 
Characterization of ME2 cDNA. To obtain cDNAs 
encoding full length ME2, a mouse newborn brain 
cDNA library was screened with the PCR derived ME2 
cDNA [9], The longest cDNA obtained was approxi­
mately 2.4 kb with an open reading frame encoding 666 
amino acids (Fig. 1) and a predicted molecular weight 
of 71,147 Da. ME2 is 98% identical to the human ITF2 
at the amino acid level and 94% identical at the 
nucleotide level. 
Expression of ME2 in the nervous system. Northern 
blot analysis revealed the presence of a single 6 kb 
mRNA expressed maximaly during embryonic develop­
ment (data not shown). By in situ hybridization analy­
sis, at embryonic day 12 (E12) ME2 expression is 
detectable in the cortex, cerebellum, pons, medulla and 
spinal cord (Fig. 2A). In non-neuronal tissues, my­
otomes and developing limbs have the strongest hy­
bridization signal. From embryonic day 18 (E18) until 
adulthood, ME2 is expressed at high levels in the 
pyramidal cells of hippocampal layers CA1-CA4, and 
in the granular cells of the dentate gyrus (Fig. 2C) and 
at lower levels in the neocortex. At postnatal day 7, 
expression of ME2 is remarkably high in the visual 
cortex which is undergoing a critical period of develop­
ment (Fig. 2B) and in the subependymal region extend­
ing from the anterior lateral ventricle into the olfactory 
bulb (Fig. 2C, E18 and P7). Cerebellar granule and 
Purkinje neurons and the ventricular zone of the olfac­
tory bulb express ME2 at all stages studied (Fig. 2C). 
In this paper, we demonstrate that ME2 is ex­
pressed in proliferative zones during development and 
in the adult in areas of neuronal plasticity (hippocam­
pus, cerebellum, olfactory neuroepithelium and neo­
cortex). The developmental profile of ME2 expression 
is different from the one of El2 [12] or MEl [9] in that 
the later ones decrease to almost undetectable levels in 
the adult. Whether the function of ME2 is the same 
during development and during synaptic plasticity is 
unknown. 
Of particular interest is the expression of ME2 in 
areas of neuronal plasticity. Induction of long-term 
potentiation (LTP) and kindling cause upregulation of 
several early response genes including the proto-onco-
genes c-fos and c-jun [1,6]. The effect of transcriptional 
activation of c-fos depends on the promoter elements 
one of which is an E-box sequence which may have a 
critical role during transcriptional induction [5]. ME2, 
like other genes expressed in areas of neuronal plastic­
ity (such as fos, jun, GAP-43 etc.) may increase during 
regeneration and LTP. It will be of interesting to 
investigate whether the levels of ME2 vary during these 
experimental conditions. 
This work was supported by funds from the Col­
orado State University (BRSG), National Science 
Foundation and the March of Dimes Birth defects 
foundation. 
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Abstract 
Class A basic-helix-loop-helix (bHLH) proteins have been referred to as ubiquitous and are believed to have redundant 
functions. They are involved in the control of several developmental pathways, such as neurogenesis and myogenesis. To 
rationalize the existence of multiple class A bHLH proteins, we evaluated the differences and similarities between ME la and 
ME2, two class A bHLH proteins, highly expressed in differentiating neuronal cells. In situ hybridization analyses reveal that 
MEla and ME2 are characterized by distinguishable patterns of expression in areas of the adult mouse brain where neuronal 
plasticity occurs. Also, DNA-binding assays show, that both proteins bind to E-boxes as homodimers and heterodimers. and show 
differences in their DNA-binding specificities, which suggest selective interactions with different binding sites of target genes. In 
addition, in vitro DNA-binding assays demonstrate that Id2 forms heterodimers with MEla and ME2. As a result of these 
interactions, their DNA-binding activity is abolished. Furthermore, overexpression of ld2 in neuronal cells suppresses MEla and 
ME2 transcriptional activity. Based on our data, we hypothesize that MEla and ME2 may activate gene expression of different 
target genes and therefore are likely to be differently involved during neurogenesis. 
Keywords Brain development; Neuronal plasticity; Helix-loop-helix; Gene expression 
1. Introduction 
Basic-helix-loop-helix (bHLH) transcription factors 
play important and specific roles in various develop­
mental pathways of many organisms. In Drosophila, 
the requirement of bHLH transcription factors in de­
termining cell fate during development of the nervous 
system has been well established 16,7,20]. Expression of 
proneural bHLH genes including daughterless, atonal 
and the Achaete-Scute Complex (AS-C) is a prerequi­
site for neuronal differentiation. For example, the 
achaete/daughterless heterodimer confers upon cells 
the potential of developing into neural precursors [14]. 
Based on a remarkable degree of similarity between 
' Corresponding author. Fax: (1) (303) 491-0494. 
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several mammalian bHLH genes and Drosophila 
proneuronal genes, it seems very likely that mam­
malian bHLH factors also regulate neuronal develop­
ment. Recently, the molecular mechanisms controlling 
the early steps of vertebrate neurogenesis have 
emerged. The rat homologues of Drosophila achaete-
scute, Mash-1 and Mash-2 are expressed in the devel­
oping nervous system at a time when neurons are being 
generated [21]. In the mouse, the expression of Mash-1 
is restricted to cells in the developing central and 
peripheral nervous systems between embryonic days 
8.5 and 12.5, suggesting it plays a critical role during 
early stages of neurogenesis [15], Recently, this has 
been confirmed by studies on mice carrying homozy­
gous null mutations in the Mash-1 gene. Mutant mice 
died shortly after birth and showed defects in a num­
ber of olfactory and peripheral autonomic neurons [16]. 
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Taken together, these data clearly indicate the impor­
tance of bHLH proteins in neuronal differentiation. 
During myogenesis, MyoD and Myf-5 bHLH tran­
scription factors play pivotal rõles and are postulated 
to be responsible for myoblast determination [39]. 
MyoD acts as a regulator of muscle specific gene 
expression and when expresssed from a constitutive 
promoter, it converts different cell types into muscle 
cells [33,43,44], Recently, it has been demonstrated 
that these myogenic regulatory factors are required for 
the determination and propagation of skeletal my­
oblasts, using mice carrying null mutations in Myf-5 
and MyoD [35]. 
Basic-helix-loop-helix transcription factors contain 
at least four functional domains including a helix-
loop-helix domain utilized for dimer formation 
[24,27,28], a basic domain required for DNA binding 
[10,42], a nuclear localization region [9,22], and a tran­
scriptional activation domain [10,18,34], The basic and 
the helix-loop-helix domains are conserved between 
many of the bHLH proteins [28,30] and because of this 
conservation they ail bind the consensus DNA se­
quence CANNTG known as the E-box. Specific ho-
modimers and heterodimers of bHLH proteins have 
different binding affinities depending upon the particu­
lar nucleotides within the internal and flanking se­
quences of the E-box [5,12], 
Helix-loop-helix transcription factors have been 
grouped into different classes depending on their ex­
pression patterns and the homology of their functional 
domains with other bHLH proteins [27]. Class A bHLH 
transcription factors, such as El2, E47, da, MEl and 
ME2, are expressed in more than one tissue and are 
characterized by their ability to readily form homod-
imers and heterodimers. They contain a conserved 
domain adjacent to the HLH motif, termed the Class A 
Specific (CAS) domain [46] and a newly identified 
loop-helix (LH) motif involved in transcriptional activa­
tion [34], Class B transcription factors, like MyoD, 
myogenin, and members of the AS-C complex, have a 
more temporal and specific distribution and are be­
lieved to bind DNA as heterodimers with a class A 
bHLH factor. Both class A and class B bHLH proteins 
can interact with Id-like proteins (i.e. extra-
macrochaete, ldl, Id2, HLH462) which contain the 
HLH motif but lack the basic domain [3,11,38]. Het­
erodimers of a bHLH protein and an Id-like protein 
are devoid of DNA-binding activity. 
As a first step in elucidating the role of bHLH 
proteins during neuronal development, we cloned sev­
eral murine cDNAs encoding class A bHLH transcrip­
tion factors, named MEl through ME4 [30]. Protein 
sequence analysis between MEl and ME2 reveals three 
highly conserved domains, LH [34], bHLH [21] and 
CAS [46]. MEl is abundantly expressed during neu­
ronal development and is down-regulated once cellular 
differentiation is completed [30], As a result of alterna­
tive splicing, the MEl gene encodes two proteins, 
MEla and MElb. MEla is enriched in neuronal cells 
and the ratio between MEla and MElb increases 
considerably during mouse neuronal development and 
neuronal differentiation of PCC7 cells in culture [30]. 
MEla is characterized by a 24 amino acid insertion 
that disrupts a leucine heptad repeat which shows a 
high degree of similarity with ankyrin-like domains 
[22]. A series of bHLH proteins closely related to the 
two forms of MEl, including the human E-box-binding 
protein HEB [19], the human transcription factor HTF4 
[46], the rat E-box-binding proteins REBa and REB^ 
[22], the Akv murine leukemia virus E-box-binding 
proteins, ALF1A and ALF1B [32] and the chicken 
E-box-binding protein CTF4 [41], have been cloned 
from cDNA libraries by screening for binding of la­
beled E-box sequences. We believe MEla (ALF1B) is 
the mouse counterpart of the rat REB0 while MElb 
(ALF1A) is the mouse counterpart of rat REBa, hu­
man HEB, human HTF4, and chick CTF4. 
It has been shown that HEB, the human homologue 
of MElb, binds to several E-box sequences as a ho-
modimer or a heterodimer with E12, 1TF-2 or myo­
genic factors and functions as a transactional activator 
[18]. REBa, the rat counterpart of HEB and MElb 
binds as a homodimer or heterodimer to the E-box 
CE-2 site located in the control region of the calci-
tonin/CGRP gene [22]. However, REB/3 (rat MEla) 
poorly dimerizes or binds to DNA [22]. ME2, another 
abundant class A bHLH transcription factor, is ex­
pressed in the mouse brain from as early as embryonic 
day 12 and throughout the development [36] and is 
highly homologous to human ITF2 [18]. ITF-2 has been 
shown to behave as a transcriptional activator only as a 
chimeric GAL4: ITF-2 protein using a reporter plas-
mid with several GAL4 DNA-binding sites [18,34]. 
As an attempt to rationalize the existence of multi­
ple class A bHLH transcription factors, we have sought 
to analyze the differences and similarities between the 
MEla and ME2 proteins. In situ hybridization analyses 
indicate overlapping as well as unique expression pat­
terns between these two class A bHLH proteins in the 
adult mouse brain. We demonstrate that MEla and 
ME2 proteins bind specific E-boxes as homodimers as 
well as heterodimers with MyoD. The assessment of 
their binding specificity reveals that MEla preferen­
tially binds to a different subset of E-box elements 
than does ME2. We demonstrate that both class A 
bHLH proteins function as transcriptional activators in 
neuronal cells, and that ld2 negatively regulates the 
transcriptional activities of MEla and ME2 by forming 
inactive heterodimers. Taken together, these results 
suggest that although MEla and ME2 are both class A 
bHLH proteins, they participate differently during the 
modulation of neurogenesis and neuronal plasticity. 
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2. Materials and methods 2.4. Antibody production 
2.1. Constructions of eukaryotic expression plasmids 
Full length ME2 cDNA was cloned into Bluescript SK vector 
(Stratagene) as described [36]. A truncated ME2 cDNA which lacks 
the first 216 N-terminal amino acids was also isolated and cloned 
into Bluescript SK vector (Fig. 1). Both ME2 forms were subcloned 
into the Sftndlll site of the eukaryotic expression vector pRcCMV 
(InVitrogen) to give CMV ME2 and CMV ( —216)ME2 for full 
length and truncated ME2, respectively. The Spei-Bst Ell fragment 
containing the entire coding sequence of MEla [30] was blunt ended 
and Hindi]] linkers were added in order to subclone into the 
WmdIIJ site of pRcCMV. This construct is referred to as CMV 
MEla. The Jflwl-Mindlll fragment carrying the complete cDNA 
sequence for Id2 was introduced into pRcCMV to give rise to the 
CMV ld2 plasmid. For in vivo studies, a reporter plasmid (MEF)X4 
TKCAT carrying four copies of the MEF1 site (CACCTG) was 
constructed by inserting the oligonucleotides containing the MEF-1 
E-box into the pBLCAT2 plasmid. 
2.2. Construction of lyacierml expression plasmids 
The Kpnl-HindUl fragment which encodes the last 333 
carboxy-terminal amino acids of MEla, including the bHLH motif 
and the 24 amino acids specific to the neuronal form of MEl (MEla) 
was subcloned into the pRSET vector and this plasmid is referred to 
as pMEla/Apnl. A Ncol- Wmdlll fragment carrying the last 238 
C-termina! amino acids of ME2 was subcloned into the pRSET 
vector and this construct is called pME2/M:oI. A Amnl-£coRI 
fragment carrying the first 117 amino terminal amino acids was 
subcloned into pRSET B vector and this construct is referred as 
pRSET/ld2 All plasmid sequences were confirmed using the USB 
Sequenase kit version 2.0 
2.3. Cell culture 
N18 (33) and NG108-15 (34) cell lines were grown in Dulbecco's 
modified Eagle's medium (DMEM) containing 109i fetal calf serum 
(Gibco). 
A polyclonal antibody was raised in New Zealand white rabbits 
»gainst a peptide carrying the sequence of the helix of the CAS 
domain (CLKRRREEEKVSAASAE) linked to the carrier KLH 
(Keyhole Limpet Hemocyanin). Protein G-Sepharose Fast Flow 
affinity chromatography (Pharmacia) was used to purify the lgG 
fraction. 
2.5. Protein purification 
The appropriate expression plasmid was transformed into the E 
coli strain, BL21 DE3 pLys-S, a T7 lysozyme producing strain which 
contains the T7 RNA polymerase gene under the control of the 
inducible lac-UV5 promoter [37], Cells were grown at 37°C to an 
O.D^oo of 0.6 and then induced with 1 mM 1PTG (Sigma). The 
polyhistidine-containing recombinant proteins were purified by Ni'"-
NTA chromatography (Qiagen) under denaturing conditions. The 
cells were lysed in 6 M guanidine.HCl pH 8 (Sigma) at room 
temperature for 30 min. The lysate was cleared by centrifugation and 
the supernatant was incubated with the Ni2*-NTA resin and loaded 
onto a column according to the manufacturers instructions (Oiagen). 
The bound recombinant proteins were eluted by lowering the pH. 
After purification, the proteins were allowed to refold by gradual 
dilution of the denaturing agents through dialysis. The recombinant 
protein was suspended in a buffer containing 109c glycerol, 20 mM 
HEPES pH 7.2, 1 mM EDTA, 0.1 M Nad, 1 mM DTT, and 1 mM 
PMSF. 
2.6 Preparation of DNA probe and specific competitors 
The following DNA oligonucleotide probes were synthesized by 
Macromolecular Resources (Colorado State University). The se­
quences of the top strands of MEF1, FIE5, #*E2. kE2 oligonu­
cleotides [19] and c-fos oligonucleotide [26] with the E-box sequence 
underlined are as follows: MEF1, 5'-CTAGATCTCC-
AACACCTGCTGCGGAT-3'; Non-specific. 5-TAAGGCTCTGAC-
GTCTCCCCC-3'; ^E5, 5'-TGCAAGAACACCTGCAAACA-3': 
/UE2. 5'-AGCTGGCAGCAGCTGGCAGCA-3'; *E2. 5-GGGTCG-
AAAGGCAGGTGGCCCAAGCT-3'; c-fos, 5 -GATGTCCATTAG 
MEla um [ 
cm aa) 
m: jEÜT 
bHLH LH 
ME2 
(M0 AA) N L  
(•21<)MEZ 
J  i  
LH bHLH LH 
Fig 1 Linear representation of MEla and ME2 proteins. The major structural-functional regions are indicated; leucine zipper (LZ), nuclear 
localization domain (NL). loop-helix transcriptional activation motif (LH), leucine heptad repeat (LMLL). basic region (b), and helix-loop-helix-
loop-helix (HLHLH). The second loop and third helix form the CAS domain. The MEla specific mini-exon is represented by a black box. The 
polyclonal antibody #597, raised against the helix motif of the CAS domain, is indicated by a thick black line. The truncated proteins used for 
EMSA are indicated at the top of each linear representation by an arrow and their names indicate which restriction site was used for their 
cloning. The construct (- 216)ME2 refers to the truncated form of ME2 cloned in the eukaryotic expression vector pRcCMV. 
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GACATCTGCGTCA-3'. The complementary oligonucleotides of the 
MEFI site were annealed and the double-stranded MEFI probe was 
labeled al the recessed 3' ends using [«"PJdCTP (Amersham) and 
Klenow polymerase (Boeringer). Unlabeled competitor DNAs (non­
specific, ^E5, p. E2, «E2 and c-fos) were prepared by annealing 
complementary oligonucleotides. 
2.7. Electrophorelic mobility shift assays 
DNA binding reactions consisted of 40 ng of purified protein 
incubated with 40 fmol of labeled oligonucleotide MEFI and I (Ml ng 
of poly(dl.dC) (Sigma) for 20 min at room temperature in presence 
of binding buffer (10 mM Tris-HCl pH 7.5, 50 mM KCl, 0.1 mM 
EDTA, 1 mM DTT, 1 mM MgCl2. 5% glycerol). When heterodimer 
formation was studied, 40 ng of purified MEl or ME2 protein and 
200 ng of MyoD were incubated for 20 min at room temperature. 
The probe (40 fmol) was added to the mixture and incubated for an 
additional 20 min at room temperature. For supershifl assays, 40 ng 
of purified recombinant protein MEla or ME2 was incubated with 1 
PLg of polyclonal antibody or rabbit preimmune serum prior to the 
incubation with the probe. For competition experiments, purified 
protein was incubated for 20 min with (he MEFI probe (40 fmol) in 
% 
. .J I VI •*> 
Cb . • 
Fig. 2. MEla and ME2 mRNA expression in adult mouse brain. A: in situ hybridization analysis of MEla on a cross seclion of adult brain, 
Hybridization signals are strongly detected in the internal granular cell layer of the cerebellum UGL) and the dentate gyrus of the hippocampus 
(DG) and poorly detected in the pyramidal cells from CA1 through CA3 (CA). B: in situ hybridization analysis of ME2 on a cross section of adult 
brain. Hybridization signals are strongly detected in the internal granular cell layer of the cerebellum (CI)), the dentate gyrus of the hippocampus 
(DG), Ihe pyramidal cells from CA1 through CA3 (CA), and the cerebral cortex (Ctx). A similar picture for ME2 has been described [36] and is 
included here for comparison purposes. 
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presence of 25 fold excess of cold competitor. The products of the 
DNA binding reactions were electrophoresed on a 5% native gel, 
0.5XTBE (45 mM Tris, 45 mM boric acid, and 1 mM EDTA) for 
1.45 h at 150 V. Gels were dried and exposed on liyperfilm MP X-ray 
film (Amersham) at -70°C. 
l4C]chloramphenicol (Amersham), and 50-100 f ig of total protein 
was incubated at 37°C for 1.5 h. After extraction with ethyl acetate, 
the radioactive forms of chloramphenicol were resolved by thin-layer 
chromatography, localized by exposing to X-ray film, and quantitated 
by Phosphorlmager analysis. All experiments were done in triplicate. 
2.8. Transfections and CA T assays 
Cells at a density of 0.5-1 x 106 in 60 mm dishes were transf'ecled 
using a calcium phosphate coprecipitation method. The total amount 
of transfecied DNA was kept constant by the addition of an appro­
priate amount of carrier DNA (empty expression vector). Twenty 
four hours later, the media was changed and cells were harvested 
after 48 h. Cells were washed in PBS, lysed in 250 mM Tris-HCI (pH 
7.6) by three freeze/thaw cycles. A 150 (i\ mixture containing 0.4 
mM acetyl coenzyme A (Sigma), 0.1 ßd of [dichloroacctyl-1,2-
2.9. In situ hybridization 
III situ hybridization was performed as described [30]. The MEla 
probe was transcribed from the MEla vector pBSMEla which is a 
full length MEla cDNA cloned into pBluescript SK [30]. The ME2 
probe was synthesized by T3 RNA polymerase from the ME2 vector 
pBSME2 containing the full length ME2 cDNA [36]. The probes 
were partially hydrolyzed wilh 0.2 M NaOH on ice for 30 min and 
neutralized with 1 M acetic acid. All in situ experiments were 
repeated at least three times using sense riboprobes to determine (he 
background level. 
ivasgbii 
-««-MElsfKmi 
•«*» f 
—MjnD 
Fig. 3. MEla and ME2 bind lo the MEFI E-box as homodimcrs and heterodimers. A: recombinant MEIa/Kpnl and ME2//V'c«l proteins were 
expressed in E. coli and purified by Ni2+ chelate chromatography. The purified proteins were assayed by SDS/PAGE and visualized by 
Coomassie staining. The size of the protein molecular weight standards is shown on the left and the position of each purified protein is indicated 
on the right. B: MEla/JCpnl protein is supershifted by a polyclonal antibody raised against the helix of the CAS domain. Forty ng of purified 
ML:. 1 ;i/KpnI was incubated with 40 fmol of labeled oligonucleotide MEFI in absence (lane 1) or presence of 1 MS of affinity-purified polyclonal 
antibody anli-CAS (lane 3) for 20 min al room temperature. Preimmune serum was added as a negative control (lane 2). The protein-DNA 
complexes were resolved by electrophoresis on a native 5% Polyacrylamide gel, 0.5 X TBE. The gel was truncated lo show only the protein-DNA 
complexes. C: MEla/Ajml forms heterodimers with MyoD. Forty ng of MEla/AJwil (lane 1) or 100 ng of purified MyoD (lane 2) was incubated 
with 40 fmol of labeled oligonucleotide MEFI lor 20 min at room temperature. When heterodimer formation was studied, the two purified 
proteins, MEla and MyoD, were incubated together for 20 min prior to the addition of probe (lane 3). The different protein-DNA complexes 
are indicated by arrows. D: ME2/Afa>I binds lo the MEFI E-box as homodimers and is supershifted by an antibody against the helix of the CAS 
domain. Forty ng of purified ME2/M.oI was incubated with 40 fmol of labeled oligonucleotide MEFI in absence (lane 1) or presence of 1 /iß of 
affinity purified polyclonal antibody anti-CAS (lane 3) for 20 min at room temperature. As a negative control, preimmune serum was also added 
(lane 2). 
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3. Results 
3.1. MEla and ME2 are expressed in oi>erlapping and 
different areas of the adult brain 
The level of expression of MEl and ME2 is regu­
lated during brain development [30,36], Soon after 
birth, MEl is expressed at low level whereas ME2 
expression remains high and gradually decreases as the 
mouse brain reaches maturity. As a further means to 
dissect the differences and similarities between the two 
class A proteins, MEla and ME2, parallel in situ 
hybridization analyses were performed on mouse adult 
brain using MEl and ME2 antisense probes. High 
levels of MEl and ME2 expression were detected at 
the internal granular cell layer (1GL) of the cerebellum 
(Fig. 2A,B). Other areas of common expression in­
cluded the granular cells of the dentate gyrus of the 
hippocampus albeit at a lower level for MEl (Fig. 
2A,B). In the adult brain, ME2 expression was very 
abundant in the pyramidal cells from CA1 through 
CA3 whereas MEl expression was barely detectable. 
Relatively strong ME2 signals were also observed 
throughout the cortex whereas MEl expression was 
not detectable beyond background in this area. These 
data clearly indicate several spatial similarities and 
differences between MEl and ME2 in areas of the 
adult brain where neuronal plasticity occurs. 
3.2. MEla and ME2 form dimers and bind to E-box 
elements 
As an attempt to elucidate the molecular mecha­
nisms of action of the two class A bHLH proteins, 
MEla and ME2, we determined their dimerization and 
DNA-binding properties. We first examined, using an 
electrophoretic mobility shift assay (EMSA), whether 
MEla could form homodimers even with the disrup­
tion of the leucine heptad repeat by the 24 amino acids 
specific to the neuronal form of MEl (Fig. 1). For all 
EMSA analyses described in this report, we used bac­
terial ly purified proteins to avoid interferences with 
products of alternative translation initiation codons 
and contaminating proteins present in the rabbit retic­
ulocyte lysate that can interact with the protein of 
interest [40]. Due to the large molecular weight of the 
full length MEla protein, we expressed the C-terminal 
fragment of MEla (MEla/Apnl). This truncated form 
carries the bHLH motif as well as the 24 amino acids 
specific to the neuronal form MEla (Fig. 1). MEla was 
expressed in E. coli and purified to near-homogeneity 
by metal affinity chromatography. An SDS/poly-
acrylamide gel of the purified MEla protein is shown 
in Fig. 3A. Fig. 3B demonstrates that MEla binds as a 
homodimer to oligonucleotides containing the E-box 
found in the muscle creatine kinase enhancer MEFI 
site. To ascertain whether this protein-DNA complex 
is specific, we added to the reaction a polyclonal anti­
body raised against the helix of the CAS peptide. In 
the gel shift assay, this antibody supershifted the 
MEla-DNA complex whereas the preimmune serum 
did not alter its mobility (Fig. 3B, lanes 2 and 3). 
To analyze ME2 DNA-binding abilities by EMSA, a 
truncated ME2 protein containing the last 300 
carboxy-terminal amino acids (ME2/AfcoI; Fig. 1) was 
expressed in E. coli. ME2/Nco) was then purified by 
nickel affinity chromatography to near homogeneity as 
shown on a coomassie stained SDS/polyacrylamide gel 
(Fig. 3A, lane 2). Binding of ME2 to an oligonucleotide 
carrying the MEFI site produced a shifted ME2-DNA 
complex (Fig. 3D, lane 1). The specificity of this com­
plex was confirmed by supershift using the polyclonal 
antibody raised against the CAS domain and the 
preimmune serum as a control (Fig. 3D, lanes 3 and 2). 
Current models propose that class A bHLH factors 
modulate transcriptional activation differently depend­
ing on whether they are bound as homodimers or 
heterodimers [2,28]. MyoD was chosen to investigate 
whether MEla or ME2 could form functional het­
erodimers with a class B bHLH protein. MEla and 
ME2 are expressed in somites and myotomes at high 
levels [30] and are likely to be endogenous heterodimer 
partners of MyoD. Full length MyoD protein was ex­
pressed in bacteria using the bacterial T7 expression 
vector system [37] and purified to near-homogeneity. 
Heterodimer formation was studied by EMSA using 
the MEFI site of the muscle creatine kinase enhancer. 
First, the heterodimers were allowed to form at room 
temperature in the absence of E-box which was then 
added to the reaction. Both MEla homodimers and 
MEla/MyoD heterodimers were detected (Fig. 3C, 
lanes 1 and 3). MyoD homodimers were also observed 
by EMSA because a high concentration (200 ng) of 
bacterially expressed MyoD was used in this assay (Fig. 
3C, lane 2). Additionally, we observed that ME2, when 
incubated with MEla or MyoD, produced an interme­
diate mobility complex suggesting that ME2 can form 
heterodimers with another class A bHLH as well as a 
class B bHLH (data not shown). Therefore, these re­
sults demonstrate that MEla, ME2 and MyoD can 
associate in vitro and bind to the MEFI site. 
3.3. MEla and ME2 homodimers have distinct DNA-
binding specificities 
Because it is not clear whether class A bHLH pro­
teins have different functional properties during devel­
opment, it is important to assess their differences in 
DNA-binding specificities in order to unravel their 
specific roles in gene expression. Therefore, the DNA-
binding specificities of MEla and ME2 homodimers 
were analysed and compared by a competition analysis 
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Table 1 
Summary of MEla and ME2 DNA-binding specificities 
Wild type E-box Binding activity " 
Name Sequence h MEla ME2 
MEF-1 CAACACCTGCTG + + + + + + + + 
nE5 GAACACCTGCAA + + + + + + + + 
tiE2 CAGCAGCTGGCA + + + + + 
k E2 AGGCAGGTGGCC + + -
c-fos GGACATCTGCGT + + + + + 
The relative binding activities were determined from data in Fig. 
4A,B. 
b
, The E-box consensus sequences are underlined. 
experiment. The design of this experiment was such 
that a 25-fold excess of each of several competitors was 
added to a reaction containing 40 ng of MEla or ME2 
protein and 40 fmoles of MEFI probe (Fig. 4A). A 
strong competitor E-box element would decrease the 
signal from the labeled shifted DNA-protein complex. 
The specific sequences of the various E-boxes used for 
this assay are indicated in Table 1. 
The MEla-DNA complex could be competed suc­
cessfully with a 25-fold excess unlabeled MEFI 
oligonucleotide (CAACACCTGCTG) but not with 
non-specific DNA (Fig. 4A, lanes 3 and 5). DNA 
containing /aE5 E-box (GAACACCTGCAA) com­
peted equally well with the MEFI probe whereas DNA 
containing /JLE2 E-box (CAGCAGCTGGCA) did not 
(Fig. 4A, lanes 6 and 7). The c-fos E-box 
(GGACATCTGCGT) located in the c-fos promoter 
(39) reduced the specific binding by 50% (Fig. 4A, lane 
9). A relatively weaker competition was obtained with 
the kE2 site (AGGCAGGTGGCC) as shown in Fig. 
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4A, lane 8. The relative levels of MEla binding affinity 
to different E-boxes are summarized in Table 1. Clearly, 
not all E-boxes are capable of binding MEla homod­
imers with the same affinity. 
The ME2-DNA complex was greatly reduced by the 
addition of a 25-fold excess unlabeled MEFI oligonu­
cleotide (Fig. 4B, lane 3). A similar excess of non­
specific DNA did not affect the amount of specific 
binding (Fig. 4B, lane 5). DNA containing /u.E5 E-box 
(GAACACCTGCAA) or ßE2 binding site 
(CAGCAGCTGGCA) competed as well as the MEFI 
probe (Fig. 4B, lanes 6 and 7). However, DNA contain­
ing the KE2 site (AGGCAGGTGGCC) did not com­
pete for binding with the MEFI E-box (Fig. 4B, lane 
8). The c-fos E-box (GGACATCTGCGT) slightly re­
duced Ihe specific binding (Fig. 4B, lane 9). The rela­
tive levels of ME2 binding activity are summarized in 
Table 1. These results show that not only MEla and 
ME2 homodimers recognize a variety of E-box se­
quences but also that they are characterized by signifi­
cantly different DNA-binding specificities. 
3.4. MEla and ME2 activate gene expression in neuronal 
cells 
To elucidate the manner by which MEla and ME2 
proteins may be involved in neuronal development, it is 
important to determine their specific functions. Thus, 
we examined their ability to activate transcription from 
a minimal promoter linked to several MEF-1 E-boxes. 
The in vivo studies were performed using the N18 
neuroblastoma cell line [1]. We constructed two expres­
sion vectors, CMV MEla and CMV ME2, and a re-
MEla/Kpnl 
Competitor 0 5X 25X 50X § H. 1. 2 i Competitor 0 5X 25X SIX » 3 ä 
> 2 3 4 5 6 7 8  9  1 2  3  4 5 6 7 8 9  
Fig. 4. MEla and ME2 are characterized by different DNA-binding specificities. A: 40 ng of MEIa/Apnl was incubated for 20 min with the 
MEFI probe in absence (lane 1) or in presence of increasing amounts of cold MEFI oligonucleotide as indicated on top of the figure (lane 2-4). 
The DNA-binding specificity of MEla was determined using a 25-fold excess of non-labeled competitor, such as non-specific (lane 5), ßE5 E-box 
(lane ft), pE2 E-box (lane 7), kE2 E-box (lane 8), and c-fos E-box (lane 9). The sequence of each cold competitor is indicated in Table 1. The 
reactions were run on a 5% native Polyacrylamide gel in 0.5 X TBE. B: 40 ng of ME12/<VcoI was incubated for 20 min with the MEFI probe in 
absence (lane 1) or in presence of increasing amounts of cold MEFI oligonucleotide as indicated on top of the figure (lane 2-4). The 
DNA-binding specificity of MEla was determined using a 25 fold excess of cold competitor (lane 5-9), as described for panel A. 
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porter plasmid containing either four MEFI E-boxes 
(MEF)X4 TKCAT upstream of the thymidine kinase 
TATA box. 
Cotransfection of MEla or ME2 expression vector 
with a reporter plasmid containing MEFI E-boxes re-
Fold Activation 
Fold Repression 
% conversion 
suited in significant increases in CAT expression in 
N18 neuronal cells (Fig. 5, lanes 3, 4, 7 and 8). This 
transactivation activity was also observed in a different 
neuronal cell line such as the neuroblastoma-glioma 
NG108 cell line [17] (data not shown). The transient 
82 
15 44 
17.7 17.4 0.4 0.4 21.2 27.6 1.6 1.7 
58 
0.3 0.8 
Cm-3-Ac — 
I 
Cm. 
'4 a » a « « * }:' 
Origin 
lane # 
(MEF-1 )X4TKC AT 
CMV/MEla 
CMV/ME2 
CMV/Id2 
+ + 
+ 
10 
Reporter 
MEF-1 TK TATA CAT 
^7 r-
Fig. 5. MEla and ME2 activates transcription through MEFI E-boxes in neuronal cells. Neuronal cells N18 were transfected with 5 /zg of 
expression plasmid as indicated at the bottom of the figure and 5 /ig of CAT reporter plasmid (MEFDX4 TKCAT by calcium phosphate 
precipitation. A schematic representation of the CAT reporter plasmid is shown at the bottom of the figure. Cells were harvested and CAT 
activities were determined. Protein concentration of cell extract was measured by Bradford assay and used for standardization of CAT activities 
which were determined by Phosphorlmager analysis. The percent of acetylated 14C-labeled chloramphenicol and the fold of activation and 
repression are indicated at the top of the figure. 
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CAT assay data clearly indicate that in mammalian 
neuronal cells, MEla and ME2 behave as transcrip­
tional activators. It is worth noting that ME2 behaves 
as a strong activator on its own, since previous trans-
fection studies showed that only a GAL4: ME2 fusion 
protein was capable of weakly activating transcription 
[18] (see Discussion). Furthermore, a truncated form of 
ME2, which lacks the first 216 N-terminal amino acids 
(Fig. 1) is still capable of stimulating gene expression 
through the MEFI E-box at levels comparable to that 
of full length ME2 (data not shown). 
3.5. Overexpression of Id2 in neuronal cells interferes 
with transcriptional activity of MEla and ME2 
Id-like proteins have been shown to negatively regu­
late the DNA binding ability of bHLH proteins in vitro 
through formation of inactive heterodimers [3,38]. Their 
C <N -o 
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Fig. 6. Id2 interacts with MEla and ME2 bHLH proteins. Two 
hundred ng of Id2 (lane 2) or 40 ng of MEIa/Kpnl (lane 3) or 
ME2/A/coI (lane 5) was incubated with 40 fmol of labeled oligonu­
cleotide MEFI for 20 min at room temperature. When heterodimer 
formation was studied between Id2 and the two class A bHLH 
proteins MEla and ME2, purified Id2 was incubated for 20 min to 
form heterodimer with MEla/Kpnl (lane 4) or ME2//fo>I (lane 6) 
prior to the addition of probe. As a control, lane 1 shows the probe 
alone. 
level of expression is usually down-regulated upon cel­
lular differentiation and their relative concentration 
varies in different cell lineages [3,23,31]. We addressed 
the question of whether Id2, an Id-like protein ex­
pressed during mouse neurogenesis [31], would impair 
the transcriptional activity of MEla and ME2 in neu­
ronal cells. The expression plasmid CMV Id2 was 
cotransfected with CMV MEla or CMV ME2 along 
with a reporter plasmid in the N18 neuronal cell line. 
A significant reduction in CAT activity was observed in 
the presence of the expression vector CMV Id2 (Fig. 5, 
lanes 5, 6, 9, and 10). However, a difference in the 
sensitivities of MEla and ME2 to Id2 inhibition was 
observed; a maximal repression of 44 fold and 15 fold 
was obtained when Id2 was cotransfected with ME2 
and MEla, respectively (Fig. 5, lanes 5 and 6, 9 and 
10). Thus, Id2 inhibits the transcriptional activity of 
both MEla and ME2 in neuronal cells. 
Since Id proteins are believed to prevent the binding 
of bHLH proteins to DNA due to the formation of 
inactive heterodimers, we examined whether Id2 in­
hibits the binding activities of MEla and ME2 through 
protein-protein interactions. We first subcloned the 
Id2 coding sequence into the bacterial expression vec­
tor pRSET and then purified recombinant Id2 protein 
to homogeneity by nickel affinity chromatography. To 
detect heterodimer formation with MEla or ME2, we 
incubated excess of Id2 (5 fold) with either protein for 
20 min before adding the MEFI probe. These protein 
complexes were analysed for their DNA-binding ability 
by EMSA (Fig. 6). We found that both MEla and ME2 
formed inactive complexes with ld2 (lanes 4 and 6, 
respectively) and therefore lost their DNA-binding 
function. These results strengthen the functional data 
obtained by CAT assay on the transcriptional inactiva-
tion of MEla and ME2 by Id2. 
4. Discussion 
Cellular differentiation is a multistep process involv­
ing activation and repression of many genes. Transcrip­
tion factors containing the basic-helix-loop-helix 
(bHLH) motif are one set of regulatory proteins con­
trolling this process. A comprehensive analysis of bind­
ing properties of class A bHLH homodimers is likely to 
provide insights as to whether these proteins interact 
selectively with specific target genes. This knowledge is 
particularly relevant in the case of class A bHLH 
proteins because it has been postulated only recently 
that class A homodimers might play an important role 
in establishing the differentiated state in different cell 
types [2,29], 
Class A bHLH proteins can readily form homod­
imers or heterodimers with a tissue-specific class B 
bHLH protein and thereby stimulate gene expression. 
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It is generally assumed that the E2A gene products 
(E12 and E47) are the heterodimeric partners of MyoD 
during muscle development. Because, MEla and ME2 
are expressed at high levels in the somites early in 
development [30,36] and readily form heterodimers 
with MyoD in vitro as shown in this report, they might 
dimerize with MyoD in vivo. However, it has been 
shown using in vitro translated proteins that REB/3, 
the rat homologue of MEla, poorly forms homodimers 
or heterodimers with MyoD [22]. This may be due to 
the slight divergence in sequence, but is more likely 
due to the use of reticulocyte lysate-translated pro­
teins, since Klein et al. [22] report that bacterially 
purified REB/3 can form homodimers. We and others 
[22,32] have shown by CAT assays that MEla and 
REB/3 are able to activate transcription, which further 
supports the fact they have similar dimerization/ 
DNA-binding properties. 
Until recently, it has been emphasized that class A 
proteins might function primarily as heterodimers [25]. 
However, examples of class A homodimers controlling 
gene expression during differentiation have been de­
scribed. For example, E47 homodimers bind to regula­
tory sequences present in the immunoglobulin heavy-
and light-chain gene enhancers, and induce transcrip­
tion activation resulting in B-cell differentiation [29]. 
Therefore, a detailed analysis of the DNA-binding 
specificity of MEla and ME2 homodimers is likely to 
yield significant insight into processes involved in neu­
ronal differentiation. The precise nature of MEla and 
ME2 binding specificities is a key issue given the 
absence of information concerning potential targets for 
transcriptional regulation by these two proteins. Our 
EMSA analyses have shown that MEla homodimers 
bind strongly to MEFI and ^,E5 E-box sequences, 
moderately to KE2 and c-fos E-box elements, and 
poorly to the fiE2 E-box element. By contrast, ME2 
homodimers bind strongly to MEFI, /J.E2, and ju.E5 
E-box sequences, less to the c-fos E-box, and not at all 
to the KE2 E-box. These results demonstrate that the 
class A bHLH MEla and ME2 homodimers exhibit 
significant differences in DNA-binding specificities, 
which may contribute to selective interactions of these 
proteins to the E-boxes of target genes. The specifici­
ties of class A homodimer-DNA interactions are likely 
to provide additional mechanisms of gene regulation 
without the participation of class B bHLH proteins. 
We can also predict that gene regulation by het­
erodimers between two class A bHLH proteins might 
play important roles during differentiation. And that, 
in vivo formation of class A homodimers might be 
regulated by events such as posttranslational modifica­
tion which has been reported for the class C bHLH 
Max protein [4], and/or the relative concentrations of 
class A and B bHLH proteins and Id-like proteins 
which are cell-stage specific and cell-type dependent. 
Although expression of MEla and ME2 is different, 
they overlap in their spatial and temporal expression 
patterns during mouse brain development. Most of 
MEla expression is down-regulated shortly after birth 
whereas ME2 expression persists much longer [30,36]. 
In the adult mouse brain, MEla and ME2 expression 
patterns are restricted to areas such as the internal 
granular-cell layer of the cerebellum and the dentate 
gyrus of the hippocampus albeit at a lower level for 
MEla in the latter tissue. In addition, ME2 expression 
is also present in the cortex and the pyramidal-cell 
layer of the hippocampus. These results show that class 
A bHLH proteins are not ubiquitous as has been 
suggested [28], but are highly regulated in their tempo­
ral and spatial distribution. Furthermore, by using a 
polyclonal antibody raised against the CAS domain of 
all class A bHLH proteins, we have detected brain 
specific class A bHLH proteins (unpublished results). 
In the adult brain, the functional significance for the 
expression of MEla and ME2 is still unknown. How­
ever, since their expression is high in areas of neuronal 
plasticity, this suggests a potential gene regulation in­
volved in the remodeling of neuronal connections. 
In neuronal cells, both MEla and ME2 behave as 
transcriptional factors. Previous transfection studies 
showed transcriptional activation only with 
GAL4:ME2 chimeric protein (ITF-2, E2-2) from a 
reporter plasmid carrying GAL4 binding sites [18,34], 
The data presented here clearly demonstrate that ME2 
is able to function as a transcription factor. Therefore, 
it contains distinct elements that dictate both efficient 
DNA binding activity, transcriptional activation and 
nuclear localization. In vitro, Id2 selectively binds to 
MEla and ME2 to form inactive heterodimers, and 
consequently inhibits their DNA-binding activity. Fur­
thermore, in vivo results support these protein-protein 
interactions which result in a loss of transcriptional 
activity of both MEla and ME2 bHLH proteins. 
Therefore, it appears that the decrease in the level of 
ld2 in some neuronal cells [36] allows MEla and ME2 
to form active homodimers and/or heterodimers and 
thereby bind to E-box sequences inducing neuronal 
gene expression. Our results indicate that ld2 may 
suppress mammalian neuronal differentiation in a simi­
lar manner to extramachrochaetae, a negative regula­
tor of differentiation during Drosophila neurogenesis 
[11,13]. A similar mechanism has been proposed for 
B-cell differentiation during which Id inhibits the ho-
modimer formation of E47 in pro-B cells [29,45]. 
Clearly, it is essential to determine the heterodimer 
partners for MEla and ME2 as well as their target 
genes in order to elucidate their specific cellular func­
tion during mammalian neuronal differentiation. It is 
possible that like daughterless, which controls sex de­
termination and neuronal differentiation [8], MEla 
and ME2 may have pleiotropic functions during devel­
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opment. These proteins have different DNA-binding 
specificities as well as differential expression during 
neurogenesis and in the adult brain. In the future, it 
should be possible to analyze the in vivo concentrations 
of bHLH homodimers and heterodimers present in a 
given tissue at a given time and to comprehend how 
the interplay between the different types of bHLH 
proteins results in the appropriate expression of tissue 
specific genes. 
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Since several viral oncoproteins block differentiation 
and induce proliferation of differentiated cells, we de­
veloped an expression screening method to isolate 
cDNAs which block neuronal differentiation and in­
duce proliferation of teratocarcinoma cells. Mouse 
K2F1, RNP-1, and RNP-2 (Regulator of Neuronal Pro­
liferation) were isolated using the developed screening 
method. Overexpression of E2F1, RNP-1, and RNP-2 
cDNAs in neuronally differentiated tcratocarcinoma 
PCC7 cells results in blocking differentiation and initia­
tion of proliferation. Also, expression of RNP-X and 
RNP-2 blocks the expression of neurofilament-L and 
GAP-43 genes in PCC7 cells, tt 1995 Acadcmic Press, inc. 
INTRODUCTION 
The regulation of differentiation and dedifferentia-
tion is a fundamental issue for understanding both de­
velopment and maintenance of tissues. The molecular 
mechanisms which regulate these processes are essen­
tially unknown, especially for neuronal cells. 
Several data demonstrate reversibility of differentia­
tion by overexpression of specific proteins in differen­
tiated cells. Expression of adenovirus E1A proteins 
disrupts neuronal differentiation and growth factor re­
sponsiveness of PC12 cells [2], In ElA-expressing cells, 
nerve growth factor receptors, pl40ttk and p75LNt:FR, 
epidermal growth factor receptor, tyrosine hydroxylase, 
and peripherin genes are repressed, while more ubiqui­
tously expressed genes remain unaffected [2]. The E1A 
conserved region 1 which binds cell cycle regulators 
pl05llb and p300 is necessary for the above described 
effects. Expression of ElA also inhibits myogenic dif­
ferentiation [4]. This inhibition may be based on the 
interaction of ElA with basic helix-loop-helix tran­
scription factors which leads to the suppression of cell-
specific gene transcription [23]. The 12S form of ElA 
has also been shown to dedifferentiate F9 teratocarci­
noma cells [24], Recently, it has been demonstrated that 
1 To whom reprint requests should be addressed. Fax: (303) 491-
7907. 
terminally differentiated myotubes can be induced to 
reenter the S phase by expressing large T antigen [5], 
We developed an expression cloning system for the 
detection and isolation of cDNAs which block differen­
tiation and induce proliferation of neuronally differen­
tiated teratocarcinoma PCC7 cells. Three cDNAs were 
isolated and the effect of their overexpression in neuro­
nally differentiated PCC7 cells was characterized. 
MATERIALS AND METHODS 
Cell culture. Mouse teratocarcinoma cell line PCC7 fl7) was 
grown in Dulbecco's modified Eagle's medium containing 10% fetal 
calf serum (Sigma). Neuronal differentiation of PCC7 cells was in­
duced with dibutyryl cyclic AMP (Bt^cAMP, 1 mM) and all-trans 
retinoic acid (RA, 0.5 pM). 
Generation of subtraction cDNA library. Undifferentiated and neu­
ronally differentiated teratocarcinoma PCC7 cells were used to iso­
late poly(A) + RNA (FastTrack, Invitrogen). Twenty micrograms of 
poly(A)"" RNA from undifferentiated cells was used to synthesize 
first-strand cDNA. Oligo(dt) primer with a Notl restriction site at the 
5' end (CTAGATCGCGAGCGGCCGCCCTTTTTTTTTTTTTT-
TTT) was used to synthesize first-strand cDNA using SuperScript 
RNase H reverse transcriptase {'200 units/j/g of poly(A}+ RNA, 
Gibco). |:wP]dCTP (50 ^ Ci, >3000 Ci/mmol, Amersham) was added to 
the first-strand synthesis reaction to trace DNA. First-strand cDNA 
was hybridized topoly(A)* RNA (200 fig) isolated from differentiated 
cells in sealed ampules (total volume 100 /il, buffer 0.5 M sodium 
phosphate, pH 6.8,300 mM NaCl,2 mMEDTA, and 0.2% SDS) for 18 
h at 70°C. The hybridization mix was diluted to a final molarity of 
0.08 M sodium phosphate, loaded onto a DNA grade hydroxylapatite 
column (4 ml vol, Rio-Rad), and washed extensively with 0.08 M so­
dium phosphate buffer (pH 6.8). Single-stranded cDNAs were eluted 
in 10 ml of 0.15 M sodium phosphate buffer. Column fractions (0.5 
ml) exhibiting radioactivity above background were pooled, and the 
cDNAs were concentrated by butanol extraction followed by chroma­
tography in STE buffer (100 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 
mM EDTA) on a Sephadex G-25 column (Pharmacia). Single-
stranded cDNAs were mixed with 40 /ig of poly(A)+ RNA from differ­
entiated cells for the second cycle of hybridization and this yielded 0.6 
Hg of first-strand cDNA. First-strand cDNAs were hybridized with 5 
/ig of the original poly(A)f RNA isolated from undifferentiated cells, 
and the resulting DNA/RNA hybrids were used as template for sec­
ond-strand synthesis with RNase H and Escherichia coli DNA poly­
merase I (Gibco). Blunt ends were created with T4 DNA polymerase, 
and the HiVidlll adapter, 5' AGCTTGGCACGAG 3', 3' ACCGTGCTC 
5' was ligated to the cDNA. Preparation of cDNAs longer than 700 bp 
for ligation into the expression vector (pRc/CMV, Invitrogen) was 
performed by digestion with Notl followed by size selection on a Se-
phacryl S-400 column (Pharmacia). cDNAs were cloned into the ex­
pression vector, pRc-CMV (Invitrogen), between the Hmdlll and Notl 
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restriction sites. The library was divided into 20 aliquots and used to 
transform E. coli DH5 cells (MAX Efficiency, Gibco). Each aliquot 
yielded S- 8 X 10 : l  colonies which were combined and grown for large-
scale plasmid isolation (> plasmid < maxi kit., Qiagen). The cDNA 
expression library has 2 X 10s independent clones with an average 
insert size of 1.5 kl> (range: 0.6-3.7 kb). To characterize the efficiency 
of subtraction cloning, we selected 10 clones and performed Northern 
blot analyses using total RNAs from undifferentiated and neuronally 
differentiated PCC7 cells. Five cDNAs hybridized exclusively with 
RNA from undifferentiated cells, three cDNAs hybridized strongly 
with RNA from undifferentiated cells and weakly with RNA from 
differentiated cells, and two cDNAs hybridized equally with RNA 
from undifferentiated and differentiated cells. This analysis demon­
strated that subtraction cloning was successful and the expression 
library is enriched for sequences expressed in undifferentiated cells. 
Transfection of cells. PCC7 cells were differentiated 3 days before 
transfection. Transfection of the cDNA library was performed by the 
calcium phosphate coprecipilation technique using 20 mk of DNA per 
100-mm tissue culture plate (Falcon) at a cell density of 2 X 10fi cells 
per plate with an incubation time of 15-16 h. This treatment, results 
in 10-15% transfection efficiency (estimated using transient/i-galac-
tosidase assay). Each aliquot of the cDNA library (n = 20) was used to 
transfect cells in 20 plates. Transfectants which were stably prolifer­
ating were identified following culture of cells in the presence of 400 
/jg/ml 0418 (Gibco) for 18- 21 days. Proliferating clones were isolated 
and subcloned. 
Isolation of transfected cDNAs. Genomic DNA was prepared from 
isolated clones (TurboGen, Invitrogen) and used as a template for 
amplification of cDNAs by polymerase chain reaction (PCR). 
Primers for cDNA amplification corresponding to flanking sequences 
in the pRcCMV vector (5' primer 5'-AGCTCTCTGGCTAACTAGA-
GAAC and 3' primer S'-AGCGAGCTCTAGCATTTAGGTGA) were 
prepared, and 35 cycles of PCR were performed using the following 
conditions: 92°C 1.2 min, 58°C 2 min, and 72°C 4 min. Amplified 
DNAs were cloned into the EcoRV site of a Bluescript plasmid (Stra-
tagene) for sequencing. Isolated cDNAs with vector (pRcCMV) se­
quences were subcloned into the pRcCMV expression vector between 
the I laid 111 and Noll sites and retested on differentiated PCC7 cells. 
Adenovirus ElA 12S and 13S forms (Generous gifts from Dr. J. Ne-
vins and Dr. E. Moran) and mouse MET [15] cDNAs were cloned into 
pRcCMV vector using //mdlll linkers and used as controls. 
Northern blot analyses. The RNA was fractionated on a 1.2% aga-
rose-formaldehyde gel and transferred to a nylon membrane (Hy-
bond N, Amersham). Twenty-five micrograms of total RNA was run 
in each lane. RNA was isolated using the acid guanidinium/phenol/ 
chloroform ext raction procedure |7|. Full-length mE2F, RNP-1 (regu­
lator of neuronal proliferation), RNP-2, GAP-43, and a mouse NF-L 
Smal/Bglll fragment were radiolabeled (a2P) using the Multiprime 
DNA labeling system (Amersham) and used as probes. The blots were 
washed at high stringency (0.2X SSC, 65°C) and exposed to X-ray 
film for 3 days. The amount and quality of transferred RNA were 
monitored by methylene blue staining of the filters before hybridiza­
tion. 
RESULTS 
Molecular Cloning of Cellular Genes Which Block 
Differentiation and Initiate Proliferation of 
Neuronally Differentiated. Teratocarcinoma PCC7 
Cells 
Teratocarcinoma PCC7 cells stop proliferation and 
differentiate into neuronal-like cells after treatment, 
with BtjcAMP and RA [17]. Differentiation is irrevers­
ible as removal of Bt2cAMP and RA does not cause de-
differentiation and reentry into the cell cycle. Expres­
sion screening of the subtraction cDNA library was 
performed to isolate genes which block neuronal differ­
entiation of PCC7 cells and induce proliferation. The 
cDNA library in pRcCMV expression vector was trans-
fected into neuronally differentiated PCC7 cells. The 
cultures of neuronally differentiated cells did not con­
tained proliferating cells as it was estimated using thy­
midine incorporation and cell cycle analysis (data not 
shown). After 3 weeks of selection in the presence of 
G418, three proliferating clones were isolated (Fig. la). 
All three clones proliferated in the presence of RA and 
Bt2c AMP and were morphologically identical to the orig­
inal undifferentiated PCC7 cells. These clones were 
propagated in the presence of RA and Bt2cAMP, and 
transfected cDNAs were isolated using PCR and re-
tested for dedifferentiation and induction of prolifera­
tion. Sequence analysis reveals that one cDNA is the 
mouse homolog of human E2F1; the second cDNA, 
RNP-1, lacks significant homology to any GeneBank 
sequences; and RNP-2 is 99.5% homologous to helix-
loop-helix transcriptional regulator Id4 [18]. RNP-1 
cDNA has a nuclear translocation sequence which sug­
gest that it is a nuclear protein. 
Efficiency of Isolated cDNAs to Initiate Proliferation 
The efficiency of isolated RNP-1 and RNP-2 cDNAs 
to dedifferentiate and initiate proliferation of neuro­
nally differentiated PCC7 cells was tested under two 
conditions: (1) transfection of cDNAs into neuronally 
differentiated PCC7 cells (the same conditions used in 
screening the expression library) and (2) transfection of 
cDNAs into proliferating PCC7 cells followed immedi­
ately by treatment with RA and Bl2cAMP to induce neu­
ronal differentiation. Adenovirus oncogene ElA12S and 
E1A1:1S forms and helix-loop-helix transcription factor 
ME1 were used as controls. MEl is expressed in several 
proliferating cell types, and its expression is downregu-
lated during differentiation [15]. Both the 12S and 13S 
forms of ElA block neuronal differentiation and initiate 
proliferation of neuronally differentiated PCC7 cells 
(Table 1). No proliferating clones were observed after 
transfection with MEl cDNA or the pRcCMV vector 
without insert. All three isolated cDNAs, mE2F, RNP-
1, and RNP-2, induced the formation of proliferating 
clones with the same efficiency under both experimen­
tal conditions (Table 1). The efficiency of ElA to induce 
proliferation is approximately 10 times higher than that 
for E2F1, RNP-1, and RNP-2 cDNAs. 
Expression of E2F, RNP-1, and RNP-2 in 
Differentiating PCC7 Cells 
Neuronal differentiation results in down regulation of 
E2F1, RNP-1, and RNP-2 expression in PCC7 cells. 
E2F1 mRNA level decreases slightly after 3 days of dif­
ferentiation (Fig. 2). This result is consistent with the 
data that E2F1 is expressed in the adult nervous system 
[10, our unpublished data]. Since E2F1 mRNA level is 
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FIG. 1. Induction of proliferation ol'neuronally differentiated PCO 7 cells, (a) Differentiated PCC7 cells after 3 days of treatment with RA 
and BtacAMP which represents the cells used for transfection of cDNAs. (b) A proliferating clone '21 days after transfection of neuronally 
differentiated PCC7 cells (as in a) with E2F cDNA growing in the presence of RA and BtjcAMP. Arrow indicates the clone of proliferating 
cells. 
only slightly downregulated during differentiation, it 
may raise the question of how it was possible to isolate 
its cDNA from the subtraction library. Our analyses 
demonstrated that the subtraction was not complete 
(see Materials and Methods) and using functional 
screening allowed us to isolate even very rare cDNAs. 
The level of RNP-1 mRNA (3.1 kb) decreases signifi­
cantly during the first 24 h of differentiation and is unde­
tectable by 48 h. Decrease of RNP-2 mRNA levels oc­
curs more gradually, and its 2.1-kb mRNA disappears 
by the third day of differentiation (Fig. 3). 
Expression of Neuronal-Specific Genes in 
Differentiating PCC7 Cells That Overexpress RNP-1 
and RNP-2 
Induction of neuronal differentiation of PCC7 cells 
results in the activation of neuronal-specific genes such 
TABLE 1 
Efficiencies of Different cDNAs to Induce Formation of Proliferating Clones from Neuronally Differentiated PCC7 Cells 
Number of clones 
Transfection into undifferentiated cells Transfection into 
followed !>v differentiation differentiated cells 
Experiments Experiments 
Construct. 1 2 3 1 2 
pRcCMV 0 0 0 0 0 0 
pRcCMV-ElA12S 150 231 112 148 219 110 
pRcCM V- E1AI ;iS 184 191 132 172 180 109 
pRcCMV-E2F 25 19 14 15 19 12 
pRcCMV-RNP-1 9 11 15 12 12 15 
pRcCMV-RNP-2 12 9 17 9 11 IG 
pRcCMV-MIEl 0 0 0 0 0 0 
Note. Results of three separate experiments are presented. All transfections were done in triplicate and each number represents the average 
number of clones from three culture dishes. The results are normalized to the transfection efficiency measured by /i-galactosidase (jö-gal) 
activity after cotransfection of #-gal driven by CMV promoter. 
as neurofilament L (NF-L) and GAP-43 (Fig. 3). Ex­
pression of NF-L and GAP-43 genes was studied to ana­
lyze the effect of RNP-1 and RNP-2 overexpression on 
neuronal differentiation. The expression of RNP-1 and 
RNP-2 varies from almost undetectable to very high 
levels, comparable to the actin mRNA level (data not 
shown) in individual clones. To normalize these differ­
ences, we used randomly selected pools of RNP-1 
(RNP-1 pool)- and RNP-2 (RNP-2 pool)-expressing 
clones (20-25 clones). RNP-1 and RNP-2 pools were 
cultured in regular media (DMEM + 10% FCS) in the 
presence of G418 to avoid the loss of transfected cDNAs 
for 7 days followed by treatment with RA and Bt2cAMP 
to induce differentiation. Northern blot analyses dem­
onstrate expression of transfected RNP-1 (1.9 kb) and 
RNP-2 cDNAs (2.1 kb) in RNP-1 and RNP-2 pools, re­
spectively. The RNP-1 and RNP-2 mRNA levels in-
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FIG. 2. Northern blot analyses of E2F, RNP-1, and RNP-2 ex­
pression during differentiation of teratocarcinoma PCC7 cells. RNA 
was isolated from untreated cells (lane 1) and cells were treated for 1, 
2, and Ü days with RA and BtjcAMP (lanes 2, 3, and 4). The same 
membranes were hybridized with MP-radiolabeled E2F, RNP-1, and 
RNP-2 cDNA probes. Methylene blue-stained 28S ribosomal RNA 
demonstrates the amount of RNA in each lane. 
creased after treatment with RA and Bt2cAMP (Fig. 3). 
This increase is a result of CMV promoter induction by 
BtjcAMP (Neuman et al., unpublished data). In non-
transfected PCC7 cells, NF-L mRNA is undetectable in 
proliferating cells, and its levels increase after induction 
with RA and Bt2cAMP (Fig. 3). The induction of the 
3.5-kb mRNA occurs more rapidly than that of 2.5-kb 
mRNA. Overexpression of RNP-1 results in the delay in 
the induction of NF-L gene, and this induction is tran­
sient. The increase of NF-L mRNA levels is detectable 
on the second day after induction with RA and 
Bt2cAMP, and the mRNA levels decrease on the third 
day (Fig. 3). No expression of NF-L was detected in 
RNP-2 pools. 
GAP-43 is expressed at relatively low levels in undif­
ferentiated PCC7 cells, and its mRNA levels increase 
rapidly after induction with RA and Bt2cAMP (Fig. 3). 
No induction of GAP-43 was detected in RNP-1 pools 
after treatment with RA and Bt2cAMP; moreover, its 
mRNA becomes undetectable after 1 day of treatment 
(Fig. 3). No expression of GAP-43 was detected in un­
differentiated RNP-2 pools or after treatment with RA 
and Bt2cAMP. 
Analyses of several individual RNP-1 and RNP-2 
overexpressing clones result in the same changes of neu­
ronal marker genes as was described for pooled clones 
(data not shown). 
DISCUSSION 
During neuronal differentiation, neuroblasts exit the 
cell cycle and become arrested in the G0 phase. This 
transition is accompanied by switching off of the cell 
cycle regulatory genes. The aim of this work was to 
identify genes which reverse this process in neuronally 
differentiated teratocarcinoma cells. Our approach was 
to develop a protocol to screen for cDNAs which induce 
proliferation of neuronally differentiated teratocarci­
noma PCC7 cells. This approach enabled us to isolate 
three cDNAs (mE2F, RNP-1, and RNP-2). Overexpres­
sion of these cDNAs blocks neuronal differentiation 
and induces proliferation of PCC7 cells. 
How the isolated genes function to induce prolifera­
tion is a subject of speculation. Cell cycle-dependent 
transcription factor E2F regulates several genes which 
are necessary for the S phase of the cell cycle [16]. The 
activity of E2F is regulated by formation of transcrip­
tionally inactive or inhibitory complexes with pl05Rb [1, 
6, 21, 22, 25]. During the Gl phase of the cell cycle, 
pl05Rh becomes hyperphosphorylated and leads to the 
release of transcriptionally active E2F [16]. Overex­
pression of E2F may lead to a situation where plOS^ is 
limiting and thus result in the excess of active E2F 
which may trigger the initiation of the cell cycle. This 
explanation is supported by the data demonstrating 
that overexpression of E2F1 induces quiescent cells to 
enter S phase [12]. Alternatively, excess of E2F could 
sequester pl05Rb and block differentiation. The evi­
dence for this is that the expression of pl05Hb is neces­
sary for the first stages of muscle differentiation when it 
forms complexes with bHLH transcription factors to 
regulate muscle-specific genes [9]. The same may be 
true in neuronal differentiation, as knock-out experi­
ments demonstrate that pl05Rb is necessary for normal 
neurogenesis [8, 11, 14]. The RNP-1 lacks remarkable 
homology to gene sequences contained in the Genbank; 
thus, it is premature to speculate on its function. The 
RNP-2, which is highly homologous to Id4, a helix-loop-
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FIG. 3. Northern blot analyses of NF-L, GAP43, RNP-1, and 
RNP-2 expression in differentiating PCC7 cells and in pools of PCC7 
cells overexpressing RNP-1 and RNP-2 (RNP-1 PCC7 and RNP-2 
PGC7). RNA was isolated from untreated cells (lane 1) and cells were 
treated for 1, 2» and 3 days with RA and Bt2cAMP (lanes 2, 3, and 4). 
The same membranes were hybridized with ,12P-radiolabeled NF-L, 
GAP43, RNP-1, and RNP-2 probes. Methylene blue-stained 28 
rRNA demonstrates the amount of RNA in each lane. 
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helix transcriptional regulator, may block the neuronal 
differentiation by forming inactive heterodimers with 
basic helix-loop-helix transcription factors which are 
expressed in neuronally differentiating cells [3, 13, 15, 
19, 20]. 
Analyses of neuronal-specific genes demonstrate that 
overexpression of RNP-1 and RNP-2 interferes with 
the induction of NF-L and GAP-43 gene expression. 
Delayed and transient induction of NF-L in RNP-1 -
overexpressing cells after induction with RA and 
Bt^cAMP suggest that RNP-1 does not completely 
block signal transduction at the initial stages of neuro­
nal differentiation. By contrast, the lack of induction of 
GAP-43 and even its repression demonstrate that RNP-
1 completely blocks the expression of at least one neuro­
nal-specific gene in PCC7 cells. These data support the 
hypothesis that different neuronal genes are regulated 
by different mechanisms. No expression of NF-L and 
GAP-43 in RNP-2-overexpressing PCC7 cells argues 
that the two isolated genes, RNP-1 and RNP-2, have at 
least partially different mechanisms of action during 
blockage of neuronal differentiation. 
We thank M. X. Zuber for GAP43 cDNA and D. Ishii for his critical 
reading of the manuscript. This work was supported by the Spinal 
Cord Society. 
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Orphan Receptor Coup-TF I Antagonizes 
Retinole Acid-Induced Neuronal 
Differentiation 
K. Neuman, A. Soosaar, H.O. Nornes, and T. Neuman 
Department of Anatomy and Neurobiology, Colorado State University, Fori Collins, Colorado 
Chicken ovalbumin upstream promoter-transcription 
factors (COUP-TF) are expressed in the developing 
nervous system and interact with nuclear hormone 
receptors to regulate expression of different genes. 
The role of COUP-TF orphan receptors in neurogen­
esis is virtually unknown. To study the possible func­
tion of COUP-TF I during neuronal differentiation, 
we generated COUP-TF I overexpressing teratocar­
cinoma PCC7 cell lines and analyzed retinoic acid 
(RA)-induced neuronal differentiation of these cells. 
COUP-TF I overexpression results in the blockade of 
morphological differentiation after induction to dif­
ferentiate. COUP-TF I represses expression of micro-
tubule-associated protein 2 (MAP2) gene and delays 
induction of growth-associated protein 43 (GAP43) 
gene expression. In contrast, expression of the neu­
rofilament light subunit (NF-L) gene is not affected 
by COUP-TF I overexpression during neuronal dif­
ferentiation. Also, cells overexpressing COUP-TF 1 
do not stop proliferating after RA and dBcAMP 
treatment and possess suppressed transcriptional ac­
tivation from different RA response elements. These 
results suggest that COUP-TF I plays an important 
role in regulating RA-induced neuronal differentia­
tion. €> 1995 Wiley-Liss, Inc. 
Key words: teratocarcinoma, nuclcar hormone re­
ceptors, neurofilament, GAP43, MAP2, gene expres­
sion 
INTRODUCTION 
A variety of regulatory mechanisms at different 
levels are involved in neuronal development. Transcrip­
tion factors belonging to the superfamily of nuclear hor­
mone receptors have a crucial role in establishing initial 
cellular diversity in the nervous system. Among the best 
characterized members of the superfamily are the recep­
tors for retinoids, thyroid hormones, steroid hormones 
and glucocorticoids whose importance during neurogen­
esis is well-described (for review see Beato 1989; Evans 
© 1995 Wiley-Liss, Inc. 
and Arriza, 1989; McEwen et al., 1991; Linney, 1992). 
The nuclcar hormone receptors are characterized by a 
highly conserved DNA binding domain and a less con­
served ligand binding domain (for review see Green and 
Chambon, 1988; Beato, 1989; Fuller, 1991). The DNA 
binding domain has two zinc finger structures which de­
termine DNA binding specificity and are involved in 
reeeptor dimerization (Luisi et al., 1991). The ligand 
binding domain is localized in the carboxy-terminal re­
gion of the molecule and besides ligand binding has a 
number of additional functions, including dimerization 
(Zhang et al., 1991, 1992) and transcriptional activation 
(Zenkcctal., 1990, Zhang et al., 1991, 1992). Hormone 
receptors activate or repress gene transcription through 
binding to cis-acting hormone response elements (HRE; 
Green and Chambon, 1988, Beato, 1989). Besides the 
ligand-activated transcription factors, the hormone re­
ceptor superfamily comprises several orphan receptors 
for which ligands are not known (for review see Evans, 
1988; Green and Chambon, 1988). One function of the 
orphan receptors is to regulate the activity of ligand-
activated hormone receptors through hcterodimer forma­
tion or competition for binding to specific response ele­
ments (Tran et al., 1992). 
Orphan receptors, chicken ovalbumin upstream 
promoter-transcription factor (COUP-TF) homologs, 
have been isolated from Drosophila (Mlodzik et al., 
1990), sea urchin (Chan et al., 1992), zebrafish (Fjose et 
al., 1993), Xenopus (Matharu and Sweeney, 1992), 
chick (Lutz et al., 1994) and mammals (Miyajima et al., 
1988; Wang et al., 1989, 1991; Ritchie et al., 1990; 
Ladias and Karathanasis, 1991). COUP-TFs have high 
binding activity to hormone response elements and can 
repress hormonal induction of target genes (Cooney et 
al., 1992; Klicwerctal., 1992;Tran et al., 1992;Widom 
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et al., 1992). Several different mechanisms may contrib­
ute to the repression of induction including heterodimer-
ization with retinoid X receptors (RXRs), direct compe­
tition of COUP-TFs for the hormone response elements, 
and suppression of transcription by COUP-TF ho­
modimers (Cooney et al., 1992, 1993; Kliewer et al., 
1992, Tran et al., 1992; Widom et al., 1992; Segars et 
al., 1993). Analyses of nuclear hormone receptors in a 
variety of systems clearly demonstrate that regulation of 
gene expression by these transcription factors depends on 
the presence of different ligands and also on the interac­
tions with activators and repressors. 
Retinoic acid (RA) affects several processes in neu­
rogenesis. High doses of RA alter the development of 
nervous system, including development of rhombomers 
in the hindbrain (Monis-Kay et al., 1991; Marshall et 
al., 1992) and morphogenesis of the brain (Durston et 
al., 1989, Ruiz i Altaba and Jessell, 1991; Agarwal and 
Sato, 1993). The effect of RA on gene expression is 
mediated via retinoic acid receptors (RAR) and (RXR; 
for review see Linney, 1992). RARs and RXRs are ex­
pressed in a complex pattern during the nervous system 
development (Mangelsdorf et al., 1992; Rowe et al., 
1991; Ruberte et al., 1991, 1993; Smith and Eichele, 
1991). At the cellular level, RA induces neurite out­
growth and survival of different neuronal types (Berrard 
et al., 1993; Wuarin and Sidell, 1991). It also induces 
nerve growth factor responsiveness of sympathetic neu­
rons (Rodriguez-Tebar and Rohrer, 1991) and p75NGFR 
(Scheibe and Wagner, 1992; Metsis et al., 1992) and 
TrkB expression (Kaplan et al., 1993). RA induces neu­
ronal differentiation in several teratocarcinoma and neu­
roblastoma cell lines (Jetten, 1990; Slack et al., 1992; 
Kaplan et al., 1993). In teratocarcinoma cells, RA treat­
ment stimulates expression and activity of RARs (Wu et 
al., 1992) which results in induction of downstream 
genes including Hox genes (Murphy et al., 1988; Sime­
one et al., 1990). The importance of RA during differ­
entiation is supported by the observation that cell lines 
expressing mutated RARs do not differentiate properly 
(Boylan et al., 1993; Espeseth et al., 1989; Pratt et al., 
1993). The complexity of RA responses in different sys­
tems is displayed by six receptor genes, encoding three 
RA receptors, RAR a, RARß, and RAR"/ and three retin­
oid X receptors, RXRa, RXRß, and RXR-y (reviewed by 
Linney, 1992). In addition to six genes, multiple iso-
forms of these receptors are generated by an alternative 
splicing and multiple promoter usage. 
The role of COUP-TF orphan receptors in neuro­
genesis is virtually unknown. In Drosophila, the expres­
sion of COUP-TF homolog seven-up is required for de­
velopment of specific subset of photoreceptor neurons 
during eye development (Mlodzik et al., 1990). 
COUP-TF 1 and COUP-TF II (Lutz et al., 1994; Qiu et 
al., 1994; our unpublished data) are expressed in a com­
plex spatial and temporal pattern during development of 
the nervous system To begin to investigate the function 
of COUP-TF I during neuronal differentiation, we have 
analyzed the effects of overexpression of COUP-TF I in 
neuronally differentiating teratocarcinoma PCC7 cells. 
Elevated levels of COUP-TF I block morphological dif­
ferentiation and expression of the microtubule-associated 
protein 2 (MAP2) gene, whereas expression of the neu­
rofilament light subunit (NF-L) gene is unchanged and 
the growth-associated protein 43 (GAP43) gene expres­
sion is altered. Also, cells overexpressing COUP-TF I do 
not stop proliferation after induction to differentiate. 
Transcriptional activation from different RA response el­
ements (RARE) is inhibited in COUP-TF1-expressing 
PCC7 cells. 
MATERIALS AND METHODS 
Cell Culture and Establishing COUP-TF I 
Overexpressing Cell Lines 
Mouse teratocarcinoma PCC7 cells (generous gift 
from Dr. S.E. Pfeiffer) were grown in Dulbecco's mod­
ified Eagle's medium (DMEM) containing 10% fetal calf 
serum (Gibco, Burlington, ON). Differentiation of PCC7 
cells was induced with all-trans retinoic acid (0.5 (j.M, 
Sigma, St. Louis, MO) in the presence or absence of 
dibutyryl cyclic AMP (1 mM). Mouse COUP-TF 1 
cDNA (2.3 kb) in pRcCMV expression vector (Invitro­
gen, San Diego, CA) was transfected into PCC7 cells 
followed by selection with G418 (400 |xg/ml, Gibco) for 
18-21 days to establish COUP-TF I-overexpressing cell 
lines. Mouse COUP-TF I cDNA was isolated from the 
newborn mouse brain cDNA library using rat COUP-TF 
I cDNA which was cloned in our laboratory (GeneBank 
accession number U10995, Connor et al., manuscript 
submitted). For growth analyses, cells were plated onto 
100 mm tissue culture dishes (Falcon, Becton Dickinson, 
Franklin Lakes, NJ) at an initial density of 1 x 106 cells 
per plate. The cell number was counted using a hemo-
cytometer (VWR) in triplicate samples from each time 
point. 
Northern Blot Analyses 
The RNA was fractionated on 1.2% agarose-form-
aldehyde gel and transferred to a nylon membrane (Hy-
bond N, Amersham, Arlington Heights, IL). Twenty-
five micrograms of total RNA were run in each lane. 
RNA was isolated using acid guanidinium/phenol/chlo-
roform extraction procedure (Chomczynski and Sacchi. 
1987). Full-length mouse COUP-TF I, rat GAP43 (gift 
from M.X. Zuber), mouse NF-L Smal/BgUI fragment, 
and mouse MAP2 clone 56 (gift from N.J. Cowan; 
Lewis et al., 1986) were radiolabeled (32P) using Mul-
tipnme DNA labeling system (Amersham) and used as 
probes. The blots were washed at high stringency (0.2 X 
SSC, 65°C) and exposed to X-ray film for 1 to 10 days. 
The amount and quality of transferred RNA were mon­
itored by methylene blue staining of the filters before 
hybridization. 
Transfections and CAT Assays 
Cells were transfected using the calcium phosphate 
coprecipitation method (Okayama and Chen, 1991). 
Cells (4 x 105) in 60 mm dishes were transfected with 
10 pg of plasmid DNA. Twenty-four hours later, the 
media were changed to regular media or differentiation 
media. For the expression assays, cells were harvested 
48 hr later. Cells were washed and harvested in phos-
phate-buffered saline (PBS), lysed in 150 p.) of 0.25 M 
Tris-HCl (pH 7.6) by freeze/thawing three times, and 
incubated at 65°C for 10 min to minimize deacylation 
activity. Protein concentration in the lysates was deter­
mined by a protein assay reagent (Pierce Chemical Co., 
Rockford, IL) with bovine serum albumin (BSA) used as 
a standard. A 150 pi mixture containing 0.4 mM acetyl 
coenzyme A, 0.1 pCi of [dichloroacetyl-1,2-uC]chlo-
ramphenicol, and 10-25 pg of protein was incubated at 
37°C for 0.5 to 1.5 hr. After extraction with ethyl ace­
tate, the radioactive forms of chloramphenicol were re­
solved by thin-layer chromatography, localized by ex­
posing to X-ray film, and quantitated by liquid 
scintillation counting. All experiments were done in trip­
licate. 
For reporter plasmid construction, oligonucleotides 
containing corresponding HRE were synthesized, trim-
erized and cloned into the EcoRV site of Bluescript II KS 
(Stratagene, San Diego, CA). The orientation of the oli­
gonucleotides was determined by sequencing. To insert 
oligos into Hindlll/Xbal digested pBLCAT2 (Luckow 
and Schütz, 1987), the Bluescript vectors containing oli­
gos were digested with Hindlll/Xbal and the fragments 
were separated by Polyacrylamide gel electrophoresis us­
ing a 10% gel in TBE buffer. The oligos were electro-
eluted and ligated to the HindlR'Xbal site of pBLCAT2. 
Oligonucleotides based on DR-1 (Kadowaki et al., 
1992), ß-RARE (Tran et al., 1992), and CRBP1 (Tran et 
al., 1992) were synthesized. 
DR-1: 
5'-GGCTTCAGGTCAGAGGTCAGAGA 
5 -GGTCTCTGACCTCTG ACCTG AAG 
ß-RARE: 
5' -GGTGTAGGGTTCACCGAAAGTTCACTCA 
5-GGTGAGTGAACTTTCGGTGAACCCTACA 
CRBP I: 
5-CCATCCAGGTCAAAAAGTCAGGA 
5 -GGTCCTGACriTlTGACCTGGAT 
HRE sequences are underlined. 
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Flow Cytometry 
Cells were fixed in 70% ethanol/PBS and stained 
with propidium iodine (50 pg/ml) for 30 minutes at 
+ 4°C. DNA content of individual cells was measured 
using flow cytometer COULTER EPICS 5, and cell cy­
cle analyses was performed using Multicycle analysis 
software (Phoenix Flow Cytometry System). 
RESULTS 
Overexpression of COUP-TF1 in Neuronally 
Differentiating Teratocarcinoma PCC7 Cells Results 
in Blocking Morphological Differentiation 
Cytomegalovirus (CMV) promoter-based eukary-
otic expression vectors allow expression of introduced 
genes at different levels during neuronal differentiation 
of PCC7 teratocarcinoma cells. CMV promoter activity 
is weak in proliferating PCC7 cells and is induced about 
45 times after induction of differentiation by RA and 
dibutyryl cyclic AMP (dBcAMP) in transient assays us­
ing bacteria] chloramphenicol acetyl transferase (CAT) 
as a reporter gene (Fig. 1). Similar activation of CMV 
promoter occurs in established cell lines with integrated 
pRcCMV-CAT vector (data not shown). Neuronal dif­
ferentiation of PCC7 cells is also inducible by RA alone; 
however, it does not increase the CMV promoter activity 
(Fig. 1). By contrast, dBcAMP treatment alone stimu­
lates CMV promoter activity but does not result in neu­
ronal differentiation. Thus, these described characteris­
tics of the CMV promoter activity during differentiation 
of PCC7 cells makes it possible to analyze neuronal dif­
ferentiation in conditions where the introduced gene is 
expressed at low or high levels. 
Teratocarcinoma PCC7 cells were transfected with 
COUP-TF I cDNA cloned into pRcCMVneo expression 
vector in order to analyze the effect of its overexpression 
during neuronal differentiation. Several clones were ran­
domly selected, and COUP-TF I expression was corre­
lated with their ability to differentiate. Northern blot 
analyses demonstrate that two clones express introduced 
COUP-TF I RNA at high levels after induction with 
dBcAMP (Fig. 2A). The same clones, 1 and 3, do not 
differentiate morphologically after treatment with RA 
and dBcAMP (Fig. 3). 
Is the failure of isolated clones to differentiate a 
result of overexpression of COUP-TF I, or selection of 
aberrant clones? To answer this question, the expression 
of transfected COUP-TF I and morphological differenti­
ation of clones 1 and 3 were analyzed after treatment 
with RA alone (weak expression of COUP-TF I) or with 
RA plus dBcAMP (induced expression of COUP-TF I). 
COUP-TF I mRNA was undetectable in control PCC7 
cells during differentiation. Expression of transfected 
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Fig. 1. Effect of dBcAMP on induction of CMV promoter 
activity in neuronally differentiating teratocarcinoma PCC7 
cells using transient CAT assay. After transfection of cells with 
the pRcCMV-CAT vector, neuronal differentiation was in­
duced with RA or RA plus dBcAMP. CMV promoter activity 
is induced 45- and 43-fold after dBcAMP treatment compared 
to control or RA-treated cells. 
COUP-TF 1 cDNA was induced in clones 1 and 3 after 
treatment with dBcAMP + RA as well as with dBcAMP 
alone but not in RA-treated cells (Fig. 2B). Morpholog­
ical differentiation of clones 1 and 3 was blocked after 
treatment with RA -I- dBcAMP (Fig. 3), i.e., in condi­
tions which induce overexpression of transfected 
COUP-TF I. No changes in morphological differentia­
tion of clones 1 and 3 were observed after treatment with 
RA (Fig. 3). These results demonstrate that clones I and 
3 differentiate normally in the conditions where intro­
duced COUP-TF I is expressed at low levels and confirm 
the hypothesis that overexpression of COUP-TF 1 blocks 
neuronal differentiation of teratocarcinoma PCC7 cells. 
Effect of COUP-TF 1 on the Expression of Neuronal 
Marker Genes 
Expressions of NF-L, GAP-43, and MAP2 
mRNAs in overexpressing COUP-TF I PCC7 cells were 
analyzed using Northern blot. Differentiation of PCC7 
cells results in induction of NF-L and MAP2 genes 48 
hours, and GAP-43 gene 12 hours after treatment with 
RA + dBcAMP (Fig. 4). Difference in the time course 
of induction indicates that neuronal specific genes are 
regulated by different mechanisms during neuronal dif­
ferentiation of PCC7 cells. Overexpression of COUP-TF 
I results in no changes of NF-L expression, delayed in-
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Fig. 2. Northern blot analysis of COUP-TF I expression in 
teratocarcinoma PCC7 cells. A: Total RNA was isolated from 
randomly selected clones 1,3, and 6 of PCC7 cells after trans­
fection with COUP-TF 1 cDNA cloned into eukaryotic expres­
sion vector pRcCMV and from control PCC7 cells. Clones I 
and 3 express introduced COUP-TF 1 mRNA (2.3 kb) at high 
levels after treatment of cells with dBcAMP (cA) compared to 
untreated cells (C). Overexpression of COUP-TF I also induces 
expression of endogenous COUP-TF 1 (4.6 kb). B: Induction 
of COUP-TF 1 mRNA expression in clones 1 and 3 after treat­
ment with dBcAMP (cA), retinoic acid (RA), and RA plus 
dBcAMP (RA + cA) compared to untreated controls (C). 
Amount of RNA ran in each lane is demonstrated by methylene 
blue staining of filters before hybridization. Positions of 28S 
and I8S ribosomal RNAs are indicated (28 S and 18 S, re­
spectively). 
duction of GAP-43 gene expression, and blocked expres­
sion of MAP2 gene (Fig. 4) after induction of neuronal 
differentiation with RA and dBcAMP. Induction of neu­
ronal differentiation without stimulation of COUP-TF I 
expression (RA treatment) results in stimulation of the 
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Fig. 3. Effect of COUP- I F 1 expression on neuronal differentiation of PCC7 cells. Control 
PCC7 cells and COUP-TF I-expressing clones I and 3 (0 h) were treated for 72 hours (72 h) 
with RA plus dBcAMP to induce neuronal differentiation and high level expression of 
COUP-TF 1 or RA alone which induces neuronal differentiation but does not result in high 
level expression of COUP-TF I. 
clone 3 
neuronal marker genes similar to control. These data 
argue for the hypothesis that separate pathways of neu­
ronal development are affected differently by COUP-
TF I. 
Overexpression of COUP-TF1 Blocks Exit of PCC7 
Cells From the Cell Cycle After Treatment With 
RA and dBcAMP 
Neuronal differentiation of PCC7 cells is accom­
panied by cessation of cell proliferation (Pfeiffer et al., 
1981). Flow cytometric analyses were performed to 
characterize changes in cell cycle during differentiation 
of control PCC7 cells and COUP-TF I overexpressing 
clones. No changes in the cell cycle were detected in 
clones 1 and 3 during normal growth (Table I). For all 
analyzed untreated clones, wild type PCC7 and 
COUP-TF I-expressing clones 1 and 3, the percentage of 
cells in the Gl phase was 41-42%, in the S phase 36-
38%, and in the G2 phase 20-24%. Differentiation of 
PCC7 cells blocks the cell cycle in Gl phase. During 
differentiation, the percentage of cells in G1/G0 phase 
increases constantly and reaches 98% after three days of 
treatment (Table I). Contrary to wild type PCC7 cells, 
the cell cycle is not blocked in COUP-TF l-overexpress-
ing clones 1 and 3. Treatment of COUP-TF I-overex-
prcssing cells with RA and dBcAMP results in an in­
crease in the portion of cells in G1/G0 from 41-42% in 
day 0 to 64-65% at day three (Table I). To quantitate the 
proliferation of COUP-TF I-expressing clones, cell 
counts were made at 12 hour intervals after RA and 
24 
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Fig. 4. Northern blot analyses of COUP-TF I effect on induc­
tion of GAP43, NF-L, and MAP2 gene expression during neu­
ronal differentiation of PCC7 cells and COUP-TF I-expressing 
clone I. Neuronal differentiation was induced with RA plus 
dBcAMP (RA + dBcAMP) or with RA alone (RA) and total 
RNA was isolated before treatment (C) and after 12, 24, 48, 
dBcAMP induction (Fig. 5). Control PCC7 cells stop 
proliferation after 36-48 hours of treatment. On the con­
trary, COUP-TF I-overexpressing cells continue prolif­
eration; however, the proliferation rate becomes reduced 
after 36 hours. 
Induction of RARE Enhancers in COUP-TF 1 
Overexpressing Cells 
COUP-TF I forms inactive heterodimers with 
RXRs and binds to retinoic acid response elements 
(RARE) from different genes as a homodimer to repress 
the retinoic acid response. To investigate whether 
COUP-TF I blocks RA signalling pathway in neuronally 
differentiating PCC7 cells, we analyzed the activities of 
CAT reporter constructs containing different RAREs in 
the front of a thymidine kinase promoter in COUP-TF 
I-overexpressing cells. Since the effects of COUP-TFs 
depend on the RARE sequences and promoter context, 
we analyzed two natural and one synthetic RAREs; the 
ßRARE, a direct repeat with a 5-bp spacer that is acti­
vated by RARa (Tran et al., 1992); the CRBP I-RARE, 
a direct repeat with a 2-bp spacer that is optimally acti­
vated by RAR/RXR heterodimers but not by RXR ho-
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RA + dRrAMP RA 
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and 72 hours (12, 24, 48, and 72, respectively). COUP-TF I 
(COUP) expression is detectable only in clone I but not in 
control PCC7 cells. Amount of RNA ran in each lane is dem­
onstrated by methylene blue staining of filters before hybrid­
ization. Positions of 28S and I8S ribosomal RNAs are indi­
cated (28 S and 18 S, respectively). 
modimers (Hermann et al., 1992; Zhang et al., 1992), 
and the DR-1, a direct repeat that contains a I-bp spacer 
and has a high affinity to COUP-TF I (Kadowaki et al., 
1992) and RXRs (Mangelsdorf et al., 1990, 1991). The 
activity of all three reporter constructs is inducible in 
PCC7 cclls with RA alone or with RA plus dBcAMP, 
and the effect of RA is potentiated by dBcAMP (Fig. 6). 
In COUP-TF I-overexpressing cells treated only with 
RA, the induction of ßRARE and CRBPI enhancers is 
reduced (2.5 and 1.5 times, respectively) compared to 
control cells, and no induction was detected from DR-1 
reporter construct. The induction of COUP-TF I expres­
sion in clones 1 and 3 by dBcAMP in the presence of RA 
results in further inhibition of ßRARE- and CRBPI-me-
diated transcription (Fig. 6). Inhibition of ßRARE-
driven reporter gene activity in COUP-TF I-overexpress­
ing cells contradicts data obtained from RARo; and 
COUP-TF I cotransfection experiments which demon­
strate that COUP-TF I does not inhibit induction of 
ßRARE by RARa (Tran et al., 1992). In differentiating 
PCC7 cells, expression of all three RARs and RXRa and 
RXRß is induced (our unpublished data) and it is un­
known which of the RAR/RXR complexes are involved 
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TABLE; I. Effect of COUP-TF1 Expression on Cell Cycle Changes During Neuronal Differentiation of PCC7 Cells* 
% Cells in Gl, S, and G2 phases of the cell cycle 
Differentiation with RA and dBcAMP 
Clone 
Untreated 1 day 2 days 3 days 
Gl /GO S G2 Gl/GO S G2 G1/G0 S G2 Gl /GO S G2 
PCC7 42 38 20 58 24 18 75 13 12 98 0 2 
Clone 1 41 38 21 50 25 25 58 23 19 65 18 17 
Clone 3 42 36 24 47 30 23 55 26 19 64 19 17 
*Numbers represent means from Ihree independent experiments. Standard deviations were less than 5% from the average 
values in all experiments. 
o 
2 
1 
24 36 12 48 60 
Fig. 5. Growth of COUP-TF-I-expressing (clone 1) and con­
trol PCC7 cells after RA + dBcAMP induction of neuronal dif­
ferentiation. Cells were treated with RA + dBcAMP for 72 
hours, and cell counts were made at 12 hour intervals using 
hemocytometer. All experiments were done in triplicate. Stan­
dard deviations were less than 7% from the average values in 
all experiments. 
in the induction of ßRARE enhancer. It is possible that 
ßRARE induction is mediated by RAR/RXR complexes 
other than RARa homodimers and that these complexes 
are differentially affected by COUP-TF I. 
DISCUSSION 
During the development of the nervous system, dif­
ferent hormone receptors including COUP-TF I and II 
have a complex spatiotemporal expression pattern. Sev­
eral in vitro studies demonstrate that COUP-TFs act as 
repressors of various steroid/thyroid hormone pathways 
in a dose-dependent manner. Analyses of apolipoprotein 
AI(Ladiasand Karathanasis, 1991; Widomet al., 1992), 
apolipoproteiins B, CIII, and All (Ladias et al., 1992), 
and ornithine transcarbamylase (Kimura et al., 1993) 
promoters show that COUP-TFs bind to direct or in­
verted repeats of GGTCA sequences with variable nu­
cleotide spacings and block the transcriptional activation 
by other hormone receptors. Repression by COUP-TFs 
may also sensitize promoters of different genes to posi­
tively acting hormone receptors (Widom et al., 1992). 
Apolipoprotein AI promoter site A is refractory to trans-
30-
25 
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con COUP-TF con COUP-TF con COUP-TF con COUP-TF 
DR-l-TKCAT ßRARE-TKCAT CRBPl-TKCAT TKCAT 
Fig. 6. The effect of COUP-TF I expression on activity of 
different RAREs in PCC7 cells treated with RA, dBcAMP, and 
RA plus dBcAMP. The transient CAT activity with DR-l-
TKCAT, ßRARE-TKCAT, CRBP I-TKCAT, and TKCAT 
constructs was measured in control (con) and COUP-TF 1-ex-
pressing clone 1 (COUP-TF) PCC7 cells. The activities repre­
sent averages of three experiments and are expressed relative to 
the value obtained by transfection of corresponding construct 
into untreated cells, for which activity was set at 1. All activ­
ities arc normalized to total cellular protein. Standard devia­
tions were less that 10% from the average values in all exper­
iments. 
activation by RXRa and RA, but prior repression of this 
promoter by ARP-1 (COUP-TF II) results in full trans-
activation by RXRa and RA. It is proposed that ARP-1 
repression uncouples the endogenous regulatory proteins 
bound to site A and thus converts site A into a form 
accessible to RXRa (Widom et al., 1992). This example 
brings up the possibility that COUP-TFs may play a fun­
damental role in switching transcription activation path­
ways from hormone-independent to hormone-dependent. 
Alternatively, COUP-TFs may be converted to positive 
transcriptional regulators by unknown ligands or neuro­
transmitters as it has been shown in the latter case for 
dopamine which activates COUP-TF I in transient trans­
fection assays (Power et al., 1991 a,b). 
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Despite the numerous data on molecular interac­
tions of COUP-TFs, the roie of these orphan receptors in 
neurogenesis remains unknown. We analyzed the effect 
of COUP-TF I on neuronal differentiation of PCC7 cells 
in conditions where the COUP-TF I was expressed either 
at low or highly induced levels. The inducible system has 
certain advantages in comparison to constitute expres­
sion systems. First, it allowed us to avoid potential arti­
facts associated with chronic high level COUP-TF I ex­
pression during weeks of selection. Second, it allowed us 
to compare the behavior of the same genetically homo­
geneous clones under inducing and noninducing condi­
tions, factoring out clonal variations. Our data demon­
strate that overexpression of COUP-TF 1 in PCC7 cells 
results in the block of morphological differentiation and 
induction of MAP2 gene. Further, COUP-TF 1 overex­
pression results in blocking cessation of cell prolifera­
tion, which normally occurs after treatment of PCC7 
cells with RA and dBcAMP. Disturbances in morpho­
logical differentiation and withdrawal from the cell cycle 
may be related to the suppression of MAP2 induction by 
COUP-TF I. It has been shown that inhibition of MAP2 
expression by antisense oligonucleotides in RA-induced 
PI9 teratocarcinoma cells results in blockade of normal 
morphological differentiation and changes in the cell cy­
cle (Dinsmore and Solomon, 1991). 
Our results also demonstrate thai induction of NF-L 
is not affected and induction of GAP43 is delayed in 
COUP-TF I-overexpressing PCC7 cells after treatment 
with RA and dBcAMP. Treatment with RA alone, which 
results in differentiation but not high level expression of 
introduced COUP-TF I, does not affect induction of any 
of the analyzed neuronal genes. However, transient CAT 
assays with different RARE scqucnces demonstrate the 
inhibition of transcriptional induction in COUP-TF 
I-overexpressing cells compared to control PCC7 cells 
after RA treatment. Induction of COUP-TF I expression 
by dBcAMP further inhibits RARE-mediated transcrip­
tional activation but does not block it completely. Con­
sidering that NF-L, GAP43, and MAP2 genes have sev­
eral RARE sequences in the 5' regulatory regions (our 
observation) it is possible that induction of NF-L gene by 
RA requires much lower levels of activated RARs or 
RXRs than activation of GAP43 and MAP2 genes. If this 
is the case, the ratio of COUP-TF I and RAR/RXRs may 
regulate the timing of switching on different neural-spe­
cific genes when neuroblasts become committed to dif­
ferentiate. This hypothesis is supported by the observa­
tions that expression of NF-L gene starts before the final 
mitoses (Bennett and DiLullo, 1985) when the neuro­
blasts are in the ventricular zone and express detectable 
levels of COUP-TF I (our unpublished data). Initiation of 
neuronal differentiation and migration out from the ven­
tricular zone correlates with the reduction of COUP-TF I 
expression. Also, withdrawal of neuroblasts from the 
cell cycle may be related to the reduced levels of 
COUP-TF I expression during the final ccll cycle. 
We conclude that COUP-TF 1 may be involved in 
control of neurogenesis by modifying activity of RAR/ 
RXRs (and other steroid hormone receptors) which reg­
ulate the expression of neuronal marker genes as well as 
genes regulating cessation of proliferation and initiation 
of migration .and differentiation of neuroblasts. 
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Abstract COUP-TF family orphan receptors regulate activity 
of ligiBd-activnted nuclear hormone receptors ar function 
independently in the regulation of geoe expression. COUP-TF 
13 kas a complex expression pattern suggesfog that different 
mechanisms are involved in the regulation of its expression. We 
isolated the 5' regulatory region of the Mouse COUP-TF II gene 
and demonstrated that the basal promoter is localized in a —200 
bp region 5' from the transcription start site. AH-tauu retinoic 
add and dibutyryl cyclic AMP have cell type specific effects on 
COUP-TF II promoter activity. The effect of cyclic AMP is 
mediated by the cyclic AMP response element that is localized 74 
nucleotides upstream from the major transcriptional start. In 
vitro promoter analyses also demonstrated that the effect of all-
trmns RA is not directly mediated by the binding of RARs or 
RXRs to the promoter sequence. 
Key words: COUP-TF II; Gene regulation; Promoter; 
Retinoic acid; Dibutyryl cyclic AMP 
1. Introduction 
Nuclcar hormone receptors play an important role during 
development of different ceil types and organ systems [1,2]. 
Retinoic acid (RA) receptors, retinoid X receptors, thyroid 
hormone receptors, steroid hormone receptors, and several 
other members of the superfamily of nuclear hormone recep­
tors regulate expression of a variety of target genes [3,4], 
These ligand de:pendent transcription factors bind as homo-
or heterodimers to hormone response elements (HRE) located 
in the regulatory regions of target genes and regulate tran­
scription [3], Recently, it has been shown that nuclear hor­
mone receptors can also suppress transcriptional activity by 
complexing with non DNA binding co-repressors [5-8]. Beside 
the ligand activated transcription factors, the nuclear hor­
mone receptor superfamily comprises orphan receptors for 
which ligands are not known [9,10]. Orphan receptors, such 
as chicken ovalbumin upstream promoter transcription factor 
(COUP-TF) homologs, have been isolated from several spe­
cies including rodents and human [11-21]. COUP-TF orphan 
receptors function as transcriptional activators or suppressors 
depending on the complexes they form and DNA sequences 
on which they bind. One function of the COUP-TFs is to 
regulate the activity of ligand activated nuclear hormone re­
ceptors [22,23], Several different mechanisms may contribute 
to the repression of induction including direct competition of 
COUP-TFs for the hormone response elements, heterodimer-
ization with retinoid X receptors (RXR) and suppression of 
•Corresponding author. Fax: (1) (970)491-7907. 
E-mail: toomas@lamar.colostate.edu 
transcription by COUP-TF homodimers [22,24-27], Repres­
sion by COUP-TFs may also sensitize promoters of different 
genes to positively acting nuclear hormone receptors [26], 
COUP-TFs may also function as a stimulatory transcription 
factors. COUP-TFs stimulate transcription of arrestin gene by 
binding to a direct repeat with a 7 bp spacer located upstream 
of the transcription start site [28]. In combination with HNF-4 
transcription factor, COUP-TF I and COUP-TF II may also 
stimulate transcription of the phosphoenolpyruvate carboxy-
kinase gene [29], 
Complex expression patterns of COUP-TF I (Ear-3) and 
COUP-TF II (ARP-1) during development argue for their 
functional roles in several developmental processes. While 
the potential functions of COUP-TFs have been extensively 
investigated, the molecular mechanisms responsible for the 
spatial and temporal expression of COUP-TFs are still poorly 
understood. Expression of COUP-TFs in different regions of 
developing and adult organisms indicates that different mech­
anisms are involved in the regulation of their spatial and 
temporal expression. 
Here we demonstrate that COUP-TF II basal promoter is 
localized in the 200 bp region 5' from the transcription start 
site, and that all-franj retinoic acid and dibutyryl cyclic AMP 
have cell type specific effects on COUP-TF II promoter activ­
ity. Also, COUP-TF I and COUP-TF II weakly inhibit RA 
induced COUP-TF II promoter activity in PCC7 cells. 
2. Materials and methods 
2.1. Plasmid construction 
A mouse genomic DNA library (Clontecb) was screened with 
mouse COUP-TF II cDNA probe (isolated in our laboratory) using 
high stringency conditions (0.1 XSSC, 65°C; 1 X SSC = 150 mM NaCl, 
15 mM Na-citrate). Fragments of isolated clones were subcloned into 
Bluescript II KS plasmid (Stratagene) for sequencing and generation 
of promoter constructs. All the COUP-TF II promoter fragments 
were cloned into the unique Bgül site of the vector pCAT3N using 
Bgfll linkers COUP-TF II promoter fragments of various lengths 
were generated by digestion of 5' regulatory region DNA with endo-
nucleases listed below: for plasmid —4000/fig/II with BamHl and 
Bgfll, for -1500/BgflI with Windlll and Bgfll. for -621/Bgfl] with 
fis/XI and Bgfll, for — 320/Apal with A pal, for -91/Apal with S/vI 
and Apal, for —320/SarIl with Apal and Sad I, for — 40/SarIl with 
Sacl and Sarll, for —40/Apa] with SocI and Apal, and for SaclUApal 
with Sarll and Apal. Constructs -258/Apal and -200/Apal were 
generated by digestion of Apal fragment with Exonuclease ill Con­
struct A5rvIA4/>aI was generated by deletion of Sr.il fragment from 
the —320/Apal plasmid. 
Site directed mutagenesis was performed using plasmid -320/Apal 
and oligonucleotides 5'-GTTGCAGCAGTCGTGATGCATTTCAC-
TATATAGAGAG (mut 1) and 5'-ACGTGCGCTAAGTTGCA-
TATGTCGTGTCAAAGTTCACT (mut 3). Erase-a-Base System 
(Promega) was used to generate mutations mut 2 and mut 4 by digest­
ing plasmids mul 1 and mut 3 with Nsil and Ndel, respectively. 
Mouse COUP-TF 1 and COUP-TF 11 (cloned in our laboratory) 
cDNAs were cloned into eukaryotic expression vector pRcCMV-neo 
(Invitrogen) using appropriate restriction endonucleases. 
0014-5793/96/S12.00 C 1996 Federation of European Biochemical Societies. All rights reserved 
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A 
BstXI 
TGGTTTGCAAGCCCAGATCCCGGCACCTTGCCACCTCCGCTGCGTACCCCTCTACAAAGA - 562 
AGGGGAGAGCATTATTCAGTCTTTTGGAATAGTGGGTTCTACATAATGCGCCGGGAGTCC - 502 
CGGTGGACCGCGAGCTCGCATTTAGAGGCATCGCAAGTTGCGAGAGACTAAGTCTTTGGC - 4 4 2 
TCCATCCTCAACCCCTTGCGGACGCTTTAAGAGTCGTAGTGTGTGCGCCGCACTAGTCTT - 3 8 2 
GCGCAGGGCGGAAACCACTGTGCCGATGCGGCGGCGGGGTCCGCGCTCGGCTGCCACCfifi - 3 2 2 
Apal 
GCCCCCATCCCCCTCTCTGTGGCCAGGACCGCGCGGCCACCCGTCCCCGCCCCCCTCCGT - 2 6 2 
CCCCGCGCGCCCCGTGCGCTTGTCTCGACGCCGCTCGCGCTAGGACCGGGCTGCTCCCGC - 2 0 2 
Styl  
TGCCGCCATGGCGGGCCGCTGCGCTCCGGCCAATGACGACGAGGGGGCGGCGCGCGCGCG -14 2 
Styl 
CGGCCGGGCCAACCCCGGCGGCTGCCTTATAAGGCGGCCCGTCGCCATGGCAACGTGCGC - 82 
* * SacI * * 
TAAGTTGCAGCAGTCGTGTCAAAGTTCACTATATAGAGAGCTCAGTGAGTGATCGAGGAG - 2 2 
* * » 
AAGCAACTTCTGCCAGCCCGGAGCCTATAAATCGCATTCCCTCCCGAGCCCCCCTTTTTA 3 7 
Sael I 
GCATATTTGATCACTTTGATTCTGCTCTTTTCTCT££G£££TGTGTGCGTCGGTGCGCGC 9 7 
GTGTGTGTTTTCTTCTCCTCCTCCTCCTCTGCGAGTTGCCTCCTTTCTCCGGGTGCGGCT 157 
GCTCTTCCCTCTTTCATTCTTTCTCTCCGTTTCTCCCCCCTCTGCGCACGAAGGATGCGC 217 
TTCTAGGTGCTGATCTGCCCTCCTTTCTCTCTTATCATCTCTCCCGCCGCCGGCGAGTTG 277 
ACTCTTTCCCTATTGCTGCTTGAGGTGTGCGGCAGCAGCAGCAGCAGCAGCAGCAGCAGC 337 
GGCTCCACCGGCGGCGGCAGCAGCGGCAGCAGCAGCAGCGACTCCACCGGGGACGGCGGG 397 
Apal 
TAGACGCAGCGGCTCCGGGCCC 
Major start 
1  1  1  I s  f  I f f  11 1 CAT ACTIVITY % conversion 
-4000/BglII PCC7 3T3 C33A 
1 y/. 1 CAT 1 8 ± 1 9 ± 2 54 ± 4 
-1500/Bgin 1 CAT I 10 i 2 9 ± 1 67 ± 6 
-621/BglII | 1 CAT 1 12 + 2 11 ± 2 75 ± 6 
-320/Apal I —1 CAT 1 12 ± 2 10 ± 2 73 ± 5 
-258/ApaI | —1 CAT I 11 i 2 11 ± 1 73 ± 6 
-200/Apal | -1 CAT I 12 i 2 11 ± 2 74 ± 6 
ASiyl/Apal H CAT I 5 ±0.6 6 ±0.4 24 ± 2 
-97/ApaI 1 —1 CAT I 3 ±0.4 2 ±0.2 13 ± 1 
-320/SacIl | C CAT I 11 ± 2 13 ± 2 74 ± 5 
-40/Sacn I—C CAT I 0.4±0.04 0.3±0.02 0.8±0.03 
-40/Apal h— —1 CAT I 0.5±0.03 0.4±0.02 0.8±0.03 
SacII/Apal h -1 CAT 1 0.1±0.03 0.1±0.05 0.2±0.06 
1 CAt 1 0.1±0.05 0.2±0.04 0.1±0.06 
Fig. 1. Nucleotide sequence of the mouse COUP-TF II 5' regulatory region (A) and its promoter activity in mouse embryo carcinoma PCC7, 
mouse fibroblast 3T3, and human cervical carcinoma C33A cells (B). (A) Nucleotide numbering starts at the major transcriptional start site (1). 
upstream nucleotides have negative numbers Minor start sites are indicated by * (above the corresponding nucleotides). The TATA-box core 
motifs are indicated by boldface letters, and restriction sites used in generation of CAT constructs are indicated (B) In the schematic represen­
tation of mCOUP-TF II promoter region restriction sites and major start site (arrow ) are indicated. The data shown are representative of at 
least three independent CAT assays. 
2.2. Cell culture 
Embryonic carcinoma cell line PCC7 was obtained from S. Pfeiffer 
and grown in Dulbecco's modified Eagle's medium (Gibco) containing 
10% fetal bovine serum (Summit Biotechnology). PCC7 cells were 
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CAT ACTIVITY 
M conversion 
-4000/BglII CONTROL RA dBcAMP dBcAHP+RA 
, y/- 1  C AT  1  2  .5 A 0. 5 11 A 2 10 A 1 38 A 3 
-1500/BgllI Y0- 1 CAT 1 2  .8 A 0. 3 9 A 1 11 A 1 41 A 3 
-621/BglII 1 1 CAT 1 2. .3 A 0. 2 11 A 2 10 A 1 39 A 2 
-320/ApaJ 1 —TOT "1 2. .0 A 0 .  1 10 A 1 9 A 1 42 A 2 
-200/Ap*] I — T T A T  1  2, ,1 A 0 .  3 11 A 1 10 A 1 42 A 3 
-9 7/Apal 1 — R C A T  1  0 .  . 4  A 0 .  05 3 A 0. .3 4 A 0 .  5 9 A 1 
-40/Apal 1 1  CAT 1  0 .  .3 A 0 .  05 0.3 A 0 .  04 0.3 A 0 .  05 0.4 ± 0.06 
Sarll/Apal ( 1  CA? J  0 .  .2 A 0 .  06 0.1 A 0 .  ,05 0.2 A 0 .  06 0.1 ± 0.05 
1  CAT  1  0 .  1 A 0 .  06 0.2 A 0 .  .05 0.2 A 0 .  05 0.1 o
 
o
 
Fig 2 Effects of aW-lrans retinoic acid and dibutyryl cAMP on COUP-TF II promoter activity in CAT assay using mouse embryo carcinoma 
PCC7 cells Cells were treated with zU-trans RA (0.5 nM), dBcAMP (1 mM) or combination of all-/ronj RA and dBcAMP The data shown 
are representative of at least three independent experiments. 
differentiated into neuronal-like cells with n\\-trans RA (0.5 jiM) and 
dibutyryl cyclic AMP (dBcAMP; 1 mM) treatment Mouse fibroblast 
3T3, rat glioblastoma C6. human glioblastoma U373, and human 
cervical carcinoma C33A cells were obtained from the American 
Type Culture Collection and were grown in Dulbecco's modified 
Eagle's medium supplemented with 10% fetal bovine serum. 
2.3. DA A transfection and CAT assays 
Cells were transacted with 15 ng of total plasmid DNA, using the 
calcium phosphate precipitation method [30] in 60 mm diameter 
dishes (1 X 10s to 3X10^ cells per dish). The medium was changed 
12-18 h after transfeclion to normal growth medium or medium con­
taining all-/ra«j RA (5X10"' M) or dBcAMP (1 mM) as indicated 
for each experiment. Cells were harvested 48 h later Cells were 
washed and harvested in PBS, lysed in 150 jil of 0.25 M Tris-HCI 
(pH 7.6) by freezeVthawing three times, and incubated at 65°C for 10 
min to minimize deacylation activity Protein concentration in the 
lysates was determined by a protein assay reagent (Pierce Chemical 
Co.) with BSA used as a standard A 150 nl mixture containing 
0 4 mM acetyl coenzyme A, 0.1 |iCi of [dichloroacetyl-1.2-
14C)chloramphenicol, and 10-25 |ig of protein was incubated at 
37°C for 0.5^1,5 h. After extraction with ethyl acetate, the radioactive 
forms of chloramphenicol were resolved by thin-layer chromatogra­
phy Quantitation of acetylation ratios was obtained by Phosphorl-
mager (Molecular Dynamics) analysis. To normalize transfection effi­
ciencies, cells were cotransfected with 1 ng of plasmid pRcRSVlacZ. 
All the reported CAT activities were normalized to total protein and 
lacZ activity. The CAT assay values represent the means of at least 
three independent transfections. 
3. Results 
3.1. Analysis of COUP-TF 11 gene promoter region 
We isolated a phage clone containing the 5' end of the 
COUP-TF II gene and sequenced a 1.5 kb fragment that ex­
tended for 622 nucleotides upstream of the major transcrip­
tion initiation site (Fig. 1A). The transcription initiation sites 
were mapped by primer extension and RNase protection ana­
lyses (data not shown) using RNA isolated from embryonic 
day 11. 13, and 15 mouse embryos. Both methods demon­
strated the presence of several transcription start sites (Fig. 
1). The sequence of the 5'-proximal region contains several 
consensus TATA box sequences in the region where al! the 
transcription start sites are localized (Ftg. 1A). TATA box 
sequences in COUP-TF II promoter do not lie at typical dis­
tances (20-30 nucleotides) from start sites which is not an 
unusual situation. 
To determine the sequences that are essentia! for transcrip­
tion of mouse COUP-TF II gene, various portions of the 5'-
flanking region were fused to the bacterial chloramphenicol 
acetyltransferase (CAT) gene as a heterologous reporter gene. 
Reporter plasmids containing different fragments of the 
COUP-TF II gene 5' region (Fig. IB) were transiently trans-
fected into the mouse teratocarcinoma PCC7, mouse fibro­
blast 3T3, and human cervical carcinoma C33A cells. CAT 
assays demonstrated that COUP-TF II promoter CAT plas­
mids -4000/Bg/II, —1500/fig/II, —621/Bg/II, -WApaX, 
—25%IApa\. —2001A pa], and — 320/SariI have similar promo­
ter activity in all studied cell lines (Fig. IB). Deletion of addi­
tional 103 nucleotides (construct —97lApa\) resulted in 4-6-
fold reduction of promoter activity. Also, deletion of nucleo­
tides — 196 to —97 from —320IApa\ construct (plasmid AStyll 
Apal) resulted in 2-3-fold reduction of promoter activity. 
CAT constructs containing 40 bp promoter sequences (con­
structs —40/Saril and —40/Apa]) and first exon sequences 
(construct Sacll/Apal) showed almost no CAT activity. This 
deletion analysis demonstrated that the COUP-TF II basal 
promoter is localized in the 200 bp region 5' from the tran­
scription start site. 
3.2. All-trans retinoic acid and cAMP induce COUP-TF 11 
promoter activity in teratocarcinoma PCC7 cells and sup­
press it in C6 and U373 glioma cells 
Since COUP-TF II is involved in the modulation of retinoic 
acid responses and may function as a part of the regulatory 
loop, we analyzed the effect of all-trans RA on the activity of 
its promoter. Initially, we used teratocarcinoma PCC7 cells 
which have been shown to express all three RAR and RXR 
genes [31]. Also, RA treatment induces expression of all three 
RAR genes in these cells ([31] and our unpublished data). 
CAT assays following transient transfection by COUP-TF II 
promoter-CAT plasmids containing different fragments of 5' 
regulatory region (—4000/fig/lI, — 1500/Bg/lI, —621/£g/Il. 
—3201 Apal. —200/Apal. —9HApa\, —AQIApal. and Sorll/ 
Apal) demonstrated that RA treatment induces promoter ac­
tivity of all plasmids which contain more than 40 bp of the 
promoter region (Fig. 2). These CAT assay data suggest that 
RA response element(s) are localized in the —97 to —40 nu­
cleotide promoter region. Increased levels of cAMP have been 
shown to potentiate the effect of RA on neuronal differentia­
tion in teratocarcinoma cells (our unpublished data). Based on 
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-IOC *ty! GIOCOCTAAv - 'id 
TCGCCATQOCAACGTQCOCTAAQTnJCAQCAtTTCOTöatflC^tTTCACTATATAGAGAGCTC auti 
TCOCCATOGCAAOGTOCGCTAAiJTTOCAOCACTCQTft* rtCACTATATACACACCTC *Jt 2 
TCGCCÄTOQCAACGTOCGCTAJlffHQCai^tGTCOTCTCAAACTTCACTATATAGAGAGCTC *»t3 
tCOCCATOGCAACGTOCG - fcCTTCACTATATACJUiAGCTC *ut4 
I • control 
eg iA 
• «cAMP 
• RA-HIBCAMP 
u ii 
wUd type awl *roU Bul3 *at4 
Fig 3. Effects of mutations in CRE and HRE on mCOUP-TF 11 
promoter activity. (A) Nucleotide lequences of wild type and mu­
tated (mut 1, mut 2, mut 3, mut 4; changed nucleotides are in lower 
case) promoter regions. (B) Effect of all-zrom retinoic acid and di­
butyryl cAMP on wild type and mutated COUP-TF 11 promoter ac­
tivity in transient CAT assay using mouse embryo carcinoma PCO 
cells. The wild type -320/Apal CAT plasmid and mutated reporter 
plasmids, mut 1, mut 2, mut 3, and mut 4 were transfected into 
PCO cells and cells were treated with all-mvu RA (0.5 (iM), 
dBcAMP (1 mM) or combination of all-rra/u RA and dBcAMP. 
The data shown are representative of at least three independent ex­
periments. 
these observations, we also analyzed the effect of dibutyryl 
cAMP (dBcAMP) on COUP-TF II promoter activity in ter­
atocarcinoma PCC7 cells. The same promoter CAT constructs 
that responded to the RA treatment were also responsive to 
dBcAMP treatment (Fig. 2). This argues that cAMP response 
element(s) are localized in —97 to —40 bp region of COUP-
TF II promoter. Cotreatment of PCC7 cells with RA and 
dBcAMP stimulated COUP-TF II promoter activity about 
15-20-fold. 
Sequence analyses of —97 to —40 bp COUP-TF II promo­
ter region revealed a cAMP response element (CRE) and a 
possible consensus sequence for hormone response element 
(HRE) localized next to each other (Fig. 3). Mutations were 
introduced into these elements to assess their functionality 
(Fig. 3). COUP-TF II 320 bp promoter CAT plasmids 
(—320/Apal CAT) containing mutated CRE and HRE were 
transfected into PCC7 cells, and effects of RA and dBcAMP 
on promoter activity were analyzed. Surprisingly, mutations 
which destroyed HRE (mut 1 and mut 2) did not affect in-
ducibility of COUP-TF II promoter activity (Fig. 3). How­
ever, mutations in CRE (mut 3) or in both CRE and HRE 
together (mut 4) completely blocked the effect of dBcAMP on 
the inducibility of the promoter. These results argue that RA 
has an indirect effect on COUP-TF II promoter activity in 
PCC7 cells. Also, the additive effect of RA and dBcAMP 
suggests that RA and dBcAMP have different pathways to 
stimulate COUP-TF II promoter activity. 
To further explore the role of RA on COUP-TF II promo­
ter activity, we performed CAT assays using mouse fibroblast 
3T3, Tat glioblastoma C6, human glioblastoma U373, and 
human cervical carcinoma C33A cells. Treatment of 3T3 
and C33A cells with RA and dBcAMP did not affect the 
activity of COUP-TF II promoter constructs — 320IApa\ and 
—4000/Bg/Il (Fig. 4A,B). On the other hand, both RA and 
dBcAMP suppressed activity of COUP-TF II promoter con­
structs in C6 and U373 cells. 
3.3. COUP-TF 1 and COUP-TF 11 weakly inhibit RA induced 
COUP-TF 11 promoter activity in PCC7 cells 
Transcription factors COUP-TF 1 and COUP-TF II block 
the stimulatory effect of RA on transcription of several genes 
[24-27], Our data demonstrate that RA induces COUP-TF II 
promoter activity in PCC7 cells. We then asked whether 
COUP-TF I and COUP-TF U block the stimulatory effect 
of RA on COUP-TF II promoter activity. We cotransfected 
the -nOIApa] COUP-TF II CAT construct with COUP-TF I 
and COUP-TF II expression plasmids into PCC7 cells and 
analyzed CAT activities. As a positive control, we used a 
plasmid containing an RARß2 promoter lacZ construct 
(from A. Zimmer, NIH) that has been shown to be inducible 
with activated RARs and RXRs. CAT assays demonstrated 
that both COUP-TF I and COUP-TF II slightly suppress RA 
and dBcAMP induced COUP-TF II promoter activity (Fig. 
4C). By contrast, COUP-TF I and COUP-TF II completely 
inhibit the RA and dBcAMP induced RARß2 promoter ac­
tivity (Fig. 4C). This is an additional indication that RA does 
not directly regulate COUP-TF II promoter activity through 
activation of RAR/RXR complexes. 
4. Discussion 
The central issue addressed in this study is the transcrip­
tional regulation of the COUP-TF 11 gene. COUP-TF II gene 
is expressed in a complex spatio-temporal pattern during de­
velopment of several organ systems including nervous system 
[19-21,32]. This complex expression pattern argues for a dif­
ferent mechanisms of COUP-TF II gene regulation in differ­
ent cell types. Our data demonstrate that the effects of RA 
and dBcAMP on the COUP-TF II promoter activity are dif­
ferent or even opposite in different cell types Also, treatment 
of mouse embryos with aW-trans RA results in stimulation of 
COUP-TF II expression in the spinal cord and suppression of 
expression in the telencephalon [33J. Additionally, it has been 
demonstrated that expression of COUP-TF I and COUP-TF 
II is induced during neuronal differentiation of teratocarcino­
ma P19 cells [19,32] but not in several other teratocarcinomas 
(our unpublished data). Our data support the hypothesis that 
COUP-TF II gene expression is regulated differently in differ­
ent cell types and that the same stimuli may regulate its ex­
pression in opposite directions depending on the cell type. 
Analyses of COUP-TF II promoter activity localized the 
functional cAMP response element 74 nucleotides upstream 
from the major transcriptional start site. This CRE is respon­
sible for the stimulatory effect of dBcAMP in teratocarcinoma 
PCC7 cells. The suppressive effect of dBcAMP on COUP-TF 
II promoter activity in C6 and U373 cells is not mediated by 
the same CRE since mutation in this sequence or deletion of it 
does not change the response of COUP-TF II promoter to 
dBcAMP in these cells. Sequence analyses of COUP-TF II 
promoter also identified a possible HRE localized 68 nucleo­
tides from the major transcriptional start site. The sequence of 
this element does not correspond exactly to HRE, but con­
sidering the high variability of HRE sequences, it is possible 
that this sequence functions as a binding site for RARs or 
RXRs. Also, CAT assays mapped the RA response element to 
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and COUP-TF I and COUP-TF I] (C) on COUP-TF II promoter 
activity in CAT assay using mouse fibroblast (3T3), rat glioblastoma 
(C6), human glioblastoma (U373), human cervical carcinoma 
(C33A), and mouse teratocarcinoma (PCC7) cells. (A and B) Mouse 
COUP-TF II -4000/ÄyflI (A) and -320/Apal (B) CAT plasmids 
were transfected into 3T3, C6, U373, and C33A cells. Cells were 
treated with all-waiu RA (0.5 pM), dBcAMP (1 mM) or combina­
tion of all-frans RA and dBcAMP and CAT activities were meas­
ured. Left side scale represents CAT activity for 3T3, C6. and U373 
cells and right side scale for C33A cells. (C) Mouse COUP-TF II 
promoter reporter plasmids —4000/ßg/II, —3201 Apal and RARß-2-
lacZ reporter plasmid were cotransfected with expression plasmid 
pRcCMVneo without any cDNA (control and dBcAMP+RA) or 
containing mCOUF-TF I (dBcAMP+RA+COUP-TF I) or mCOUP-
TF II (dBcAMP+RA+COUP-TF II) cDNA into PCC7 cells. Cells 
were treated with all-franj RA (0.5 (lM) and dBcAMP (1 mM) and 
CAT and lacZ activities were measured. Left side scale represents 
CAT activity for —4000/fly/Il and -320//4paI constructs and right 
side scale represents lacZ activity for for RARß-2-tocZ construct. 
The data shown are representative of at least three independent ex­
periments. 
the region —97 to —40. The putative HRE localized 68 nu­
cleotides from the major start site is the only sequence that 
has certain homology to HRE in this region. Mutations in this 
HRE or deletion of this sequence do not affect inducibility of 
COUP-TF II promoter activity by RA. Also, coexpression of 
COUP-TF I or COUP-TF II, which completely blocks RA 
inducibility of RARß2 promoter activity, only slightly reduces 
RA inducibility of COUP-TF II promoter activity. These data 
suggest that the effect of RA on COUP-TF II promoter ac­
tivity is not directly mediated by the binding of RARs or 
RXRs to the response element, but is indirect. This hypothesis 
is supported by the data which demonstrate that the induction 
of the COUP-TF II gene expression by RA in teratocarcino­
ma P19 cells is a relatively slow process. Induction of COUP-
TF II gene expression occurs 24-40 h after treatment of P19 
cells with M-trans or 9-eis retinoic acid [19,34]. In contrast, 
induction of genes that are directly regulated by the RARs or 
RXRs, for example RARß and midkine [31,35,36], occurs in 
less than S h. 
Analyses of COUP-TF II promoter activity in different cell 
lines revealed that all-rranj RA either stimulates, suppresses 
or has no effect on transcription. These results suggest that 
COUP-TF II is involved at least in two different functions of 
retinoids. First, in cells where COUP-TF II promoter activity 
is stimulated by retinoids, it may function as a part of the 
negative feedback loop to suppress effects of retinoids. Sec­
ond, in cells where COUP-TF II promoter activity is sup­
pressed by retinoids, the retinoid response may be long last­
ing. At the same time, COUP-TF II may also be involved in 
timing the switches of retinoic acid mediated gene regulation. 
Detailed analyses of regulation of COUP-TF II expression in 
different cell types, and characterization of its role in cell type 
specific gene regulation are required to understand the logic of 
COUP-TF II functioning during development and in the adult 
organisms. 
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